0001757073-22-000061.txt : 20220504 0001757073-22-000061.hdr.sgml : 20220504 20220504163911 ACCESSION NUMBER: 0001757073-22-000061 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 96 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envista Holdings Corp CENTRAL INDEX KEY: 0001757073 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 832206728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39054 FILM NUMBER: 22892142 BUSINESS ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 BUSINESS PHONE: 714-516-7774 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 FORMER COMPANY: FORMER CONFORMED NAME: DH Dental Holding Corp. DATE OF NAME CHANGE: 20181025 10-Q 1 nvst-20220401.htm 10-Q nvst-20220401
false2022Q1--12-310001757073http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member0.047586200017570732022-01-012022-04-0100017570732022-04-29xbrli:shares00017570732022-04-01iso4217:USD00017570732021-12-31iso4217:USDxbrli:shares00017570732021-01-012021-04-020001757073us-gaap:CommonStockMember2021-12-310001757073us-gaap:AdditionalPaidInCapitalMember2021-12-310001757073us-gaap:RetainedEarningsMember2021-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001757073us-gaap:ParentMember2021-12-310001757073us-gaap:NoncontrollingInterestMember2021-12-3100017570732021-01-012021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2021-12-310001757073us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073us-gaap:ParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:CommonStockMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AdditionalPaidInCapitalMember2021-12-310001757073us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:ParentMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:NoncontrollingInterestMember2021-12-310001757073us-gaap:NoncontrollingInterestMember2022-01-012022-04-010001757073us-gaap:AdditionalPaidInCapitalMember2022-01-012022-04-010001757073us-gaap:ParentMember2022-01-012022-04-010001757073us-gaap:RetainedEarningsMember2022-01-012022-04-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-04-010001757073us-gaap:CommonStockMember2022-04-010001757073us-gaap:AdditionalPaidInCapitalMember2022-04-010001757073us-gaap:RetainedEarningsMember2022-04-010001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-010001757073us-gaap:ParentMember2022-04-010001757073us-gaap:NoncontrollingInterestMember2022-04-010001757073us-gaap:CommonStockMember2020-12-310001757073us-gaap:AdditionalPaidInCapitalMember2020-12-310001757073us-gaap:RetainedEarningsMember2020-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001757073us-gaap:ParentMember2020-12-310001757073us-gaap:NoncontrollingInterestMember2020-12-310001757073us-gaap:AdditionalPaidInCapitalMember2021-01-012021-04-020001757073us-gaap:ParentMember2021-01-012021-04-020001757073us-gaap:RetainedEarningsMember2021-01-012021-04-020001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-04-020001757073us-gaap:CommonStockMember2021-04-020001757073us-gaap:AdditionalPaidInCapitalMember2021-04-020001757073us-gaap:RetainedEarningsMember2021-04-020001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-020001757073us-gaap:ParentMember2021-04-020001757073us-gaap:NoncontrollingInterestMember2021-04-0200017570732020-12-3100017570732021-04-02nvst:segment0001757073us-gaap:ConvertibleDebtMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073nvst:PlamencaMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2021-12-310001757073nvst:PlamencaMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-01-012022-04-010001757073nvst:PlamencaMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-04-010001757073nvst:PlamencaMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2021-01-012021-04-020001757073us-gaap:LandAndLandImprovementsMember2022-04-010001757073us-gaap:LandAndLandImprovementsMember2021-12-310001757073us-gaap:BuildingAndBuildingImprovementsMember2022-04-010001757073us-gaap:BuildingAndBuildingImprovementsMember2021-12-310001757073us-gaap:MachineryAndEquipmentMember2022-04-010001757073us-gaap:MachineryAndEquipmentMember2021-12-310001757073us-gaap:ConstructionInProgressMember2022-04-010001757073us-gaap:ConstructionInProgressMember2021-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2021-12-310001757073nvst:EquipmentandConsumablesMember2021-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2022-01-012022-04-010001757073nvst:EquipmentandConsumablesMember2022-01-012022-04-010001757073nvst:SpecialtyProductsandTechnologiesMember2022-04-010001757073nvst:EquipmentandConsumablesMember2022-04-010001757073nvst:USTermLoanDue2024Member2019-09-200001757073nvst:EuroTermLoanDue2024Member2022-04-01iso4217:EUR0001757073us-gaap:InterestRateContractMemberus-gaap:NetInvestmentHedgingMember2022-04-010001757073us-gaap:InterestRateContractMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-04-010001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2022-04-010001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-04-010001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-04-010001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-04-010001757073us-gaap:InterestRateContractMemberus-gaap:NetInvestmentHedgingMember2021-04-020001757073us-gaap:InterestRateContractMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-04-020001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-04-020001757073us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-04-020001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2021-04-020001757073nvst:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-04-020001757073us-gaap:OtherNoncurrentAssetsMember2022-04-010001757073us-gaap:OtherNoncurrentAssetsMember2021-12-310001757073us-gaap:AccountsPayableAndAccruedLiabilitiesMember2022-04-010001757073us-gaap:AccountsPayableAndAccruedLiabilitiesMember2021-12-310001757073us-gaap:LongTermDebtMember2022-04-010001757073us-gaap:LongTermDebtMember2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel1Member2022-04-010001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel2Member2022-04-010001757073us-gaap:FairValueInputsLevel3Memberus-gaap:CurrencySwapMember2022-04-010001757073us-gaap:CurrencySwapMember2022-04-010001757073us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2022-04-010001757073us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2022-04-010001757073us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2022-04-010001757073us-gaap:InterestRateSwapMember2022-04-010001757073us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel1Member2022-04-010001757073us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel2Member2022-04-010001757073us-gaap:FairValueInputsLevel3Memberus-gaap:LiabilityMember2022-04-010001757073us-gaap:LiabilityMember2022-04-010001757073us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:CurrencySwapMember2021-12-310001757073us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:LiabilityMember2021-12-310001757073us-gaap:LiabilityMember2021-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CurrencySwapMember2022-04-010001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CurrencySwapMember2022-04-010001757073us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:InterestRateSwapMember2022-04-010001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:InterestRateSwapMember2022-04-010001757073us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-04-010001757073us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-04-010001757073us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001757073nvst:USTermLoanDue2024Member2022-04-010001757073nvst:USTermLoanDue2024Member2021-12-310001757073nvst:EuroTermLoanDue2024Member2021-12-310001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2020-05-210001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2022-04-010001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2021-12-310001757073us-gaap:OtherDebtSecuritiesMember2022-04-010001757073us-gaap:OtherDebtSecuritiesMember2021-12-3100017570732019-09-202019-09-200001757073nvst:USTermLoanDue2024Member2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2019-09-200001757073us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2021-02-092021-02-090001757073us-gaap:RevolvingCreditFacilityMember2019-09-202019-09-200001757073us-gaap:RevolvingCreditFacilityMember2021-06-152021-06-150001757073us-gaap:RevolvingCreditFacilityMember2021-06-15xbrli:pure0001757073us-gaap:RevolvingCreditFacilityMember2022-04-010001757073us-gaap:RevolvingCreditFacilityMemberus-gaap:StandbyLettersOfCreditMember2022-04-010001757073us-gaap:RevolvingCreditFacilityMember2021-12-310001757073srt:MinimumMembernvst:CreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-04-010001757073srt:MaximumMembernvst:CreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-04-010001757073srt:MinimumMemberus-gaap:BaseRateMember2022-01-012022-04-010001757073srt:MaximumMemberus-gaap:BaseRateMember2022-01-012022-04-010001757073srt:MinimumMember2022-01-012022-04-010001757073srt:MaximumMember2022-01-012022-04-010001757073nvst:USTermLoanDue2024Member2022-01-012022-04-010001757073nvst:USTermLoanDue2024Member2021-01-012021-12-310001757073nvst:EuroTermLoanDue2024Member2022-01-012022-04-010001757073nvst:EuroTermLoanDue2024Member2021-01-012021-12-310001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesOverAllotmentOptionMember2020-05-210001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2020-05-212020-05-210001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2021-04-020001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2021-01-012021-12-310001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2022-01-012022-04-01nvst:tradingDay0001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesMember2021-01-012021-04-020001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesCappedCallsMember2020-05-212020-05-210001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesCappedCallsMember2020-05-210001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-04-010001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-04-010001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-04-010001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-04-010001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-010001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-010001757073us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-04-020001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-04-020001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-04-020001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-04-020001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-020001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-020001757073srt:NorthAmericaMembernvst:SpecialtyProductsandTechnologiesMember2022-01-012022-04-010001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2022-01-012022-04-010001757073srt:NorthAmericaMember2022-01-012022-04-010001757073nvst:WesternEuropeMembernvst:SpecialtyProductsandTechnologiesMember2022-01-012022-04-010001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2022-01-012022-04-010001757073nvst:WesternEuropeMember2022-01-012022-04-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2022-01-012022-04-010001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2022-01-012022-04-010001757073nvst:OtherDevelopedMarketsMember2022-01-012022-04-010001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2022-01-012022-04-010001757073nvst:HighGrowthMarketsMembernvst:EquipmentandConsumablesMember2022-01-012022-04-010001757073nvst:HighGrowthMarketsMember2022-01-012022-04-010001757073srt:NorthAmericaMembernvst:SpecialtyProductsandTechnologiesMember2021-01-012021-04-020001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2021-01-012021-04-020001757073srt:NorthAmericaMember2021-01-012021-04-020001757073nvst:WesternEuropeMembernvst:SpecialtyProductsandTechnologiesMember2021-01-012021-04-020001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2021-01-012021-04-020001757073nvst:WesternEuropeMember2021-01-012021-04-020001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2021-01-012021-04-020001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2021-01-012021-04-020001757073nvst:OtherDevelopedMarketsMember2021-01-012021-04-020001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2021-01-012021-04-020001757073nvst:HighGrowthMarketsMembernvst:EquipmentandConsumablesMember2021-01-012021-04-020001757073nvst:HighGrowthMarketsMember2021-01-012021-04-020001757073nvst:SpecialtyProductsandTechnologiesMember2021-01-012021-04-020001757073nvst:EquipmentandConsumablesMember2021-01-012021-04-020001757073nvst:ConsumablesMember2022-01-012022-04-010001757073nvst:ConsumablesMember2021-01-012021-04-020001757073nvst:EquipmentSalesMember2022-01-012022-04-010001757073nvst:EquipmentSalesMember2021-01-012021-04-0200017570732022-04-022022-04-010001757073us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernvst:LargestCustomerMember2022-01-012022-04-010001757073us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernvst:LargestCustomerMember2021-01-012021-04-020001757073us-gaap:EmployeeSeveranceMember2021-12-310001757073us-gaap:FacilityClosingMember2021-12-310001757073us-gaap:EmployeeSeveranceMember2022-01-012022-04-010001757073us-gaap:FacilityClosingMember2022-01-012022-04-010001757073us-gaap:EmployeeSeveranceMember2022-04-010001757073us-gaap:FacilityClosingMember2022-04-010001757073us-gaap:AllOtherSegmentsMember2022-01-012022-04-010001757073us-gaap:AllOtherSegmentsMember2021-01-012021-04-020001757073us-gaap:CostOfSalesMember2022-01-012022-04-010001757073us-gaap:CostOfSalesMember2021-01-012021-04-020001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-04-010001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-04-020001757073us-gaap:StockCompensationPlanMember2022-01-012022-04-010001757073us-gaap:StockCompensationPlanMember2021-01-012021-04-020001757073us-gaap:OperatingSegmentsMembernvst:SpecialtyProductsandTechnologiesMember2022-01-012022-04-010001757073us-gaap:OperatingSegmentsMembernvst:SpecialtyProductsandTechnologiesMember2021-01-012021-04-020001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2022-01-012022-04-010001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2021-01-012021-04-020001757073us-gaap:CorporateNonSegmentMember2022-01-012022-04-010001757073us-gaap:CorporateNonSegmentMember2021-01-012021-04-020001757073us-gaap:OperatingSegmentsMembernvst:SpecialtyProductsandTechnologiesMember2022-04-010001757073us-gaap:OperatingSegmentsMembernvst:SpecialtyProductsandTechnologiesMember2021-12-310001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2022-04-010001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2021-12-310001757073us-gaap:MaterialReconcilingItemsMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-04-010001757073us-gaap:MaterialReconcilingItemsMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2021-12-310001757073us-gaap:CorporateNonSegmentMember2022-04-010001757073us-gaap:CorporateNonSegmentMember2021-12-310001757073nvst:CarestreamDentalTechnologyMemberus-gaap:SubsequentEventMember2022-04-202022-04-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________
FORM 10-Q
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2022
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from         to         
    
Commission File Number: 001-39054
nvst-20220401_g1.jpg
ENVISTA HOLDINGS CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware83-2206728
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
200 S. Kraemer Blvd., Building E92821-6208
Brea,California
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: 714-817-7000
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueNVSTNew York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.     Yes   ☒     No  ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).     Yes   ☒     No  ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer☒ Accelerated Filer☐
Non-accelerated Filer☐ Smaller Reporting company☐
Emerging Growth Company☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes   ☐     No  ☒
The number of shares of common stock outstanding as of April 29, 2022, was 162,617,557.



TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
PAGE
Item 1.
Item 2.
Item 3.
Item 4.
PART II. OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
($ in millions, except share amounts)
As of
April 1, 2022December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents$1,078.3 $1,073.6 
Trade accounts receivable, less allowance for credit losses of $20.3 and $20.7, respectively
342.6 331.9 
Inventories, net280.4 263.8 
Prepaid expenses and other current assets197.4 154.3 
Assets held for sale10.2 12.2 
Total current assets1,908.9 1,835.8 
Property, plant and equipment, net264.2 264.1 
Operating lease right-of-use assets127.0 128.1 
Other long-term assets174.9 167.8 
Goodwill3,090.5 3,132.0 
Other intangible assets, net1,006.8 1,046.4 
Total assets$6,572.3 $6,574.2 
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt$507.8 $432.4 
Trade accounts payable180.6 185.8 
Accrued expenses and other liabilities541.4 562.3 
Operating lease liabilities23.5 23.7 
Liabilities held for sale2.4 4.0 
Total current liabilities1,255.7 1,208.2 
Operating lease liabilities120.6 120.4 
Other long-term liabilities288.2 304.2 
Long-term debt876.9 883.4 
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at April 1, 2022 and December 31, 2021
— — 
Common stock - $0.01 par value, 500.0 million shares authorized;163.2 million shares issued and 162.6 million shares outstanding at April 1, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021
1.6 1.6 
Additional paid-in capital3,667.9 3,732.6 
Retained earnings563.2 466.9 
Accumulated other comprehensive loss(201.8)(143.5)
Total Envista stockholders’ equity4,030.9 4,057.6 
Noncontrolling interests— 0.4 
Total stockholders’ equity4,030.9 4,058.0 
Total liabilities and stockholders’ equity$6,572.3 $6,574.2 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
1

ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
($ and shares in millions, except per share amounts)
 Three Months Ended
 April 1, 2022April 2, 2021
Sales$631.4 $612.6 
Cost of sales257.3 254.2 
Gross profit374.1 358.4 
Operating expenses:
Selling, general and administrative258.2 237.5 
Research and development24.4 25.8 
Operating profit91.5 95.1 
Nonoperating income (expense):
Other income0.3 0.3 
Interest expense, net(5.9)(18.0)
Income before income taxes85.9 77.4 
Income tax expense15.5 15.6 
Income from continuing operations, net of tax 70.4 61.8 
Income from discontinued operations, net of tax (refer to Note 2)4.5 9.9 
Net income$74.9 $71.7 
Earnings per share:
Earnings from continuing operations - basic$0.43 $0.39 
Earnings from continuing operations - diluted$0.39 $0.35 
Earnings from discontinued operations - basic$0.03 $0.06 
Earnings from discontinued operations - diluted$0.03 $0.06 
Earnings - basic$0.46 $0.45 
Earnings - diluted$0.42 $0.41 
Average common stock and common equivalent shares outstanding:
Basic162.2 160.5 
Diluted179.8 175.9 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
2

ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
($ in millions)
Three Months Ended
April 1, 2022April 2, 2021
Net income$74.9 $71.7 
Other comprehensive (loss) income, net of income taxes:
Foreign currency translation adjustments(59.6)(53.7)
Cash flow hedge adjustments1.4 1.4 
Pension plan adjustments(0.1)0.2 
Total other comprehensive loss, net of income taxes(58.3)(52.1)
Comprehensive income $16.6 $19.6 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
3


ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited)
 ($ in millions)
Three Months Ended April 1, 2022
Common StockAdditional Paid-in CapitalRetained EarningsAccumulated Other
Comprehensive Loss		Total
Envista
Equity		Noncontrolling Interests
Balance, December 31, 2021$1.6 $3,732.6 $466.9 $(143.5)$4,057.6 $0.4 
Cumulative effect of adjustment related to change in accounting principle. See Notes 1 and 12— (77.8)21.4 — (56.4)— 
Balance, January 1, 20221.6 3,654.8 488.3 (143.5)4,001.2 0.4 
Change in noncontrolling interest— — — — — (0.4)
Common stock-based award activity— 13.1 — — 13.1 — 
Net income— — 74.9 — 74.9 — 
Other comprehensive loss— — — (58.3)(58.3)— 
Balance, April 1, 2022$1.6 $3,667.9 $563.2 $(201.8)$4,030.9 $— 

Three Months Ended April 2, 2021
Common StockAdditional Paid-in CapitalRetained EarningsAccumulated Other
Comprehensive Loss		Total
Envista
Equity		Noncontrolling Interests
Balance, December 31, 2020$1.6 $3,684.4 $126.4 $(91.8)$3,720.6 $0.4 
Common stock-based award activity— 6.7 — — 6.7 — 
Net income— — 71.7 — 71.7 — 
Other comprehensive loss— — — (52.1)(52.1)— 
Balance, April 2, 2021$1.6 $3,691.1 $198.1 $(143.9)$3,746.9 $0.4 
See the accompanying Notes to the Condensed Consolidated Financial Statements.

4

ENVISTA HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
($ in millions)
 Three Months Ended
 April 1, 2022April 2, 2021
Cash flows from operating activities:
Net income $74.9 $71.7 
Noncash items:
Depreciation7.8 10.3 
Amortization23.5 21.0 
Allowance for credit losses1.7 2.9 
Stock-based compensation expense7.5 6.4 
Gain on sale of Kavo treatment unit and instrument business(6.0)— 
Restructuring charges(1.9)— 
Impairment charges3.9 1.9 
Amortization of right-of-use assets6.4 7.2 
Amortization of debt discount and issuance costs1.0 6.2 
Change in trade accounts receivable(16.2)(5.1)
Change in inventories(20.3)(20.4)
Change in trade accounts payable(2.5)(27.6)
Change in prepaid expenses and other assets(16.8)(7.9)
Change in accrued expenses and other liabilities(51.5)(37.9)
Change in operating lease liabilities(8.0)(12.1)
Net cash provided by operating activities3.5 16.6 
Cash flows from investing activities:
Payments for additions to property, plant and equipment(19.8)(8.3)
Proceeds from sale of Kavo treatment unit and instrument business30.0 — 
All other investing activities, net(5.1)2.8 
Net cash provided by (used in) investing activities5.1 (5.5)
Cash flows from financing activities:
Payment of debt issuance and other deferred financing costs— (0.4)
Proceeds from borrowings0.3 — 
Repayment of borrowings(0.5)(475.5)
Proceeds from stock option exercises13.1 5.3 
Tax withholding payment related to net settlement of equity awards(7.6)(5.2)
All other financing activities— 6.2 
Net cash provided by (used in) financing activities5.3 (469.6)
Effect of exchange rate changes on cash and cash equivalents(9.2)10.8 
Net change in cash and cash equivalents4.7 (447.7)
Beginning balance of cash and cash equivalents1,073.6 888.9 
Ending balance of cash and cash equivalents$1,078.3 $441.2 
Supplemental data:
Cash paid for interest$2.8 $10.5 
Cash paid for taxes$14.1 $5.7 
ROU assets obtained in exchange for operating lease obligations$7.1 $2.6 
See the accompanying Notes to the Condensed Consolidated Financial Statements.
5

ENVISTA HOLDINGS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
NOTE 1. BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.

The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of April 1, 2022 and December 31, 2021, and its results of operations and cash flows for the three month periods ended April 1, 2022 and April 2, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.

As discussed in Note 2, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

During the first quarter of 2022, the Company continued to see positive signs of recovery in certain markets in which it operates, however, certain markets continue to be more adversely impacted than others. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted the Company’s operations in China. The extent to which these restrictions continue and the possible geographical expansion of these restrictions will depend upon the Chinese authorities’ response to the affected regions of China.

6

The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on the Company's customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, the ability of the Company to continue to manufacture and source its products and to find suitable alternative products at reasonable prices, the Company’s ability to continue to ship and deliver its products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on the Company’s ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can resume, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, the Company may continue to experience materially adverse impacts on the Company’s financial condition and results of operations.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including by impacting the Company’s ability to market and sell products in Russia, by impacting its ability to enforce its intellectual property rights in Russia, by creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

Accounting Standards Recently Adopted

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Condensed Consolidated Financial Statements.

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.

The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 12 for a further discussion of the impact of adopting ASU 2020-06.

7

Accounting Standards Not Yet Adopted

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform, if certain criteria are met. The ASU is effective for public entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. If an entity elects to apply any of the amendments for an eligible hedging relationship existing as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of that interim period and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable). If an entity elects to apply any of the amendments for a new hedging relationship entered into as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of the hedging relationship and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable).

The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company has not yet completed its assessment of the impact of the new standard on the Company’s Condensed Consolidated Financial Statements.

NOTE 2. DISCONTINUED OPERATIONS
On December 31, 2021, the Company completed the sale of substantially all of KaVo Treatment Units and Instruments Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, the Company received cash consideration of $317.3 million upon closing, which remains subject to certain adjustments.

The Company recognized a gain of $4.6 million on the Divestiture during the three months ended April 1, 2022 primarily due to the recognition of certain purchase price adjustments. In addition, the Company received an earnout payment of $30.0 million in the first quarter of 2022.

On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") will be deferred until the purchaser has formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement can be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture. The Company recognized a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions as of April 1, 2022, and December 31, 2021. The Company will recognize the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. As of April 1, 2022, none of the Relevant Jurisdictions had closed. The Relevant Jurisdictions are expected to close at various points throughout 2022.

In conjunction with the Divestiture, the Company entered into a customary transition services agreement, which requires support transition services to Planmeca throughout the applicable transition period.

For the three months ended April 1, 2022 the Divestiture continued to meet the criteria to be classified as held for sale and to be presented as a discontinued operation. Accordingly, the Company reclassified the results of operations and financial position of the Divestiture to discontinued operations in its accompanying Condensed Consolidated Statements of Income and Condensed Consolidated Balance Sheets for all periods presented. The Company’s Condensed Consolidated Statements of Cash Flows for all periods presented include the financial results of the KaVo Treatment Unit and Instruments Business.
For the three months ended April 2, 2021, balances represent activity for the entire Divestiture, while balances for the three month ended April 1, 2022, represent activity for the remaining Relevant Jurisdictions.

8



The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):

As of
April 1, 2022December 31, 2021
ASSETS
Current assets:
Assets for relevant jurisdictions$10.2 $12.2 
Current assets held for sale$10.2 $12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for relevant jurisdictions$2.4 $4.0 
Current liabilities held for sale$2.4 $4.0 

The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions):
 Three Months Ended
 April 1, 2022April 2, 2021
Sales$6.9 $96.6 
Cost of sales5.9 57.7 
Gross profit1.0 38.9 
Operating expenses:
Selling, general and administrative1.1 21.3 
Research and development— 4.4 
Operating (loss) profit(0.1)13.2 
Income tax (benefit) expense— 3.3 
(Loss) income from discontinued operations(0.1)9.9 
Gain on sale of discontinued operations, net of tax4.6 — 
Net income from discontinued operations$4.5 $9.9 

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Cash flows from operating activities
Depreciation and amortization1
$— $2.1 
Cash flows from investing activities:
Capital expenditures$— $0.9 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.

NOTE 3. CREDIT LOSSES

The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.

9

Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors.

The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required.

The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation0.2 
Provision for credit losses1.7 
Write-offs charged against the allowance(1.6)
Recoveries(0.7)
Balance at April 1, 2022$20.3 

NOTE 4. INVENTORIES
The classes of inventory are summarized as follows ($ in millions):
April 1, 2022December 31, 2021
Finished goods$228.0 $214.3 
Work in process23.5 22.0 
Raw materials87.5 88.3 
Reserve for inventory obsolescence(58.6)(60.8)
Total$280.4 $263.8 

NOTE 5. PROPERTY, PLANT AND EQUIPMENT
The classes of property, plant and equipment are summarized as follows ($ in millions):
April 1, 2022December 31, 2021
Land and improvements$10.7 $10.7 
Buildings and improvements161.1 168.7 
Machinery, equipment and other assets360.1 354.5 
Construction in progress48.9 45.6 
Gross property, plant and equipment580.8 579.5 
Less: accumulated depreciation(316.6)(315.4)
Property, plant and equipment, net$264.2 $264.1 

10

NOTE 6. GOODWILL
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance at December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Foreign currency translation(33.0)(8.5)(41.5)
Balance at April 1, 2022$1,996.7 $1,093.8 $3,090.5 

NOTE 7. ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities were as follows ($ in millions):
April 1, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$140.8 $19.6 $188.9 $17.9 
Restructuring-related employee severance, benefits and other14.0 — 21.9 — 
Pension benefits5.6 40.1 5.6 41.7 
Taxes, income and other48.3 184.4 48.1 201.4 
Contract liabilities73.3 5.7 60.1 5.1 
Sales and product allowances63.7 1.5 75.4 1.2 
Loss contingencies10.1 30.9 8.4 30.3 
Derivative financial instruments0.4 — 19.6 — 
Other185.2 6.0 134.3 6.6 
Total$541.4 $288.2 $562.3 $304.2 

NOTE 8.  HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintains cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively convert the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offsets the impact of changes in currency rates on foreign currency denominated net investments. The changes in the fair value of these instruments are recorded in accumulated other comprehensive loss in equity, in the accompanying Condensed Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss as reflected in Note 13. Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps is recorded in interest expense, net in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. These instruments mature in September 2024.

11

The Company also has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Condensed Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 13). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 12 for a further discussion of the above loan facilities.
The Company uses interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchange interest payments based on variable rates for interest payments based on fixed rates. The changes in the fair value of these instruments are recorded in accumulated other comprehensive loss in equity (see Note 13). Any ineffective portions of the cash flow hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps is recorded in interest expense in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. The current outstanding interest rate swap matures in September 2022.
The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):

Notional AmountGain Recognized in OCI
Three Months Ended April 1, 2022
Interest rate contract$250.0 $1.8 
Foreign currency contracts650.0 17.9 
Foreign currency denominated debt229.7 6.8 
Total$1,129.7 $26.5 
Notional AmountGain Recognized in OCI
Three Months Ended April 2, 2021
Interest rate contracts$450.0 $1.8 
Foreign currency contracts650.0 25.6 
Foreign currency denominated debt244.7 16.2 
Total$1,344.7 $43.6 

Gains or losses related to the foreign currency contracts and foreign currency denominated debt are classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 13, as these items are attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts are classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 13. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the three months ended April 1, 2022 and April 2, 2021. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the three months ended April 1, 2022 and April 2, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Condensed Consolidated Statements of Cash Flows.

12

The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):
April 1, 2022December 31, 2021
Derivative Assets:
Other long-term assets$0.9 $— 
Derivative liabilities:
Accrued expenses and other liabilities$0.4 $19.6 
Nonderivative hedging instruments:
Long-term debt$229.7 $236.5 
Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.

NOTE 9. FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
April 1, 2022:
Assets:
Cross-currency swap derivative contracts$— $0.9 $— $0.9 
Liabilities:
Interest rate swap derivative contracts$— $0.4 $— $0.4 
Deferred compensation plans$— $17.9 $— $17.9 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
13

Derivative Instruments
The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. The interest rate swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and forward curves as inputs. Refer to Note 8 for additional information.
Deferred Compensation Plans
Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Condensed Consolidated Balance Sheets (refer to Note 7). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
April 1, 2022December 31, 2021
 Carrying AmountFair ValueCarrying AmountFair Value
Assets:
Cross-currency swap derivative contracts$0.9 $0.9 $— $— 
Liabilities:
Interest rate swap derivative contracts$0.4 $0.4 $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$507.8 $1,213.8 $432.1 $1,162.5 
Long-term debt$876.9 $876.9 $883.4 $883.4 
The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on April 1, 2022 and December 31, 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.

NOTE 10. WARRANTY
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
14

The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year4.2 
Settlements made(3.7)
Effect of foreign currency translation(0.1)
Balance at April 1, 2022$9.8 

NOTE 11. LITIGATION AND CONTINGENCIES
The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated.

The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $41.0 million and $38.7 million as of April 1, 2022 and December 31, 2021, respectively, which are included in accrued liabilities in the Condensed Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Condensed Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.

NOTE 12. DEBT AND CREDIT FACILITIES
The components of the Company’s debt were as follows ($ in millions):
April 1, 2022December 31, 2021
Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $2.4 and $2.7, respectively
$647.6 $647.3 
Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.4 and $0.5, respectively
229.3 236.1 
Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $9.7 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively
507.8 432.1 
Other— 0.3 
Total debt1,384.7 1,315.8 
Less: current portion(507.8)(432.4)
Long-term debt$876.9 $883.4 
As of April 1, 2022 unamortized debt issuance costs totaled $12.5 million. As of December 31, 2021 unamortized debt issuance costs and discount totaled $88.6 million. Unamortized debt issuance costs and discount have been netted against their respective aggregate principal amounts of the related debt in the table above, and are being amortized to interest expense over the term of the respective debt.
15

Long-Term Indebtedness
Credit Agreement
On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan Facility and the three-year €600.0 million Euro Term Loan Facility (together with the Term Loan Facility, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (the “Revolving Credit Facility” and together with the Term Loans, the “Senior Credit Facilities”). Pursuant to the Separation Agreement, all of the net proceeds of the Term Loans were paid to Danaher as partial consideration for the Dental business Danaher transferred to Envista.

On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan Facility.

On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks including Bank of America, N.A. as administrative agent (the “Administrative Agent”). The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the Revolving Credit Facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the Revolving Credit Facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the Revolving Credit Facility and the Term Loan Facility has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

The Revolving Credit Facility includes an aggregate principal amount of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit. The Revolving Credit Facility can be used for working capital and other general corporate purposes. As of April 1, 2022 and December 31, 2021, there were no borrowings outstanding under the Revolving Credit Facility.
Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the Revolving Credit Facility, whether drawn or not.
16

The interest rates for borrowings under the Term Loan Facility were 1.34% and 1.25% as of April 1, 2022 and December 31, 2021, respectively. The interest rate for borrowings under the Euro Term Loan Facility was 0.95% as of April 1, 2022 and December 31, 2021. Interest is payable quarterly for the Term Loans. The Company has entered into interest rate swap derivative contracts for the Term Loan Facility, as further discussed in Note 8. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of April 1, 2022.
Convertible Senior Notes (the “Notes”)

On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.

Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.

Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, as discussed in Note 1, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs.

As of April 1, 2022, the unamortized debt issuance costs on the Notes was $9.7 million and is being amortized over the term of the Notes.

The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.

17

Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of April 1, 2022 and December 31, 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended April 1, 2022 and December 31, 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt.

The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption.

The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Three Months Ended
April 1, 2022April 2, 2021
Contractual interest expense
$3.1 $3.1 
Amortization of debt issuance costs
0.7 0.5 
Amortization of debt discount
— 4.6 
Total interest expense
$3.8 $8.2 

For the three months ended April 1, 2022, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0%, to interest expense over the term of the Notes.

As of April 1, 2022 and December 31, 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $667.0 million and $592.1 million, respectively.

Capped Call Transactions

In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.



18

NOTE 13. ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended April 1, 2022
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive (loss) income before reclassifications:
(Decrease) increase(53.8)1.8 — (52.0)
Income tax impact(5.8)(0.4)— (6.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(59.6)1.4 — (58.2)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.2)(0.2)
Income tax impact— — 0.1 0.1 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive (loss) income, net of income taxes(59.6)1.4 (0.1)(58.3)
Balance, April 1, 2022$(199.2)$(0.3)$(2.3)$(201.8)
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended April 2, 2021
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive loss before reclassifications:
(Decrease) increase(43.4)1.8 — (41.6)
Income tax impact(10.3)(0.4)— (10.7)
Other comprehensive (loss) income before reclassifications, net of income taxes(53.7)1.4 — (52.3)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — 0.2 0.2 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — 0.2 0.2 
Net current period other comprehensive (loss) income, net of income taxes(53.7)1.4 0.2 (52.1)
Balance, April 2, 2021$(116.2)$(4.9)$(22.8)$(143.9)


19

NOTE 14. REVENUE
The following table presents the Company’s revenues disaggregated by geographical region for the three months ended April 1, 2022 and April 2, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Three Months Ended April 1, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$179.3 $156.3 $335.6 
Western Europe106.3 32.0 138.3 
Other developed markets24.4 10.3 34.7 
Emerging markets87.1 35.7 122.8 
Total$397.1 $234.3 $631.4 

Three Months Ended April 2, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$162.6 $164.7 $327.3 
Western Europe94.7 31.0 125.7 
Other developed markets25.5 10.3 35.8 
Emerging markets83.5 40.3 123.8 
Total$366.3 $246.3 $612.6 

Sales by Major Product Group:
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Consumables$529.9 $514.0 
Equipment101.5 98.6 
Total$631.4 $612.6 
Remaining Performance Obligations
Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.
As of April 1, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $35.5 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.
20

Contract Liabilities
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of April 1, 2022 and December 31, 2021, the contract liabilities were $79.0 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Revenue recognized during the three months ended April 1, 2022 that was included in the contract liability balance at December 31, 2021 was $24.8 million. Revenue recognized during the three months ended April 2, 2021 that was included in the contract liability balance at December 31, 2020 was $18.9 million.
Significant Customers
Sales to the Company’s largest customer were 10% and 13% of sales for the three months ended April 1, 2022 and April 2, 2021, respectively. No other individual customer accounted for more than 10% of sales for the three months ended April 1, 2022 and April 2, 2021, respectively.

Seasonality

Based on historical experience, the Company generally has more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, the Company generally has more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in the Equipment & Consumables segment. As a result of this seasonality in sales, profitability in the Equipment & Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future and the ongoing COVID-19 pandemic may impact these trends.

NOTE 15. RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS
Restructuring Activities
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, either in the normal course of business or pursuant to significant restructuring programs.
The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 $21.9 
Costs incurred(0.8)0.3 (0.5)
Paid/settled(7.0)(0.4)(7.4)
Balance, April 1, 2022$13.6 $0.4 $14.0 

Restructuring related charges recorded for the three months ended April 1, 2022 and April 2, 2021, by segment were as follows ($ in millions): 
Three Months Ended
April 1, 2022April 2, 2021
Specialty Products & Technologies$4.0 $3.4 
Equipment & Consumables(0.9)1.9 
Other0.6 2.5 
Total$3.7 $7.8 
21

The restructuring related charges incurred during the three months ended April 1, 2022 and April 2, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Cost of sales$(0.3)$2.9 
Selling, general and administrative expenses4.0 4.9 
Total$3.7 $7.8 

NOTE 16. INCOME TAXES
The Company’s effective tax rates from continuing operations of 18.0% and 20.2% for the three months ended April 1, 2022 and April 2, 2021, respectively, differ from the U.S. federal statutory rate of 21.0%, primarily due to the Company’s geographical mix of earnings and net discrete tax benefits.

NOTE 17.  EARNINGS PER SHARE
Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares in the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the three months ended April 1, 2022 and April 2, 2021.

In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 12), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.

22

The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Three Months Ended
April 1, 2022April 2, 2021
Numerator:
Income from continuing operations, net of tax$70.4 $61.8 
Income from discontinued operations, net of tax$4.5 $9.9 
Net income $74.9 $71.7 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share162.2 160.5 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units4.2 4.4 
Assumed conversion of the Notes13.4 11.0 
Weighted average common shares outstanding used in diluted earnings (loss) per share179.8 175.9 
Earnings per share:
Earnings from continuing operations - basic$0.43 $0.39 
Earnings from continuing operations - diluted$0.39 $0.35 
Earnings from discontinued operations - basic$0.03 $0.06 
Earnings from discontinued operations - diluted$0.03 $0.06 
Earnings - basic$0.46 $0.45 
Earnings - diluted$0.42 $0.41 

The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Three Months Ended
April 1, 2022April 2, 2021
Stock-based awards0.6 0.6 
Total0.6 0.6 

NOTE 18. SEGMENT INFORMATION
The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense) and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.

The Company’s Specialty Products & Technologies products include implants, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

23

On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment & Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 2 for more information on the Company’s discontinued operations.

Segment related information is shown below ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Sales:
Specialty Products & Technologies$397.1 $366.5 
Equipment & Consumables234.3 246.1 
Total$631.4 $612.6 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$70.3 $78.4 
Equipment & Consumables45.5 45.0 
Other(24.3)(28.3)
Operating profit91.5 95.1 
Nonoperating income (expense):
   Other income0.3 0.3 
   Interest expense, net(5.9)(18.0)
Income before taxes from continuing operations$85.9 $77.4 
Identifiable assets:April 1, 2022December 31, 2021
Specialty Products & Technologies$3,418.8 $3,498.2 
Equipment & Consumables2,005.0 1,946.1 
Held for Sale10.2 12.2 
Other1,138.3 1,117.7 
Total$6,572.3 $6,574.2 
NOTE 19. SUBSEQUENT EVENT
On April 20, 2022, the Company completed its purchase of Carestream Dental Technology Parent Limited’s (“Carestream”) intraoral scanner business for total consideration of approximately $582.5 million, subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021. The Company has purchased the intraoral scanner business through the acquisition of certain assets and the assumption of certain liabilities, as well as the acquisition of the equity of certain subsidiaries of Carestream.


24

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with other information, including our Condensed Consolidated Financial Statements and related notes included in Part I, Item 1, Financial Information, of this Quarterly Report on Form 10-Q, our consolidated and combined financial statements appearing in our Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 10-K”), and Part II, Item 1A, Risk Factors, of this Quarterly Report on Form 10-Q. Unless the context otherwise requires, all references herein to the “Company,” “we,” “us” or “our,” or similar terms, refer to Envista Holdings Corporation and its consolidated subsidiaries.

Certain statements included or incorporated by reference in this Quarterly Report are “forward-looking statements” within the meaning of the U.S. federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: the potential impacts of the COVID-19 pandemic on our business, financial condition, and results of operations; projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spin-offs, split-offs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; future regulatory approvals and the timing thereof; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Envista intends or believes will or may occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,” “estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, the following: the impact of the COVID-19 pandemic, including new variants of the virus, the pace of recovery in the markets in which we operate, global supply chain disruptions and potential staffing shortages, the conditions in the U.S. and global economy, the markets served by us and the financial markets, the impact of our debt obligations on our operations and liquidity, developments and uncertainties in trade policies and regulations, contractions or growth rates and cyclicality of markets we serve, fluctuations in inventory of our distributors and customers, loss of a key distributor, our relationships with and the performance of our channel partners, competition, our ability to develop and successfully market new products and services, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, penalties associated with any off-label marketing of our products, modifications to our products that require new marketing clearances or authorizations, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures, security breaches or other disruptions of our information technology systems or violations of data privacy laws, our ability to adequately protect our intellectual property, the impact of our restructuring activities on our ability to grow, risks relating to currency exchange rates, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, risks relating to product, service or software defects, risks relating to product manufacturing, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole or limited sources of supply, the impact of regulation on demand for our products and services, labor matters, international economic, political, legal, compliance and business factors and disruptions relating to war, terrorism, climate change, widespread protests and civil unrest, man-made and natural disasters, public health issues and other events, and other risks and uncertainties set forth under “Item 1A. Risk Factors” in the 2021 10-K and this Quarterly Report on Form 10-Q.

Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Forward-looking statements contained herein speak only as of the date of this Quarterly Report. Except to the extent required by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

25

BASIS OF PRESENTATION
The accompanying Condensed Consolidated Financial Statements present our historical financial position, results of operations, changes in stockholders’ equity and cash flows in accordance with GAAP.
Sale of the KaVo Treatment Unit and Instrument Business
On December 31, 2021, we completed the Divestiture to Planmeca, pursuant to the Purchase Agreement among us, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, we received cash consideration of $317.3 million upon closing, which remains subject to certain adjustments. We received the earnout payment of $30.0 million in the first quarter of 2022. We also recognized a gain of $4.6 million on the Divestiture during the three months ended April 1, 2022 due primarily to the recognition of certain purchase price adjustments.
The Divestiture was part of our strategy to structurally improve our long-term margins and represents a strategic shift with a major effect on our operations and financial results as described in ASC 205-20. The sale met the criteria to be accounted for as a discontinued operation. Accordingly, we have applied discontinued operations treatment for the Divestiture as required by ASC 205-20. In accordance with ASC 205-20, we reclassified the Divestiture to assets and liabilities held for sale on our Condensed Consolidated Balance Sheets as of April 1, 2022 and December 31, 2021 and reclassified the financial results of the Divestiture in our Condensed Consolidated Statements of Income for all periods presented. Our Condensed Consolidated Statements of Cash Flows for the three months ended April 1, 2022 and April 2, 2021 include the financial results of the KaVo Treatment Unit and Instrument Business. We also revised our discussion and presentation of operating and financial results to be reflective of our continuing operations as required by ASC 205-20. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

With the sale of the KaVo Treatment Unit and Instrument business, we continue to make significant progress toward our long-term goal of re-calibrating our product portfolio to higher growth and higher margin segments. The Divestiture shifts our revenue mix from approximately 50% each for the Specialty Products & Technology and Equipment & Consumables segments to approximately 60% for the Specialty Products & Technology segment and approximately 40% for the Equipment & Consumables segment. The Specialty Products & Technology segment is a higher growth and higher margin business than the Equipment & Consumables segment. The Divestiture is a strategic shift that will allow us to focus more on higher value and higher margin consumables, imaging, and digital workflow solutions.

OVERVIEW
General
We provide products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. With leading brand names, innovative technology and significant market positions, we are a leading worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services, and are dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. Our research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 30 countries across North America, Asia, Europe, the Middle East and Latin America.
We operate in two business segments: Specialty Products & Technologies and Equipment & Consumables. Our Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
26

For the three months ended April 1, 2022, sales derived from customers outside of the United States were 51.2%, compared to the three months ended April 2, 2021 of 50.5%. As a global provider of dental consumables, equipment and services, our operations are affected by worldwide, regional and industry-specific economic and political factors. Given the broad range of dental products, software and services provided and geographies served, we do not use any indices other than general economic trends to predict our overall outlook. Our individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and the outlook for the future.
As a result of our geographic and product line diversity, we face a variety of opportunities and challenges, including rapid technological development in most of our served markets, the expansion and evolution of opportunities in emerging markets, trends and costs associated with a global labor force, consolidation of our competitors and increasing regulation. We operate in a highly competitive business environment in most markets, and our long-term growth and profitability will depend in particular on our ability to expand our business in emerging geographies and market segments, identify, consummate and integrate appropriate acquisitions, develop innovative and differentiated new products and services, expand and improve the effectiveness of our sales force, continue to reduce costs and improve operating efficiency and quality and effectively address the demands of an increasingly regulated global environment. We are making significant investments to address the rapid pace of technological change in our served markets and to globalize our manufacturing, research and development and customer-facing resources (particularly in emerging markets and our dental implant business) in order to be responsive to our customers throughout the world and improve the efficiency of our operations.

Key Trends and Conditions Affecting Our Results of Operations
There have been no material changes to the key trends and conditions affecting our results of operations that were disclosed in our 2021 10-K.

COVID-19

The extent of the impact of the COVID-19 pandemic on our business is highly uncertain and difficult to predict because of the dynamic and evolving nature of the crisis. During the first quarter of 2022, we continued to see positive signs of recovery in certain markets in which we operate, however, certain markets continue to be more adversely impacted than others. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted our operations in China. The extent to which these restrictions continue and the possible geographical expansion of these restrictions will depend upon the Chinese authorities’ response to the affected regions of China.

The severity of the impact of the COVID-19 pandemic on our business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on our customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, our ability to continue to manufacture and source our products and to find suitable alternative products at reasonable prices, our ability to continue to ship and deliver our products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on our ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can continue, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, we may continue to experience materially adverse impacts on our financial condition and results of operations.

For additional information on the risks of COVID-19 to our business, please refer to the “Item 1A. Risk Factors—Risks Related to COVID-19” section of our 2021 Annual Report on Form 10-K.

Russia-Ukraine Conflict
Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our business, including our ability to market and sell products in Russia, impacting our ability to enforce our intellectual property rights in Russia, creating disruptions in the global supply chain, and potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise. Russia’s invasion of Ukraine did not have a material impact on our financial position or results of operations as of and for the three months ended April 1, 2022.

27

Foreign Currency Exchange Rates
On a period-over-period basis, currency exchange rates negatively impacted reported sales by 2.3% for the three months ended April 1, 2022, compared to the comparable period of 2021, primarily due to the strength of the U.S. dollar against most major currencies. Any future strengthening of the U.S. dollar against major currencies would negatively impact our sales and results of operations for the remainder of the year, and any weakening of the U.S. dollar against major currencies would positively impact our sales and results of operations for the remainder of the year.

Envista Business Systems
Throughout this discussion, references to sales volume refer to the impact of both price and unit sales and references to productivity improvements generally refer to improved cost-efficiencies resulting from the ongoing application of Envista Business Systems (“EBS”). We believe our deep-rooted commitment to EBS helps drive our market leadership and differentiates us in the dental products industry. EBS encompasses not only lean tools and processes, but also methods for driving growth, innovation and leadership. Within the EBS framework, we pursue a number of ongoing strategic initiatives relating to customer insight generation, product development and commercialization, efficient sourcing, and improvement in manufacturing and back-office support, all with a focus on continually improving quality, delivery, cost, growth and innovation.
Non-GAAP Measures
References to the non-GAAP measure of core sales (also referred to as core revenues or sales/revenues from existing businesses) refer to sales calculated according to GAAP, but excluding:
•sales from acquired businesses for one year from the acquisition date;
•sales from discontinued products; and
•the impact of currency translation.
Sales from discontinued products includes major brands or major products that we have made the decision to discontinue as part of a portfolio restructuring. Discontinued brands or products consist of those which we (1) are no longer manufacturing, (2) are no longer investing in the research or development of, and (3) expect to discontinue all significant sales of within one year from the decision date. The portion of sales attributable to discontinued brands or products is calculated as the net decline of the applicable discontinued brand or product from period-to-period.
The portion of sales attributable to currency translation is calculated as the difference between:
•the period-to-period change in sales; and
•the period-to-period change in sales after applying current period foreign exchange rates to the prior year period.
Core sales growth should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies. We believe that reporting the non-GAAP financial measure of core sales growth provides useful information to investors by helping identify underlying growth trends in our on-going business and facilitating comparisons of our sales performance with our performance in prior and future periods and to our peers. We also use core sales growth to measure our operating and financial performance. We exclude sales from discontinued products because discontinued products do not have a continuing contribution to operations and management believes that excluding such items provides investors with a means of evaluating our on-going operations and facilitates comparisons to our peers. We exclude the effect of currency translation from core sales because currency translation is not under our control, is subject to volatility and can obscure underlying business trends.

28

RESULTS OF OPERATIONS
All comparisons, variances, increases or decreases discussed below are for the three months ended April 1, 2022 compared to the three months ended April 2, 2021.
Three Months Ended
($ in millions)April 1, 2022April 2, 2021% Change
Sales$631.4 100.0%$612.6 100.0%3.1 %
Cost of sales257.3 40.8%254.2 41.5%1.2 %
Gross profit374.1 59.2%358.4 58.5%4.4 %
Operating costs:
Selling, general and administrative (“SG&A”) expenses258.2 40.9%237.5 38.8%8.7 %
Research and development (“R&D”) expenses24.4 3.9%25.8 4.2%(5.4)%
Operating profit91.5 14.5%95.1 15.5%(3.8)%
Nonoperating income (expense):
Other income0.3 —%0.3 —%— %
Interest expense, net(5.9)(0.9)%(18.0)(2.9)%(67.2)%
Income before income taxes85.9 13.6%77.4 12.6%11.0 %
Income tax expense15.5 2.5%15.6 2.5%(0.6)%
Income from continuing operations70.4 11.1%61.8 10.1%13.9 %
Income from discontinued operations, net of tax4.5 0.7%9.9 1.6%(54.5)%
Net income $74.9 11.9%$71.7 11.7%4.5 %
Effective tax rate from continuing operations18.0 %20.2 %
GAAP Reconciliation
Sales and Core Sales Growth
% Change Three Month Period Ended April 1, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)3.1 %
Plus the impact of:
Currency exchange rates 2.3 %
Core sales growth (non-GAAP)5.4 %
Sales and core sales growth for the three months ended April 1, 2022 increased 3.1% and 5.4%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 1.5% on period-over-period basis, while sales increased by 3.9% due to higher volume. Sales in developed markets increased primarily due to an increase in North America and Western Europe. Sales in emerging markets increased primarily due to continued recovery from the COVID-19 pandemic, partially offset by a decrease in China due to localized COVID-19 pandemic related lockdowns.

29

COST OF SALES AND GROSS PROFIT
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Sales$631.4 $612.6 
Cost of sales257.3 254.2 
Gross profit$374.1 $358.4 
Gross profit margin59.2 %58.5 %
The increase in cost of sales during the three months ended April 1, 2022, as compared to the comparable period in 2021, was primarily due to higher sales and unfavorable impact from foreign exchange rates and inflation, partially offset by favorable incremental period-over-period savings associated with productivity improvements.
The increase in gross profit margin during the three months ended April 1, 2022, as compared to the comparable period in 2021, was primarily due to higher sales volume, price, product mix and favorable incremental period-over-period savings associated with productivity improvement actions taken in prior periods, partially offset by the impact of foreign exchange rates and the impact of inflation.
OPERATING EXPENSES
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Sales$631.4 $612.6 
Selling, general and administrative expenses$258.2 $237.5 
Research and development expenses$24.4 $25.8 
SG&A as a % of sales40.9 %38.8 %
R&D as a % of sales3.9 %4.2 %
The increase in SG&A expenses as a percentage of sales for the three months ended April 1, 2022 as compared to the comparable period of 2021, was primarily due to higher sales and marketing and compensation related spend, partially offset by higher sales volume.
The decrease in R&D expenses as a percentage of sales for the three months ended April 1, 2022, as compared to the comparable period of 2021, was primarily due to an increase in sales.
OPERATING PROFIT
Operating profit margin was 14.5% for the three months ended April 1, 2022, as compared to an operating profit margin of 15.5% for the comparable period of 2021. The decrease in operating profit margin was primarily due to higher sales and marketing, compensation spend, unfavorable impact of foreign exchange rates and inflation; partially offset by higher sales volume and favorable incremental period-over-period savings associated with productivity improvements.
OTHER INCOME
Net periodic benefit costs included in other income for both the three months ended April 1, 2022 and April 2, 2021 were $0.3 million.

INTEREST COSTS AND FINANCING
Interest costs were $5.9 million and $18.0 million for the three months ended April 1, 2022 and April 2, 2021, respectively. The decrease in interest expense for the three months ended April 1, 2022 as compared to the comparable period of 2021 was due to lower interest rates on the outstanding debt as a result of entering into the amendment to the Credit Agreement and making a $472.0 million partial repayment of the Euro term loan in February 2021. In addition, we are no longer incurring accretion expense on the convertible debt discount during the current year period as a result of adopting ASU 2020-06. Refer to Note 12 for a further discussion of the convertible debt instrument.
30

INCOME TAXES
Three Months Ended
April 1, 2022April 2, 2021
Effective tax rate from continuing operations18.0 %20.2 %

Our effective tax rate from continuing operations of 18.0% for the three months ended April 1, 2022 was lower than the 20.2% from the comparable period in 2021 primarily due to the Company’s geographical mix of earnings and an increase in net discrete tax benefits.

COMPREHENSIVE INCOME
For the three months ended April 1, 2022, comprehensive income was $16.6 million as compared to $19.6 million for the comparable period of 2021. The increase for the three months ended April 1, 2022 was primarily due to net income generated in the current period, partially offset by higher foreign currency translation losses.
RESULTS OF OPERATIONS - BUSINESS SEGMENTS
Specialty Products & Technologies
Our Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.
Specialty Products & Technologies Selected Financial Data
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Sales$397.1 $366.5 
Operating profit$70.3 $78.4 
Operating profit as a % of sales17.7 %21.4 %
Sales and Core Sales Growth
% Change Three Month Period Ended April 1, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)8.3 %
Plus the impact of:
Currency exchange rates 2.9 %
Core sales growth (non-GAAP)11.2 %
Sales
Sales and core sales growth for the three months ended April 1, 2022 increased 8.3% and 11.2%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 1.3% on a period-over-period basis, while sales increased by 9.9% due to higher volume and product mix as demand improved for implant systems and orthodontic products. Sales in developed markets increased primarily due to an increase in North America and Western Europe. Sales in emerging markets increased primarily due to continued recovery from the COVID-19 pandemic, partially offset by a decrease in China due to localized COVID-19 pandemic related lockdowns.
31

Operating Profit

Operating profit margin was 17.7% for the three months ended April 1, 2022, as compared to an operating profit margin of 21.4% for the comparable period of 2021. The decrease in operating profit margin was primarily due to higher sales and marketing, higher related compensation, unfavorable product mix and inflation, partially offset by higher sales volume and favorable period-over-period savings associated with productivity improvements.
EQUIPMENT & CONSUMABLES
Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Equipment & Consumables Selected Financial Data
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Sales$234.3 $246.1 
Operating profit$45.5 $45.0 
Operating profit as a % of sales19.4 %18.3 %
Sales and Core Sales Growth
% Change Three Month Period Ended April 1, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)(4.8)%
Plus the impact of:
Currency exchange rates 1.5 %
Core sales growth (non-GAAP)(3.3)%
Sales
Sales and core sales growth for the three months ended April 1, 2022 decreased 4.8% and 3.3%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 1.8% on a period-over-period basis, while Sales decreased by 5.1% due to lower volume primarily due to lower demand in infection prevention products, partially offset by higher sales of imaging products and restorative solutions. Sales in developed markets decreased primarily due to a decrease in North America partially offset by an increase in Western Europe. Sales in emerging markets decreased primarily due to a decrease in China due to localized COVID-19 pandemic related lockdowns.
Operating Profit
Operating profit margin was 19.4% for the three months ended April 1, 2022, as compared to an operating profit margin of 18.3% for the comparable period of 2021. The increase in operating profit margin was primarily due to favorable product mix, higher prices and favorable period-over-period savings associated with restructuring and productivity improvements, partially offset by lower sales volume, higher compensation spend and inflation.

32

LIQUIDITY AND CAPITAL RESOURCES
We assess our liquidity in terms of our ability to generate cash to fund our operating and investing activities. We continue to generate substantial cash from operating activities and believe that our operating cash flow and other sources of liquidity are sufficient to allow us to manage our capital structure on a short-term and long-term basis and continue investing in existing businesses and consummating strategic acquisitions. For the three months ended April 2, 2021, balances represent activity for the entire Divestiture, while balances for the three month ended April 1, 2022, represent activity for the remaining Relevant Jurisdictions.
Following is an overview of our cash flows and liquidity:
Overview of Cash Flows and Liquidity
 Three Months Ended
 April 1, 2022April 2, 2021
Net cash provided by operating activities$3.5 $16.6 
Payments for additions to property, plant and equipment(19.8)(8.3)
Proceeds from sale of Kavo treatment unit and instrument business30.0 — 
All other investing activities, net(5.1)2.8 
Net cash provided by (used in) investing activities$5.1 $(5.5)
Payment of debt issuance and other deferred financing costs— (0.4)
Proceeds from borrowings0.3 — 
Repayment of borrowings(0.5)(475.5)
Proceeds from stock option exercises13.1 5.3 
Tax withholding payment related to net settlement of equity awards(7.6)(5.2)
All other financing activities— 6.2 
Net cash provided by (used in) financing activities$5.3 $(469.6)

Operating Activities
Cash flows from operating activities can fluctuate significantly from period-to-period due to working capital needs and the timing of payments for income taxes, restructuring activities, pension funding and other items impacting reported cash flows.

Net cash provided by operating activities was $3.5 million during the three months ended April 1, 2022, as compared to net cash provided by operating activities of $16.6 million for the comparable period of 2021, primarily due to higher payments of accrued liabilities partially offset by lower working capital requirements.

Investing Activities
Cash flows relating to investing activities consist primarily of cash used for capital expenditures and acquisitions. Capital expenditures are made primarily for increasing capacity, replacing equipment, supporting new product development and improving information technology systems.

Net cash provided by investing activities was $5.1 million for the three months ended April 1, 2022, as compared to net cash used in investing activities of $5.5 million for the comparable period in 2021, primarily due to the earnout from the sale of the Kavo Treatment Unit and Instruments Business, partially offset by higher purchases of property, plant and equipment.

Financing Activities and Indebtedness
Cash flows relating to financing activities consist primarily of cash flows associated with debt borrowings and the issuance of common stock.
33

Net cash provided by financing activities was $5.3 million during the three months ended April 1, 2022, compared to $469.6 million used in financing activities for the comparable period of 2021, primarily due to the February 2021 repayment of $472.0 million of the Euro Term Loan Facility in connection with an amendment to the Credit Agreement.

For a description of our outstanding debt as of April 1, 2022, refer to Note 12 to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

We intend to satisfy any short-term liquidity needs that are not met through operating cash flow and available cash primarily through our Revolving Credit Facility.

As of April 1, 2022, we had no borrowings outstanding under the Revolving Credit Facility.

Cash and Cash Requirements

As of April 1, 2022, we held $1,078.3 million of cash and cash equivalents that were held on deposit with financial institutions. Of this amount, $206.1 million was held within the United States and $872.2 million was held outside of the United States. We will continue to have cash requirements to support working capital needs, capital expenditures and acquisitions, pay interest and service debt, pay taxes and any related interest or penalties, fund our restructuring activities and pension plans as required and support other business needs. We generally intend to use our revolving credit facility, available cash and internally generated funds to meet these cash requirements, but in the event that additional liquidity is required, particularly in connection with acquisitions, we may need to enter into new credit facilities or access the capital markets. We may also access the capital markets from time to time to take advantage of favorable interest rate environments or other market conditions. However, there is no guarantee that we will be able to obtain alternative sources of financing on commercially reasonable terms or at all. See “Item 1A. Risk Factors—Risks Related to Our Business” in our 2021 10-K.

While repatriation of some cash held outside the United States may be restricted by local laws, most of our foreign cash could be repatriated to the United States. Following enactment of the Tax Cut and Jobs Act of 2017 (“TCJA”) and the associated transition tax, in general, repatriation of cash to the United States can be completed with no incremental U.S. tax; however, repatriation of cash could subject us to non-U.S. jurisdictional taxes on distributions. The cash that our non-U.S. subsidiaries hold for indefinite reinvestment is generally used to finance foreign operations and investments, including acquisitions. The income taxes, if any, applicable to such earnings including basis differences in our foreign subsidiaries are not readily determinable.

As of April 1, 2022, we believe that we have sufficient sources of liquidity to satisfy our cash needs over the next 12 months and beyond, including our cash needs in the United States.

There were no material changes to our contractual obligations during the three months ended April 1, 2022. For a description of our remaining contractual obligations, such as leases see “Item 8. Financial Statements and Supplementary Data - Notes to Condensed Consolidated Financial Statements - “Note 8. Leases” in the 2021 10-K.

Off-Balance Sheet Arrangements

There were no material changes to the Company’s off-balance sheet arrangements described in the 2021 10-K that would have a material impact on the Company’s Condensed Consolidated Financial Statements.
Debt Financing Transactions

For a description of our outstanding debt as of April 1, 2022, refer to Note 12 to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Sale of the KaVo Treatment Unit and Instrument Business
We plan to use the net proceeds from the Divestiture to continue our product portfolio transformation with a disciplined approach to capital deployment.

34

CRITICAL ACCOUNTING ESTIMATES

There were no material changes to our critical accounting estimates described in the 2021 10-K that have had a material impact on our Condensed Consolidated Financial Statements.

The extent of the impact of the COVID-19 pandemic on our business is highly uncertain and difficult to predict. If actual results are not consistent with management’s estimates and assumptions used for valuation allowances, contingencies, potential impairments, revenue recognition and income taxes, the related account balances may be overstated or understated and a charge or credit to net income may be required.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Quantitative and qualitative disclosures about market risk appear in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Qualitative and Quantitative Disclosures About Market Risk,” in our 2021 10-K. There were no material changes to this information reported in our 2021 10-K during the quarter ended April 1, 2022.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this report. Based on such evaluation, our President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, have concluded that, as of the end of such period, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended April 1, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
35

PART II. Other Information
Item 1. Legal Proceedings

There have been no material changes to legal proceedings from our 2021 10-K. For additional information regarding legal proceedings, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Legal Proceedings” in our 2021 10-K.

Item 1A. Risk Factors

You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2021 10-K, which could materially affect our business, financial position, or future results of operations. The risks described in our 2021 10-K, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations. The risk factors set forth below update, and should be read together with, the risk factors described in our 2021 10-K.

If we cannot adjust our manufacturing capacity or the purchases required for our manufacturing activities to reflect changes in market conditions and customer demand, our profitability may suffer. In addition, our reliance upon sole or limited sources of supply for certain materials, components and services could cause production interruptions, delays and inefficiencies.

We purchase materials, components and equipment from third parties for use in our manufacturing operations, including metallic-based components, electronic components, chemicals, plastics and other petroleum-based products. Our profitability could be adversely impacted if we are unable to adjust our purchases to reflect changes in customer demand and market fluctuations, including those caused by seasonality or cyclicality. During a market upturn, suppliers may extend lead times, limit supplies or increase prices. If we cannot purchase sufficient products at competitive prices and quality and on a timely enough basis to meet increasing demand, we may not be able to satisfy market demand, product shipments may be delayed, our costs may increase or we may breach our contractual commitments and incur liabilities. Conversely, in order to secure supplies for the production of products, we sometimes enter into non-cancelable purchase commitments with vendors, which could impact our ability to adjust our inventory to reflect declining market demands. If demand for our products is less than we expect, we may experience additional excess and obsolete inventories and be forced to incur additional charges and our profitability may suffer.

In addition, some of our businesses purchase certain materials, components and services from sole or limited source suppliers for reasons of quality assurance, regulatory requirements, cost effectiveness, availability or uniqueness of design. If these or other suppliers encounter financial, operating or other difficulties or if our relationship with them changes, we might not be able to quickly establish or qualify replacement sources of supply. The supply chains for our businesses could also be disrupted by supplier capacity constraints, bankruptcy or exiting of the business for other reasons, decreased availability of key raw materials or commodities and external events such as natural disasters, pandemic health issues, including COVID-19 and related lockdowns and restrictions, war, terrorist actions, widespread protests and civil unrest, governmental actions and legislative or regulatory changes. Any of these factors could result in production interruptions, delays, extended lead times and inefficiencies. For example, we are experiencing higher prices and supply shortages on certain petroleum-based supplies/chemicals and microchips due to current global supply chain issues, particularly in our Imaging business. The supply chains for our businesses have also been impacted by the recent COVID-19 related lockdowns in China and the Russia-Ukraine conflict. Failure to obtain the needed supply of these products or to offset the increased costs could adversely impact our operating results.

International economic, political, legal, compliance and business factors could negatively affect our financial statements.

In 2021, 51% of our sales were derived from customers outside the U.S. In addition, many of our manufacturing operations, suppliers and employees are located outside the U.S. Since our growth strategy depends in part on our ability to further penetrate markets outside the U.S. and increase the localization of our products and services, we expect to continue to increase our sales and presence outside the U.S., particularly in the emerging markets. Our international business (and particularly our business in emerging markets) is subject to risks that are customarily encountered in non-U.S. operations, including:

36

•interruption in the transportation of materials to us and finished goods to our customers;
•differences in terms of sale, including payment terms;
•local product preferences and product requirements;
•changes in a country’s or region’s political or economic conditions, such as the devaluation of particular currencies;
•trade protection measures, embargoes and import or export restrictions and requirements;
•unexpected changes in laws or regulatory requirements, including changes in tax laws;
•capital controls and limitations on ownership and on repatriation of earnings and cash;
•the potential for nationalization of enterprises;
•changes in medical reimbursement policies and programs;
•limitations on legal rights and our ability to enforce such rights;
•difficulty in staffing and managing widespread operations;
•differing labor regulations;
•difficulties in implementing restructuring actions on a timely or comprehensive basis;
•differing protection of intellectual property;
•greater uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, including with respect to product and other regulatory approvals; and
•other factors beyond our control, such has terrorism, war, natural disasters and pandemics, including fluctuations in the severity and duration of the COVID-19 pandemic and resulting restrictions on business activity which may vary significantly by region.

Any of these risks could negatively affect our financial statements, business, growth rate, competitive position, results of operations and financial condition.

For example, we generate approximately 10% of our annual sales from Greater China. Accordingly, our business, financial condition and results of operations may be adversely influenced by evolving political, economic and social conditions in China generally. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which has impacted our business in China, including our ability to manufacture certain of our products and to obtain materials from our suppliers in the affected area. Additionally, China’s government continues to play a significant role in regulating industry development by imposing industrial policies, and it maintains control over China’s economic growth through setting monetary policy and determining treatment of particular industries or companies. Further, considerable uncertainty exists regarding the long-term effects of the expansionary monetary and fiscal policies adopted by the central banks and financial authorities of some of the world’s leading economies, including the United States and China. Any uncertainty or adverse changes to economic conditions in China or the policies of China’s government or its laws and regulations could have a material adverse effect on the overall economic growth of China and could impact our business and operating results, leading to a reduction in demand for our products and adversely affecting our business, growth rate, competitive position, results of operations and financial condition.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our business, including by impacting our ability to market and sell products in Russia, by impacting our ability to enforce our intellectual property rights in Russia, by creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.
37


Item 6. Exhibits

EXHIBIT INDEX
Exhibit
Number		Description
3.1
3.2
10.1
10.2*
10.3*
10.4*
10.5*
10.6*
10.7*
31.1
31.2
32.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*Indicates management contract or compensatory plan, contract or arrangement.
38

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ENVISTA HOLDINGS CORPORATION
Date: May 4, 2022
By:/s/ Howard H. Yu
Howard H. Yu
Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

39
 EX-10.1 2 carestreamclosingagreement.htm EX-10.1 Document
EXECUTION VERSION
AGREEMENT

This agreement (the “Agreement”), dated April 20, 2022, is made by and between Envista Holdings Corporation (“Purchaser”) and Carestream Dental Technology Parent Limited (“Carestream Parent”). Reference is made to the Stock and Asset Purchase Agreement (as amended, modified or supplemented from time to time, the “Purchase Agreement”), dated as of December 21, 2021, by and between Purchaser and Carestream Parent. Defined terms used herein without definition shall have the meaning given to such terms in the Purchase Agreement. Purchaser and Carestream Parent are referred to herein as the “Parties”.
WHEREAS, the Parties wish to set forth their agreement with respect to certain matters relating to the transactions contemplated by the Purchase Agreement.
NOW, THEREFORE, in consideration of the mutual promises and covenants made herein and of the mutual benefits to be derived herefrom, the Parties agree as follows:
1.Intercompany Note.
a.The amount outstanding pursuant to the Intercompany Note immediately prior to the Closing shall not exceed the Adjusted Purchase Price.
b.Immediately after the Closing on the Closing Date, Purchaser (i) shall cause Dental Imaging Technologies Corporation to contribute to UK IPCo an amount of cash, in exchange for the issuance by UK IPCo to Dental Imaging Technologies Corporation of additional shares of UK IPCo, sufficient (when taken together with cash on hand at UK IPCo) to repay in full the outstanding amount of the Intercompany Note and (ii) immediately thereafter, shall cause UK IPCo to pay to Carestream Dental Technology Topco Limited the outstanding amount of the Intercompany Note in full satisfaction of UK IPCo’s obligations under the terms of the Intercompany Note.
c.The parties agree that the purchase price for the shares of UK IPCo shall be calculated net of the Intercompany Note.
2.Pre-Closing Reorganization and UK ServiceCo.
a.Schedule A of the Purchase Agreement is hereby amended and restated in its entirety by Schedule A hereto.
b.The third recital of the Purchase Agreement is hereby amended and restated in its entirety as follows:
WHEREAS, prior to the Closing, and upon the terms and subject to the conditions contained in this Agreement, Carestream Parent will, and will cause its Affiliates to, effect an internal reorganization in accordance with the terms set forth in Schedule A (the “Pre-Closing Reorganization”), pursuant to which, among other things, it is contemplated that (a) Carestream Dental Technology Topco Limited will transfer certain contracts to Carestream Dental Technology Limited, a wholly owned private limited company registered in England and Wales (“UK IPCo” or the “Newco Transferred Entity” and together with Carestream China, the “Transferred Entities”), (b) Carestream Parent will cause Carestream Dental Technology Topco Limited to convey, assign, transfer and deliver its economic rights to the Transferred Intellectual Property as set forth in Schedule A (“Newco Intellectual Property”) to UK IPCo, (c) UK IPCo will form a U.S.
1007642791v15

branch and allocate certain NewCo Intellectual Property to such branch, (d) the assets, properties and rights of Carestream China that are not Transferred Assets shall be transferred from Carestream China to one or more entities designated by Carestream Parent on or prior to the Closing Date, and (e) the liabilities of Carestream China that are not Assumed Liabilities shall be assumed by one or more entities designated by Carestream Parent (other than the Transferred Entities) on or prior to the Closing Date;
c.Any reference to “Newco Transferred Entities” in the Purchase Agreement shall be read as “Newco Transferred Entity” (as defined in the amended third recital in this Agreement), along with any other changes necessary to reflect the change from plural to singular.
d.Section 5.13(f) of the Purchase Agreement is amended by deleting “and UK Service Co”.
e.Section 9.2(a) of the Purchase Agreement is amended by deleting the following in its entirety: ““UK ServiceCo” shall have the meaning set forth in the recitals.”.
f.Sellers and Purchaser acknowledge and agree that Sellers’ remaining interest in the Direct Sale IP (including all legal rights, benefits and burdens thereto) is, as at the Closing, sold, assigned, transferred, conveyed and delivered to Nobel Biocare Services AG.
3.The Supply Agreement.
a.Exhibit E in the Table of Contents of the Purchase Agreement is hereby amended to read “Exhibit E – Nil”.
b.Sections 2.2(a)(iii), 2.2(b)(i), 3.19, 3.22, 4.8(d), 5.11(b), 5.20(a), and 9.2(a) of the Purchase Agreement are amended by deleting all references to “the Supply Agreement” (and any grammatical changes necessary to preserve the intent of the foregoing sections following such deletion).
c.Section 5.20(b) of the Purchase Agreement is hereby deleted from the Purchase Agreement in its entirety.
d.Section 9.2(a) of the Purchase Agreement is amended by deleting the following in its entirety: ““Supply Agreement” means the transitional supply agreement between Purchaser and Carestream Parent or an Affiliate of Carestream Parent, consistent with the terms set forth in Exhibit E.”.
4.Transitional Distribution Agreement.
a.Exhibit G in the Table of Contents of the Purchase Agreement is hereby amended to read “Exhibit G – Nil”.
b.Sections 2.2(a)(iii), 2.2(b)(i), 3.19, and 9.2(a) of the Purchase Agreement are amended by deleting all references to “the Transitional Distribution Agreement” (and any grammatical changes necessary to preserve the intent of the foregoing sections following such deletion).
1007642791v15

c.Section 5.28 of the Purchase Agreement is amended by deleting the following in its entirety:
To the extent that Purchaser does not arrange by the Closing for new agreements with all such distributors and dealers to be entered into in connection with the Closing, the parties hereto shall enter into a master distribution agreement to provide for the distribution of Business Products by Carestream Parent and its Affiliates to such distributors and dealers following the Closing until the date that is six (6) months from the date hereof (or until such time as Purchaser enters into a new agreement with the applicable distributor or dealer) and on such other terms as may be mutually reasonably agreed upon by the parties hereto prior to the Closing, which terms shall be consistent with Exhibit G (the “Transitional Distribution Agreement”).
d.Section 9.2(a) of the Purchase Agreement is amended by deleting the following in its entirety: ““Transitional Distribution Agreement” shall have the meaning set forth in Section 5.28.”.
5.Disclosure Schedule Amendments.
a.The Disclosure Schedules are hereby amended to include the information set forth in Schedule B hereto as Section 5.9(j)(iv) of the Disclosure Schedules, immediately following Section 5.9(i)(iii) of the Disclosure Schedules, effective as of the date of the Purchase Agreement.
b.The Disclosure Schedules are hereby amended to include the following as Section 3.3(b), immediately following Section 3.3(a) of the Disclosure Schedules, effective as of the date of the Purchase Agreement: “As of the Closing, US$15.6M of the registered capital of Carestream China will be paid up.”
c.Section 3.8(a) of the Disclosure Schedules is amended to delete “1.    Csdentalconnect.com” and replace such phrase with “Nil.”.
6.Severance (other than China Severance). Purchaser and Carestream Parent agree that the Estimate includes an adjustment for $493,200.43, which represents an estimate of the 50% of the Severance payable as contemplated in Section 5.9(h)(ii)(A) and (B). Purchaser and Carestream Parent agree such amount will not be subject to any upward or downward adjustment pursuant to Section 1.7 of the Purchase Agreement, any other section of the Purchase Agreement or otherwise and irrevocably waive the applicability of the reimbursement obligation of the Purchaser pursuant to the first proviso to Section 5.9(h)(ii)(A) and (B) in respect of the Severance contemplated in Section 5.9(h)(ii)(A) and (B).
7.China Severance. The Severance payable to employees pursuant to Section 5.9(h)(ii)(C) of the Purchase Agreement shall be paid by Carestream China following Closing at its next scheduled payroll date. Accordingly, Purchaser and Carestream Parent agree that Carestream Parent shall include 50% of such Severance as a current liability in the calculation of Working Capital, subject to adjustment pursuant to Section 1.7 of the Purchase Agreement, and Carestream Parent irrevocably waives the applicability of the reimbursement obligation of the Purchaser pursuant to the first proviso to Section 5.9(h)(ii)(C) in respect of such Severance contemplated in Section 5.9(h)(ii)(C).
1007642791v15

8.China Intercompany Balances. Section 5.10(a)(i) is hereby deleted in its entirety and replaced with the following:
As promptly as possible following the Closing, Carestream Parent and Purchaser shall cause the Carestream China Intercompany Balances to be settled; provided that if the Carestream China Intercompany Balances Adjustment Amount is positive and the Carestream China Intercompany Balances are not settled within six (6) months following the Closing, Purchaser shall pay to Carestream Parent the amount of such Carestream China Intercompany Balances Adjustment Amount, without duplication and in full satisfaction of the Carestream China Intercompany Balances, net of any Tax and other costs and expenses that would reasonably be expected to be incurred in connection with the cancellation of the accounts payable related to the Carestream China Intercompany Balances. In the event Carestream Parent receives both payment from Purchaser directly and from Carestream China in respect of the same Carestream China Intercompany Balance, Carestream Parent shall reimburse Purchaser for the amount of any such payment.
9.China Fixed Assets. At the end of the term of Schedule R11 of the ‘R&D’ section of the Transition Services Agreement between Purchaser and Carestream Parent, dated on or about the date hereof (the “TSA”), Purchaser will cause Carestream China to deliver possession of the assets listed on Schedule C hereto to Shanghai CC Dental Trading Co., Ltd. (“CareCapital”) provided that, the costs of such delivery shall be borne by Carestream Parent. Carestream China acknowledges it is holding the assets listed on Schedule C hereto in trust for the benefit of CareCapital and shall use commercially reasonable efforts to only use the assets for the specific purpose of providing the services set forth in Schedule R8 of the ‘R&D’ section of the TSA.
10.Inventory at MLV.    Purchaser agrees that Carestream Parent and its Affiliates shall retain physical possession and use of the spare parts Inventory forming part of the Transferred Assets located at the facility in MLV, France as of the Closing (the “Spare Parts”). Carestream Parent shall use the Spare Parts solely in the provision of its services under the TSA related to repair of Business Products and not for any other purpose. At the end of the term of such service, in accordance with the terms of the TSA, Carestream Parent shall deliver, for no additional cost, any unused Spare Parts to the address specified by Purchaser in writing, at Purchaser’s sole cost and expense.
11.Assets and Fixtures at Rayco.     Purchaser acknowledges and agrees that Carestream Parent shall retain all rights to all assets and fixtures at the Rayco (Shanghai) Medical Products Company Limited (“Rayco”) facility primarily related to the Retained Products or Retained Business. At the end of the term of the Specified Contract, as may be amended, restated, modified, supplemented or replaced from time to time, to the extent such assets and fixtures are returned to Purchaser or any of its Affiliates, Purchaser shall notify Carestream Parent of the return of such assets in writing and, for no consideration, execute and deliver, or cause to be executed and delivered, any documents required to convey such assets to Carestream Parent. Carestream Parent shall be responsible for all costs in relation to the conveyance and delivery of such assets to Carestream Parent. Carestream Parent shall not, and will cause its Affiliates not to, remove or request the removal of any such assets and fixtures from the Rayco facility or limit the use of such assets or fixtures by Rayco, in each case prior to the end of the term of the Specified Contract as may be amended, restated, modified, supplemented or replaced from time to time, to the extent such assets and fixtures are also used in
1007642791v15

the Business or by Rayco for the manufacture of Business Products. Purchaser shall not, and will cause its Affiliates not to, remove or request the removal of any assets and fixtures owned by it from the Rayco facility or limit the use of such assets or fixtures by Rayco, in each case prior to the end of the term of the Specified Contract as may be amended, restated, modified, supplemented or replaced from time to time, to the extent such assets and fixtures are also used in the Retained Business or by Rayco for the manufacture of Retained Products.
12.Germany Payroll. Carestream Parent shall cause Carestream Dental Germany (“Carestream Germany”) to make April 22 payroll payments and remittances for the Transferred Employees in Germany covering the period from April 1-30, 2022. Purchaser shall cause EH Germany to reimburse Carestream Germany for the payroll payments and related remittances for the period from the Closing Date through April 30, 2022. Carestream Germany shall provide to EH Germany an invoice for such costs within 30 days after Closing, and Purchaser shall cause EH Germany to pay such invoice within 30 days of receipt.
13.Italy Local Transfer Agreement. To the extent the Local Transfer Agreement between Carestream Dental Italy S.r.l. (“Carestream Italy”) and KaVo Italia S.r.l. (“Kavo Italy”) is not executed and notarized prior to the Closing Date, each of Carestream Parent and Purchaser undertake to cause Carestream Italy and Kavo Italy to execute and have the Local Transfer Agreement notarized as soon as practicable following Closing and to lodge the Local Transfer Agreement with the relevant Governmental promptly thereafter. Until the Local Transfer Agreement is executed and notarized Carestream Parent and the Purchaser agree that the relevant Transferred Contracts assigned thereunder shall be subject to Section 1.3 of the Purchase Agreement.
14.Company Seal. To the extent any documents related to the Pre-Closing Reorganization, any Transaction Documents or other Closing deliverables related to Carestream China require the affixation of the company seal that is not so affixed prior to Closing or any local registration authority requires original, wet-ink signature pages of any documents related to the Pre-Closing Reorganization, any Transaction Documents or other Closing deliverables related to Carestream China, Carestream Parent and Purchaser agree to cooperate with each other, and cause their respective Affiliates to, affix the applicable company seal and deliver any required original, wet-ink signature pages, in each case, as soon as reasonably practicable following the Closing.
15.Confirmatory Patent Assignment.  Reasonably promptly following the Closing, Carestream Parent will cause its applicable Affiliates to execute and deliver to Purchaser assignment documents, mutually agreed upon by Purchaser and Carestream Parent, confirming such Affiliates have assigned legal title in certain of the Transferred Patents to Carestream Dental LLC or Trophy SAS, as applicable.
16.Governing Law. This Agreement, and all proceedings (whether based on contract, tort or otherwise) arising out of or relating to this Agreement or the actions of the Parties in the negotiation, administration, performance and enforcement hereof shall be governed by and construed in accordance with the Laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Law of any jurisdiction other than the State of Delaware. Each Party hereby irrevocably submits to the
1007642791v15

exclusive jurisdiction of the Delaware Court of Chancery (or, if the Delaware Court of Chancery shall be unavailable, any other court of the State of Delaware or, in the case of claims to which the federal courts have exclusive subject matter jurisdiction, any federal court of the United States of America sitting in the State of Delaware) solely in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents referred to in this Agreement, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement hereof or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any of such documents may not be enforced in or by said courts, and the Parties irrevocably agree that all claims with respect to such action or proceeding shall be heard and determined in such Delaware State or federal court. Each Party hereby consents to and grants any such court jurisdiction over the person of such parties and over the subject matter of any such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 9.1 of the Purchase Agreement, or in such other manner as may be permitted by law, shall be valid and sufficient service thereof. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY IN CONNECTION WITH ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF THE PARTIES IN THE NEGOTIATION, EXECUTION, PERFORMANCE AND ENFORCEMENT OF THIS AGREEMENT.
17.Miscellaneous. Except to the extent expressly provided in this letter agreement, all of the terms and provisions of the Purchase Agreement are and will remain in full force and effect and nothing herein shall be construed as a waiver, modification or amendment of any provision of the Purchase Agreement. The provisions of Sections 9.3 (Severability), 9.4 (Entire Agreement; No Third-Party Beneficiaries), 9.5 (Amendment; Waiver), 9.6 (Binding Effect; Assignment), 9.10 (Construction) and 9.12 (Counterparts) of the Purchase Agreement are hereby incorporated into and will apply to this letter mutatis mutandis.
[Remainder of Page Intentionally Left Blank]

1007642791v15

    IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.



CARESTREAM DENTAL
TECHNOLOGY PARENT LIMITED
By: /s/ Jane Guinn
Name: Jane Guinn
Title: Director
ENVISTA HOLDINGS CORPORATION
By: /s/ Amir Aghdaei
Name: Amir Aghdaei
Title: CEO








[Signature Page to Closing Agreement]
1007642791v15
 EX-31.1 3 exhibit311412022.htm EX-31.1 Document

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Amir Aghdaei, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Envista Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 4, 2022
/s/ Amir Aghdaei
                                Amir Aghdaei
President and Chief Executive Officer


 EX-31.2 4 exhibit312412022.htm EX-31.2 Document

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Howard H. Yu, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Envista Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 4, 2022
/s/ Howard H. Yu
                                Howard H. Yu
Senior Vice President and Chief Financial Officer


 EX-32.1 5 exhibit321412022.htm EX-32.1 Document

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Amir Aghdaei, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Envista Holdings Corporation for the period ended April 1, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Envista Holdings Corporation as of and for the periods presented in the Report.
Date: May 4, 2022
/s/ Amir Aghdaei
Amir Aghdaei
President and Chief Executive Officer
I, Howard H. Yu, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Envista Holdings Corporation for the period ended April 1, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Envista Holdings Corporation as of and for the periods presented in the Report.
Date: May 4, 2022
/s/ Howard H. Yu
Howard H. Yu
Senior Vice President and Chief Financial Officer


 EX-101.SCH 6 nvst-20220401.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Business And Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Business And Basis Of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Business And Basis Of Presentation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2104102 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Discontinued Operations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Discontinued Operations - Operating Results (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) link:presentationLink link:calculationLink link:definitionLink 2110103 - Disclosure - Credit Losses link:presentationLink link:calculationLink link:definitionLink 2311302 - Disclosure - Credit Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Credit Losses - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Credit Losses - Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 2114104 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2315303 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2416408 - Disclosure - Inventories - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 2117105 - Disclosure - Property, Plant And Equipment link:presentationLink link:calculationLink link:definitionLink 2318304 - Disclosure - Property, Plant And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2419409 - Disclosure - Property, Plant And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2120106 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 2321305 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2422410 - Disclosure - Goodwill - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 2123107 - Disclosure - Accrued Expenses And Other Liabilities link:presentationLink link:calculationLink link:definitionLink 2324306 - Disclosure - Accrued Expenses And Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2425411 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 2126108 - Disclosure - Hedging Transactions And Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2327307 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2428412 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2429413 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 2430414 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2131109 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2332308 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2433415 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2434416 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2135110 - Disclosure - Warranty link:presentationLink link:calculationLink link:definitionLink 2336309 - Disclosure - Warranty (Tables) link:presentationLink link:calculationLink link:definitionLink 2437417 - Disclosure - Warranty - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2438418 - Disclosure - Warranty - Warranty Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 2139111 - Disclosure - Litigation And Contingencies link:presentationLink link:calculationLink link:definitionLink 2440419 - Disclosure - Litigation And Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2141112 - Disclosure - Debt And Credit Facilities link:presentationLink link:calculationLink link:definitionLink 2342310 - Disclosure - Debt And Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2443420 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2444421 - Disclosure - Debt And Credit Facilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2445422 - Disclosure - Debt And Credit Facilities - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2146113 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 2347311 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 2448423 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 2149114 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2350312 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2451424 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details) link:presentationLink link:calculationLink link:definitionLink 2452425 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2452425 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2453426 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2154115 - Disclosure - Restructuring Activities And Related Impairments link:presentationLink link:calculationLink link:definitionLink 2355313 - Disclosure - Restructuring Activities And Related Impairments (Tables) link:presentationLink link:calculationLink link:definitionLink 2456427 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2457428 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2458429 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2159116 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2460430 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2161117 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2362314 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2463431 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2464432 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2465433 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2166118 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2367315 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2468434 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2469435 - Disclosure - Segment Information - Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink 2170119 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2471436 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nvst-20220401_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 nvst-20220401_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 nvst-20220401_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Supplemental data: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Increase Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax US term loan due 2024 US Term Loan Due 2024 [Member] US Term Loan Due 2024 Work in process Inventory, Work in Process, Gross Total borrowings under term loan Total Borrowings under Term Loan Total Borrowings under Term Loan Convertible Debt Convertible Debt [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net income Net income Net Income (Loss) Attributable to Parent Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Preferred shares outstanding (in shares) Preferred Stock, Shares Outstanding Compensation and benefits Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Interest rate contracts Interest Rate Contract [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Goodwill Goodwill Disclosure [Text Block] Capital expenditures Capital Expenditure, Discontinued Operations Derivative liabilities Derivative Liability Rate in excess of Eurocurrency rate Rate in excess of Eurocurrency rate Rate in excess of Eurocurrency rate Security Exchange Name Security Exchange Name Consideration Disposal Group, Including Discontinued Operation, Consideration Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Conversion price (in USD per share) Debt Instrument, Convertible, Conversion Price Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Numerator: Earnings Per Share Reconciliation [Abstract] Restructuring Type [Axis] Restructuring Type [Axis] Litigation And Contingencies Commitments Contingencies and Guarantees [Text Block] Other long-term assets Other Assets, Noncurrent Segments [Axis] Segments [Axis] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number Redemption price Debt Instrument, Redemption Price, Percentage Credit facility Credit Facility [Member] Credit Facility [Member] Common stock-based award activity APIC, Share-based Payment Arrangement, Increase for Cost Recognition Contingency provision on the ratio of indebtedness to net capital Ratio of Indebtedness to Net Capital, Contingency Provision Ratio of Indebtedness to Net Capital, Contingency Provision Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Operating expenses: Disposal Group, Including Discontinued Operation, Operating Expenses [Abstract] Disposal Group, Including Discontinued Operation, Operating Expenses Assumed conversion of the Notes (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Cost of sales Disposal Group, Including Discontinued Operation, Costs of Goods Sold Revenue recognized Contract with Customer, Liability, Revenue Recognized Subsequent Events [Abstract] Western Europe Western Europe [Member] Western Europe [Member] Business Acquisition [Axis] Business Acquisition [Axis] Facility fee Line of Credit Facility, Commitment Fee Percentage Interest coverage ratio (at least) Interest Coverage Ratio Interest Coverage Ratio Disposal Group Name [Axis] Disposal Group Name [Axis] Components of Note Interest Expense Convertible Debt [Table Text Block] Local Phone Number Local Phone Number Credit Facility [Domain] Credit Facility [Domain] ASSETS Assets [Abstract] Hedging Transactions and Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Held for sale Segment Reconciling Items [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Concentration risk percentage Concentration Risk, Percentage Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at April 1, 2022 and December 31, 2021 Preferred Stock, Value, Issued Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Convertible debt, consecutive trading days (in trading days) Debt Instrument, Convertible, Threshold Consecutive Trading Days Accrued expenses and other [Abstract] Accrued expenses and other [Abstract] Accrued expenses and other [Abstract] Retained Earnings Retained Earnings [Member] Debt Instrument [Axis] Debt Instrument [Axis] Change in prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Liabilities for relevant jurisdictions Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Cash flows from operating activities Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations [Abstract] Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations Change in trade accounts receivable Increase (Decrease) in Accounts Receivable Income tax (benefit) expense Discontinued Operation, Tax Effect of Discontinued Operation ROU assets obtained in exchange for operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Repayment of borrowings Repayments of Short-term Debt, Maturing in Three Months or Less Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Number of business segments (in segments) Number of operating segments (in segments) Number of Operating Segments Gain on sale of Kavo treatment unit and instrument business Gain (Loss) on Disposition of Business Earnings - basic (in USD per share) Earnings Per Share, Basic Plamenca Plamenca [Member] Plamenca Pension plan adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Revenue Revenue from Contract with Customer [Text Block] Total interest expense Interest Expense, Debt Schedule of Disaggregation of Revenue by Geographical Region and Type Disaggregation of Revenue [Table Text Block] Raw materials Inventory, Raw Materials, Gross Largest customer Largest Customer [Member] Largest Customer Fair Value Measurement [Domain] Fair Value Measurement [Domain] Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Machinery, equipment and other assets Machinery and Equipment [Member] Pension benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Current Change in operating lease liabilities Operating Lease, Payments Cash and cash equivalent threshold Debt Instrument, Covenant, Cash and Cash Equivalent Threshold Debt Instrument, Covenant, Cash and Cash Equivalent Threshold Recoveries Accounts Receivable, Allowance for Credit Loss, Recovery If-converted value in excess of principal Debt Instrument, Convertible, If-converted Value in Excess of Principal Costs incurred Restructuring Costs and Asset Impairment Charges Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Consideration transferred Business Combination, Consideration Transferred Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Goodwill [Roll Forward] Goodwill [Roll Forward] Earnings from continuing operations - diluted (in USD per share) Income (Loss) from Continuing Operations, Per Diluted Share Long-term Debt Total debt Total debt Long-term Debt Specialty Products & Technologies Specialty Products and Technologies [Member] Specialty Products and Technologies Quoted Prices in Active Market (Level 1) Fair Value, Inputs, Level 1 [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Base Rate Base Rate [Member] Total liabilities and stockholders’ equity Liabilities and Equity Other Other Accrued Liabilities, Current Contract liabilities Contract with Customer, Liability, Current Additional paid-in capital Additional Paid in Capital LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Change in trade accounts payable Increase (Decrease) in Accounts Payable Interest rate swap derivative contracts Interest rate swap derivative contracts Interest Rate Swap [Member] Hedging Relationship [Domain] Hedging Relationship [Domain] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Income tax impact Reclassification from AOCI, Current Period, Tax Held for Sale Disposal Group, Including Discontinued Operation, Assets Earnings Per Share Earnings Per Share [Text Block] Derivative financial instruments Derivative Liability, Current Entity Interactive Data Current Entity Interactive Data Current Provision for credit losses Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations Standby letters of credit Standby Letters of Credit [Member] Minimum Minimum [Member] Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Gross profit Gross Profit Line of credit facility, outstanding borrowings Long-term Line of Credit Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Convertible debt, conversion ratio Debt Instrument, Convertible, Conversion Ratio Balance Sheet Location [Domain] Balance Sheet Location [Domain] Selling, general and administrative Selling, General and Administrative Expense Debt issuance and deferred financing costs Debt Issuance Costs, Net Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Other comprehensive (loss) income, net of income taxes: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Preferred shares authorized (in shares) Preferred Stock, Shares Authorized Nonderivative hedging instruments Nonderivative Hedging Instruments Nonderivative Hedging Instruments Amortization Amortization of Other Deferred Charges Loss contingencies Loss Contingency, Accrual, Noncurrent Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Euro term loan due 2024 Euro Term Loan Due 2024 [Member] Euro Term Loan Due 2024 Equipment & Consumables Equipment and Consumables [Member] Equipment and Consumables Entity Address, State or Province Entity Address, State or Province Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Balance at beginning of year Balance at end of year Restructuring Reserve Operating (loss) profit Disposal Group, Including Discontinued Operation, Operating Income (Loss) Increase (decrease) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax 2.375% convertible senior notes, capped calls 2.375% Convertible Senior Notes, Capped Calls [Member] 2.375% Convertible Senior Notes, Capped Calls [Member] Current liabilities: Liabilities, Current [Abstract] Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Debt And Credit Facilities Debt Disclosure [Text Block] Line of Credit Line of Credit [Member] Product warranty period Product Warranty Period Product Warranty Period Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Inventories Inventory Disclosure [Text Block] Credit Losses Credit Loss, Financial Instrument [Text Block] Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Derivative Instrument [Axis] Derivative Instrument [Axis] Number of reportable segments (in segments) Number of Reportable Segments Document Transition Report Document Transition Report Income from continuing operations, net of tax Income from continuing operations, net of tax Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Common stock - $0.01 par value, 500.0 million shares authorized;163.2 million shares issued and 162.6 million shares outstanding at April 1, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021 Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Liability for proceeds related to the Relevant Jurisdictions Disposal Group, Including Discontinued Operation, Liabilities Customer Concentration Risk Customer Concentration Risk [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Commitments and contingencies Commitments and Contingencies Subsequent Event [Table] Subsequent Event [Table] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Taxes, income and other Accrued Income Taxes, Noncurrent Restructuring charges Inventory Write-down Payment of debt issuance and other deferred financing costs Payments of Debt Issuance Costs Disposal Group Classification [Axis] Disposal Group Classification [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Cover [Abstract] Cover [Abstract] Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Goodwill [Line Items] Goodwill [Line Items] Other comprehensive (loss) income before reclassifications, net of income taxes Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Adjusted balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Pension benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Income tax impact Other Comprehensive Income (Loss) before Reclassifications, Tax Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current The Components of Accrued Expenses and Other Liabilities Other Liabilities [Table Text Block] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Sales Revenue from Contract with Customer, Excluding Assessed Tax Current liabilities: Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract] Consolidation Items [Domain] Consolidation Items [Domain] Equity [Abstract] Equity [Abstract] Carrying Amount Reported Value Measurement [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Document Quarterly Report Document Quarterly Report Paid/settled Payments for Restructuring Common Stock Common Stock [Member] Variable Rate [Axis] Variable Rate [Axis] Segment Information Segment Reporting Disclosure [Text Block] Operating profit Operating profit (loss) Operating Income (Loss) Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] 2.375% convertible senior notes over allotment option 2.375% Convertible Senior Notes Over Allotment Option [Member] 2.375% Convertible Senior Notes Over Allotment Option [Member] Operating lease liabilities Operating Lease, Liability, Current Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Restructuring Activities And Related Impairments Restructuring and Related Activities Disclosure [Text Block] Variable Rate Variable Rate [Domain] Long-term debt Long-term Debt [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation Depreciation Repayment of debt Repayments of Debt Other developed markets Other Developed Markets [Member] Other developed markets [Member] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Payments of debt restructuring costs Payments of Debt Restructuring Costs Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Noncurrent deferred compensation liability Deferred Compensation Liability, Classified, Noncurrent Warranty Accrual Schedule of Product Warranty Liability [Table Text Block] Cash paid for taxes Income Taxes Paid Notional Amount Derivative, Notional Amount Other income Other Nonoperating Income (Expense) EBITDA threshold Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold Long-term debt Fair value of notes Long-term Debt, Fair Value Settlements made Standard and Extended Product Warranty Accrual, Decrease for Payments All other investing activities, net Payments for (Proceeds from) Other Investing Activities Credit Loss [Abstract] Payments for additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Accrued expenses and other liabilities Total Other Liabilities, Current Facility Exit and Related Facility Closing [Member] Accrued Expenses And Other Liabilities Other Liabilities Disclosure [Text Block] Maximum Maximum [Member] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Consolidation Items [Axis] Consolidation Items [Axis] Total Envista stockholders’ equity Stockholders' Equity Attributable to Parent Common stock, shares issued (in shares) Common Stock, Shares, Issued Sales and product allowances Sales And Product Allowances, Noncurrent Sales And Product Allowances, Noncurrent Preferred shares issued (in shares) Preferred Stock, Shares Issued City Area Code City Area Code Foreign currency denominated debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated debt [Member] Emerging markets High-Growth Markets [Member] The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Entity Address, City or Town Entity Address, City or Town Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Cash flow hedge adjustments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Balance Sheet Location [Axis] Balance Sheet Location [Axis] Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Operating lease liabilities Operating Lease, Liability, Noncurrent Convertible debt, capped calls (in shares) Debt Instrument, Convertible, Capped Calls, Shares Debt Instrument, Convertible, Capped Calls, Shares Term loan Debt Instrument, Face Amount Interest expense, net Interest Expense Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Number of portfolio segments (in segments) Number Of Portfolio Segments Number Of Portfolio Segments Proceeds from borrowings Proceeds from Short-term Debt, Maturing in Three Months or Less Retained earnings Retained Earnings (Accumulated Deficit) Operating segments Operating Segments [Member] Stock-based awards Share-based Payment Arrangement [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category ASSETS Disposal Group, Including Discontinued Operation, Assets [Abstract] Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Increase limit of revolving credit facility Debt Instrument, Accordion Feature, Increase Limit Debt Instrument, Accordion Feature, Increase Limit Fair Value Estimate of Fair Value Measurement [Member] Entity Registrant Name Entity Registrant Name Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Contingency provision, purchase price in excess of $100 million Contingency Provision, Purchase Price in Excess of $100 million Contingency Provision, Purchase Price in Excess of $100 million LIABILITIES AND EQUITY Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Other long-term assets Other Noncurrent Assets [Member] Proceeds from stock option exercises Proceeds from Stock Options Exercised Accruals for warranties issued during the year Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Income tax expense Income Tax Expense (Benefit) Total stockholders’ equity Balance, beginning of period Balance, end of period Stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Trade accounts receivable, less allowance for credit losses of $20.3 and $20.7, respectively Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Effect of foreign currency translation Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Equity Components [Axis] Equity Components [Axis] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Selling, general and administrative Disposal Group, Including Discontinued Operation, General and Administrative Expense Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Concentration Risk Type [Domain] Concentration Risk Type [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Inventories, net Total Inventory, Net Segment Results Schedule of Segment Reporting Information, by Segment [Table Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Gross profit Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Warranty Product Warranty Disclosure [Text Block] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Revenue Benchmark Revenue Benchmark [Member] Equity Component [Domain] Equity Component [Domain] Discontinued Operations, Disposed of by Sale Discontinued Operations, Disposed of by Sale [Member] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Disposal Group Name [Domain] Disposal Group Name [Domain] Assets for relevant jurisdictions Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current Current assets: Disposal Group, Including Discontinued Operation, Assets, Current [Abstract] Cash flows from investing activities: Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities [Abstract] Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities Amortization of debt discount Amortization of Debt Discount (Premium) Debt issuance costs Debt Issuance Costs, Gross Statement [Line Items] Statement [Line Items] Convertible debt, stock price trigger (in USD per share) Debt Instrument, Convertible, Stock Price Trigger Impairment charges Impairment of Intangible Assets, Finite-lived Remaining performance obligation Revenue, Remaining Performance Obligation, Amount (Loss) income from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Convertible senior notes due 2025 Convertible Debt, Fair Value Disclosures Debt Disclosure [Abstract] Debt Disclosure [Abstract] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Contractual interest expense Interest Expense, Debt, Excluding Amortization Contract liabilities Contract with Customer, Liability, Noncurrent Liabilities held for sale Current liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Other Corporate, Non-Segment [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Type of Restructuring [Domain] Type of Restructuring [Domain] Sales Disposal Group, Including Discontinued Operation, Revenue Customer [Axis] Customer [Axis] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Convertible debt, trading days (in trading days) Debt Instrument, Convertible, Threshold Trading Days Title of 12(b) Security Title of 12(b) Security Total assets Identifiable assets Assets Other Other Accrued Liabilities, Noncurrent Common stock, shares authorized (in shares) Common Stock, Shares Authorized Research and development Disposal Group, Including Discontinued Operation, Research And Development Expense Disposal Group, Including Discontinued Operation, Research And Development Expense Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Leverage ratio Ratio of Indebtedness to Net Capital Change in noncontrolling interest Noncontrolling Interest, Period Increase (Decrease) Document Type Document Type Product and Service [Domain] Product and Service [Domain] Noncontrolling Interests Noncontrolling Interest [Member] Research and development Research and Development Expense Senior unsecured revolving credit facility Senior Unsecured Revolving Credit Facility Senior Unsecured Revolving Credit Facility Interest rate Debt Instrument, Interest Rate, Stated Percentage Gain (loss) on disposal Gain on sale of discontinued operations, net of tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Derivative Contract [Domain] Derivative Contract [Domain] Loss contingencies Loss Contingency, Accrual, Current Revolving Credit Facility Revolving Credit Facility [Member] Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Accrued expenses and other liabilities Accounts Payable and Accrued Liabilities [Member] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Short-term debt Short-term Debt Other Other Segments [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Geographical [Axis] Geographical [Axis] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Basic (in shares) Weighted-average common shares outstanding used in basic earnings per share (in shares) Weighted Average Number of Shares Outstanding, Basic Earnings - diluted (in USD per share) Earnings Per Share, Diluted Segments [Domain] Segments [Domain] Amortization of debt discount and issuance costs Amortization of Debt Issuance Costs and Discounts Threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Net investment hedging Net Investment Hedging [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible Enumeration] Subsequent Events Subsequent Events [Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Employee Severance and Related Employee Severance [Member] Contract liability Contract with Customer, Liability Restructuring-related employee severance, benefits and other Restructuring Reserve, Current Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Average common stock and common equivalent shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Equipment Equipment Sales [Member] Equipment Sales [Member] Net deferred tax liability Deferred Income Tax Liabilities, Net Derivative financial instruments Derivative Liability, Noncurrent Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Earnings from continuing operations - basic (in USD per share) Income (Loss) from Continuing Operations, Per Basic Share Net income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Consumables Consumables [Member] Consumables [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Costs incurred Restructuring Charges Concentration Risk Type [Axis] Concentration Risk Type [Axis] Foreign currency translation Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation Total Envista Equity Parent [Member] Schedule of Financial Assets And Liabilities At Carrying and Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Earnings from discontinued operations - basic (in USD per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Proceeds from issuance of convertible senior notes Proceeds from Convertible Debt Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Change in inventories Increase (Decrease) in Inventories Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Derivative [Table] Derivative [Table] Beginning balance Ending balance Standard and Extended Product Warranty Accrual Cost of sales Cost of Goods and Services Sold Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Document Period End Date Document Period End Date Proceeds from sale of Kavo treatment unit and instrument business Proceeds from Divestiture of Businesses Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Convertible senior notes due 2025 2.375% convertible senior notes 2.375% Convertible Senior Notes [Member] 2.375% Convertible Senior Notes [Member] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Carestream Dental Technology Carestream Dental Technology [Member] Carestream Dental Technology Income Statement Location [Domain] Income Statement Location [Domain] Debt instrument, term Debt Instrument, Term Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Property, Plant And Equipment Property, Plant and Equipment Disclosure [Text Block] Land and improvements Land and Land Improvements [Member] Other long-term liabilities Total Other Liabilities, Noncurrent Compensation and benefits Due to Employees, Noncurrent Components Of Debt Schedule of Long-term Debt Instruments [Table Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Earnings per share: Earnings Per Share [Abstract] Earnings from discontinued operations - diluted (in USD per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Derivative assets Derivative Asset Gross property, plant and equipment Property, Plant and Equipment, Gross Allowance for credit losses Beginning balance Ending balance Accounts Receivable, Allowance for Credit Loss Amounts reclassified from accumulated other comprehensive loss, net of income taxes Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Foreign currency contracts Foreign Exchange Contract [Member] Finished goods Inventory, Finished Goods, Gross Accrual for legal matters Loss Contingency Accrual Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Operating expenses: Costs and Expenses [Abstract] Long-term debt Long-term debt Long-term Debt, Excluding Current Maturities Liabilities: Liabilities, Fair Value Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Entity Current Reporting Status Entity Current Reporting Status Earnings per share: Earnings Per Share, Basic and Diluted [Abstract] Change in accrued expenses and other liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Effective tax rate Effective Income Tax Rate Reconciliation, Percent Current Other Liabilities, Current [Abstract] Other Other Debt Obligations [Member] Less: current portion Debt, Current Amortization of debt issuance costs Amortization of Debt Issuance Costs Reserve for inventory obsolescence Inventory Valuation Reserves Construction in progress Construction in Progress [Member] Beginning balance of cash and cash equivalents Ending balance of cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Sales and product allowances Sales And Product Allowances, Current Sales And Product Allowances, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Current assets: Assets, Current [Abstract] All other financing activities Proceeds from (Payments for) Other Financing Activities LIBOR London Interbank Offered Rate (LIBOR) [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Income from discontinued operations, net of tax (refer to Note 2) Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Diluted (in shares) Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Total other comprehensive loss, net of income taxes Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Margin spread of variable interest rate Debt Instrument, Basis Spread on Variable Rate Write-offs charged against the allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Gain Recognized in OCI Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments Schedule of Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Dilution threshold (in USD per share) Derivative, Cap Price, Dilution Threshold Derivative, Cap Price, Dilution Threshold Unrealized Gain (Loss) on Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Measurement Basis [Axis] Measurement Basis [Axis] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Noncurrent Other Liabilities, Noncurrent [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Nonoperating income (expense): Nonoperating Income (Expense) [Abstract] Cross-currency swap derivative contracts Cross-currency swap derivative contracts Currency Swap [Member] Credit Facility [Axis] Credit Facility [Axis] Entity Address, Address Line One Entity Address, Address Line One Restructuring-related employee severance, benefits and other Restructuring Reserve, Noncurrent Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Buildings and improvements Building and Building Improvements [Member] Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Loan facility interest rates Debt Instrument, Interest Rate During Period Entity Shell Company Entity Shell Company Total current liabilities Liabilities, Current Tax withholding payment related to net settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Revolving credit facility maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Trade accounts payable Accounts Payable, Trade, Current Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Unamortized debt issuance costs and discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Assets held for sale Current assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Statement [Table] Statement [Table] Liability Liability [Member] Accounting Standards Recently Adopted and Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Convertible debt expense, capped calls Debt Instrument, Convertible, Capped Calls, Expense Debt Instrument, Convertible, Capped Calls, Expense Statistical Measurement [Axis] Statistical Measurement [Axis] Unamortized discount (premium), net Debt Instrument, Unamortized Discount (Premium), Net Subsequent Event Subsequent Event [Member] North America North America [Member] Depreciation and amortization Depreciation and Amortization, Discontinued Operations Goodwill Beginning balance Ending balance Goodwill Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Cost of sales Cost of Sales [Member] Taxes, income and other Accrued Income Taxes, Current Rollforward and Carrying Value Of Goodwill Schedule of Goodwill [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Unamortized discount Debt Instrument, Unamortized Discount Unrealized Pension Costs Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Noncash items: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Rate in excess of Federal funds rate Prime Rate Prime Rate Accounting Standards Update 2020-06 [Member] EX-101.PRE 10 nvst-20220401_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 nvst-20220401_g1.jpg GRAPHIC begin 644 nvst-20220401_g1.jpg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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page - shares
 3 Months Ended
Apr. 01, 2022
Apr. 29, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Apr. 01, 2022  
Document Transition Report false  
Entity File Number 001-39054  
Entity Registrant Name ENVISTA HOLDINGS CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 83-2206728  
Entity Address, Address Line One 200 S. Kraemer Blvd., Building E  
Entity Address, City or Town Brea,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92821-6208  
City Area Code 714  
Local Phone Number 817-7000  
Title of 12(b) Security Common stock, $0.01 par value  
Trading Symbol NVST  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   162,617,557
Amendment Flag false  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
Entity Central Index Key 0001757073  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,078.3 $ 1,073.6
Trade accounts receivable, less allowance for credit losses of $20.3 and $20.7, respectively 342.6 331.9
Inventories, net 280.4 263.8
Prepaid expenses and other current assets 197.4 154.3
Assets held for sale 10.2 12.2
Total current assets 1,908.9 1,835.8
Property, plant and equipment, net 264.2 264.1
Operating lease right-of-use assets 127.0 128.1
Other long-term assets 174.9 167.8
Goodwill 3,090.5 3,132.0
Other intangible assets, net 1,006.8 1,046.4
Total assets 6,572.3 6,574.2
Current liabilities:    
Short-term debt 507.8 432.4
Trade accounts payable 180.6 185.8
Accrued expenses and other liabilities 541.4 562.3
Operating lease liabilities 23.5 23.7
Liabilities held for sale 2.4 4.0
Total current liabilities 1,255.7 1,208.2
Operating lease liabilities 120.6 120.4
Other long-term liabilities 288.2 304.2
Long-term debt 876.9 883.4
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at April 1, 2022 and December 31, 2021 0.0 0.0
Common stock - $0.01 par value, 500.0 million shares authorized;163.2 million shares issued and 162.6 million shares outstanding at April 1, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021 1.6 1.6
Additional paid-in capital 3,667.9 3,732.6
Retained earnings 563.2 466.9
Accumulated other comprehensive loss (201.8) (143.5)
Total Envista stockholders’ equity 4,030.9 4,057.6
Noncontrolling interests 0.0 0.4
Total stockholders’ equity 4,030.9 4,058.0
Total liabilities and stockholders’ equity $ 6,572.3 $ 6,574.2
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 20.3 $ 20.7
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred shares authorized (in shares) 15,000,000 15,000,000
Preferred shares issued (in shares) 0 0
Preferred shares outstanding (in shares) 0 0
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 163,200,000 162,000,000
Common stock, shares outstanding (in shares) 162,600,000 161,600,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Income Statement [Abstract]    
Sales $ 631.4 $ 612.6
Cost of sales 257.3 254.2
Gross profit 374.1 358.4
Operating expenses:    
Selling, general and administrative 258.2 237.5
Research and development 24.4 25.8
Operating profit 91.5 95.1
Nonoperating income (expense):    
Other income 0.3 0.3
Interest expense, net (5.9) (18.0)
Income before income taxes 85.9 77.4
Income tax expense 15.5 15.6
Income from continuing operations, net of tax 70.4 61.8
Income from discontinued operations, net of tax (refer to Note 2) 4.5 9.9
Net income $ 74.9 $ 71.7
Earnings per share:    
Earnings from continuing operations - basic (in USD per share) $ 0.43 $ 0.39
Earnings from continuing operations - diluted (in USD per share) 0.39 0.35
Earnings from discontinued operations - basic (in USD per share) 0.03 0.06
Earnings from discontinued operations - diluted (in USD per share) 0.03 0.06
Earnings - basic (in USD per share) 0.46 0.45
Earnings - diluted (in USD per share) $ 0.42 $ 0.41
Average common stock and common equivalent shares outstanding:    
Basic (in shares) 162.2 160.5
Diluted (in shares) 179.8 175.9
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Statement of Comprehensive Income [Abstract]    
Net income $ 74.9 $ 71.7
Other comprehensive (loss) income, net of income taxes:    
Foreign currency translation adjustments (59.6) (53.7)
Cash flow hedge adjustments 1.4 1.4
Pension plan adjustments (0.1) 0.2
Total other comprehensive loss, net of income taxes (58.3) (52.1)
Comprehensive income $ 16.6 $ 19.6
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Total Envista Equity
Total Envista Equity
Adjustment
Total Envista Equity
Adjusted balance
Common Stock
Common Stock
Adjusted balance
Additional Paid-in Capital
Additional Paid-in Capital
Adjustment
Additional Paid-in Capital
Adjusted balance
Retained Earnings
Retained Earnings
Adjustment
Retained Earnings
Adjusted balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Adjusted balance
Noncontrolling Interests
Noncontrolling Interests
Adjusted balance
Balance, beginning of period at Dec. 31, 2020   $ 3,720.6     $ 1.6   $ 3,684.4     $ 126.4     $ (91.8)   $ 0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   6.7         6.7                  
Net income $ 71.7 71.7               71.7            
Other comprehensive income (loss) $ (52.1) (52.1)                     (52.1)      
Balance, end of period at Apr. 02, 2021   3,746.9     1.6   3,691.1     198.1     (143.9)   0.4  
Balance, beginning of period at Dec. 31, 2020   3,720.6     1.6   3,684.4     126.4     (91.8)   0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                              
Balance, end of period at Dec. 31, 2021 $ 4,058.0 4,057.6 $ (56.4) $ 4,001.2 1.6 $ 1.6 3,732.6 $ (77.8) $ 3,654.8 466.9 $ 21.4 $ 488.3 (143.5) $ (143.5) 0.4 $ 0.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Change in noncontrolling interest                             (0.4)  
Common stock-based award activity   13.1         13.1                  
Net income 74.9 74.9               74.9            
Other comprehensive income (loss) (58.3) (58.3)                     (58.3)      
Balance, end of period at Apr. 01, 2022 $ 4,030.9 $ 4,030.9     $ 1.6   $ 3,667.9     $ 563.2     $ (201.8)   $ 0.0  
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Cash flows from operating activities:    
Net income $ 74.9 $ 71.7
Noncash items:    
Depreciation 7.8 10.3
Amortization 23.5 21.0
Allowance for credit losses 1.7 2.9
Stock-based compensation expense 7.5 6.4
Gain on sale of Kavo treatment unit and instrument business (6.0) 0.0
Restructuring charges (1.9) 0.0
Impairment charges 3.9 1.9
Amortization of right-of-use assets 6.4 7.2
Amortization of debt discount and issuance costs 1.0 6.2
Change in trade accounts receivable (16.2) (5.1)
Change in inventories (20.3) (20.4)
Change in trade accounts payable (2.5) (27.6)
Change in prepaid expenses and other assets (16.8) (7.9)
Change in accrued expenses and other liabilities (51.5) (37.9)
Change in operating lease liabilities (8.0) (12.1)
Net cash provided by operating activities 3.5 16.6
Cash flows from investing activities:    
Payments for additions to property, plant and equipment (19.8) (8.3)
Proceeds from sale of Kavo treatment unit and instrument business 30.0 0.0
All other investing activities, net (5.1) 2.8
Net cash provided by (used in) investing activities 5.1 (5.5)
Cash flows from financing activities:    
Payment of debt issuance and other deferred financing costs 0.0 (0.4)
Proceeds from borrowings 0.3 0.0
Repayment of borrowings (0.5) (475.5)
Proceeds from stock option exercises 13.1 5.3
Tax withholding payment related to net settlement of equity awards (7.6) (5.2)
All other financing activities 0.0 6.2
Net cash provided by (used in) financing activities 5.3 (469.6)
Effect of exchange rate changes on cash and cash equivalents (9.2) 10.8
Net change in cash and cash equivalents 4.7 (447.7)
Beginning balance of cash and cash equivalents 1,073.6 888.9
Ending balance of cash and cash equivalents 1,078.3 441.2
Supplemental data:    
Cash paid for interest 2.8 10.5
Cash paid for taxes 14.1 5.7
ROU assets obtained in exchange for operating lease obligations $ 7.1 $ 2.6
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Business And Basis Of Presentation
 3 Months Ended
Apr. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Basis of Presentation BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.

The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of April 1, 2022 and December 31, 2021, and its results of operations and cash flows for the three month periods ended April 1, 2022 and April 2, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.

As discussed in Note 2, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

During the first quarter of 2022, the Company continued to see positive signs of recovery in certain markets in which it operates, however, certain markets continue to be more adversely impacted than others. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted the Company’s operations in China. The extent to which these restrictions continue and the possible geographical expansion of these restrictions will depend upon the Chinese authorities’ response to the affected regions of China.
The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on the Company's customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, the ability of the Company to continue to manufacture and source its products and to find suitable alternative products at reasonable prices, the Company’s ability to continue to ship and deliver its products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on the Company’s ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can resume, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, the Company may continue to experience materially adverse impacts on the Company’s financial condition and results of operations.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including by impacting the Company’s ability to market and sell products in Russia, by impacting its ability to enforce its intellectual property rights in Russia, by creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

Accounting Standards Recently Adopted

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Condensed Consolidated Financial Statements.

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.

The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 12 for a further discussion of the impact of adopting ASU 2020-06.
Accounting Standards Not Yet Adopted

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform, if certain criteria are met. The ASU is effective for public entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. If an entity elects to apply any of the amendments for an eligible hedging relationship existing as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of that interim period and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable). If an entity elects to apply any of the amendments for a new hedging relationship entered into as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of the hedging relationship and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable).
The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company has not yet completed its assessment of the impact of the new standard on the Company’s Condensed Consolidated Financial Statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations
 3 Months Ended
Apr. 01, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations DISCONTINUED OPERATIONS
On December 31, 2021, the Company completed the sale of substantially all of KaVo Treatment Units and Instruments Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, the Company received cash consideration of $317.3 million upon closing, which remains subject to certain adjustments.

The Company recognized a gain of $4.6 million on the Divestiture during the three months ended April 1, 2022 primarily due to the recognition of certain purchase price adjustments. In addition, the Company received an earnout payment of $30.0 million in the first quarter of 2022.

On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") will be deferred until the purchaser has formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement can be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture. The Company recognized a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions as of April 1, 2022, and December 31, 2021. The Company will recognize the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. As of April 1, 2022, none of the Relevant Jurisdictions had closed. The Relevant Jurisdictions are expected to close at various points throughout 2022.

In conjunction with the Divestiture, the Company entered into a customary transition services agreement, which requires support transition services to Planmeca throughout the applicable transition period.

For the three months ended April 1, 2022 the Divestiture continued to meet the criteria to be classified as held for sale and to be presented as a discontinued operation. Accordingly, the Company reclassified the results of operations and financial position of the Divestiture to discontinued operations in its accompanying Condensed Consolidated Statements of Income and Condensed Consolidated Balance Sheets for all periods presented. The Company’s Condensed Consolidated Statements of Cash Flows for all periods presented include the financial results of the KaVo Treatment Unit and Instruments Business.
For the three months ended April 2, 2021, balances represent activity for the entire Divestiture, while balances for the three month ended April 1, 2022, represent activity for the remaining Relevant Jurisdictions.
The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):

As of
April 1, 2022December 31, 2021
ASSETS
Current assets:
Assets for relevant jurisdictions$10.2 $12.2 
Current assets held for sale$10.2 $12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for relevant jurisdictions$2.4 $4.0 
Current liabilities held for sale$2.4 $4.0 

The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions):
 Three Months Ended
 April 1, 2022April 2, 2021
Sales$6.9 $96.6 
Cost of sales5.9 57.7 
Gross profit1.0 38.9 
Operating expenses:
Selling, general and administrative1.1 21.3 
Research and development— 4.4 
Operating (loss) profit(0.1)13.2 
Income tax (benefit) expense— 3.3 
(Loss) income from discontinued operations(0.1)9.9 
Gain on sale of discontinued operations, net of tax4.6 — 
Net income from discontinued operations$4.5 $9.9 

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Cash flows from operating activities
Depreciation and amortization1
$— $2.1 
Cash flows from investing activities:
Capital expenditures$— $0.9 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Credit Losses
 3 Months Ended
Apr. 01, 2022
Credit Loss [Abstract]  
Credit Losses CREDIT LOSSESThe allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.
Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors.

The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required.

The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation0.2 
Provision for credit losses1.7 
Write-offs charged against the allowance(1.6)
Recoveries(0.7)
Balance at April 1, 2022$20.3 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Inventories
 3 Months Ended
Apr. 01, 2022
Inventory Disclosure [Abstract]  
Inventories INVENTORIES
The classes of inventory are summarized as follows ($ in millions):
April 1, 2022December 31, 2021
Finished goods$228.0 $214.3 
Work in process23.5 22.0 
Raw materials87.5 88.3 
Reserve for inventory obsolescence(58.6)(60.8)
Total$280.4 $263.8 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Property, Plant And Equipment
 3 Months Ended
Apr. 01, 2022
Property, Plant and Equipment [Abstract]  
Property, Plant And Equipment PROPERTY, PLANT AND EQUIPMENT
The classes of property, plant and equipment are summarized as follows ($ in millions):
April 1, 2022December 31, 2021
Land and improvements$10.7 $10.7 
Buildings and improvements161.1 168.7 
Machinery, equipment and other assets360.1 354.5 
Construction in progress48.9 45.6 
Gross property, plant and equipment580.8 579.5 
Less: accumulated depreciation(316.6)(315.4)
Property, plant and equipment, net$264.2 $264.1 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill
 3 Months Ended
Apr. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GOODWILL
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance at December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Foreign currency translation(33.0)(8.5)(41.5)
Balance at April 1, 2022$1,996.7 $1,093.8 $3,090.5 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses And Other Liabilities
 3 Months Ended
Apr. 01, 2022
Accrued expenses and other [Abstract]  
Accrued Expenses And Other Liabilities ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities were as follows ($ in millions):
April 1, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$140.8 $19.6 $188.9 $17.9 
Restructuring-related employee severance, benefits and other14.0 — 21.9 — 
Pension benefits5.6 40.1 5.6 41.7 
Taxes, income and other48.3 184.4 48.1 201.4 
Contract liabilities73.3 5.7 60.1 5.1 
Sales and product allowances63.7 1.5 75.4 1.2 
Loss contingencies10.1 30.9 8.4 30.3 
Derivative financial instruments0.4 — 19.6 — 
Other185.2 6.0 134.3 6.6 
Total$541.4 $288.2 $562.3 $304.2 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Transactions And Derivative Financial Instruments
 3 Months Ended
Apr. 01, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Transactions and Derivative Financial Instruments HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS The Company uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintains cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively convert the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offsets the impact of changes in currency rates on foreign currency denominated net investments. The changes in the fair value of these instruments are recorded in accumulated other comprehensive loss in equity, in the accompanying Condensed Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss as reflected in Note 13. Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps is recorded in interest expense, net in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. These instruments mature in September 2024.
The Company also has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Condensed Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 13). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 12 for a further discussion of the above loan facilities.
The Company uses interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchange interest payments based on variable rates for interest payments based on fixed rates. The changes in the fair value of these instruments are recorded in accumulated other comprehensive loss in equity (see Note 13). Any ineffective portions of the cash flow hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps is recorded in interest expense in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. The current outstanding interest rate swap matures in September 2022.
The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):

Notional AmountGain Recognized in OCI
Three Months Ended April 1, 2022
Interest rate contract$250.0 $1.8 
Foreign currency contracts650.0 17.9 
Foreign currency denominated debt229.7 6.8 
Total$1,129.7 $26.5 
Notional AmountGain Recognized in OCI
Three Months Ended April 2, 2021
Interest rate contracts$450.0 $1.8 
Foreign currency contracts650.0 25.6 
Foreign currency denominated debt244.7 16.2 
Total$1,344.7 $43.6 

Gains or losses related to the foreign currency contracts and foreign currency denominated debt are classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 13, as these items are attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts are classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 13. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the three months ended April 1, 2022 and April 2, 2021. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the three months ended April 1, 2022 and April 2, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Condensed Consolidated Statements of Cash Flows.
The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):
April 1, 2022December 31, 2021
Derivative Assets:
Other long-term assets$0.9 $— 
Derivative liabilities:
Accrued expenses and other liabilities$0.4 $19.6 
Nonderivative hedging instruments:
Long-term debt$229.7 $236.5 
Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
 3 Months Ended
Apr. 01, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
April 1, 2022:
Assets:
Cross-currency swap derivative contracts$— $0.9 $— $0.9 
Liabilities:
Interest rate swap derivative contracts$— $0.4 $— $0.4 
Deferred compensation plans$— $17.9 $— $17.9 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
Derivative Instruments
The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. The interest rate swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and forward curves as inputs. Refer to Note 8 for additional information.
Deferred Compensation Plans
Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Condensed Consolidated Balance Sheets (refer to Note 7). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
April 1, 2022December 31, 2021
 Carrying AmountFair ValueCarrying AmountFair Value
Assets:
Cross-currency swap derivative contracts$0.9 $0.9 $— $— 
Liabilities:
Interest rate swap derivative contracts$0.4 $0.4 $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$507.8 $1,213.8 $432.1 $1,162.5 
Long-term debt$876.9 $876.9 $883.4 $883.4 
The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on April 1, 2022 and December 31, 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Warranty
 3 Months Ended
Apr. 01, 2022
Commitments and Contingencies Disclosure [Abstract]  
Warranty WARRANTYThe Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year4.2 
Settlements made(3.7)
Effect of foreign currency translation(0.1)
Balance at April 1, 2022$9.8 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Litigation And Contingencies
 3 Months Ended
Apr. 01, 2022
Commitments and Contingencies Disclosure [Abstract]  
Litigation And Contingencies LITIGATION AND CONTINGENCIES
The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated.

The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $41.0 million and $38.7 million as of April 1, 2022 and December 31, 2021, respectively, which are included in accrued liabilities in the Condensed Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Condensed Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Debt And Credit Facilities
 3 Months Ended
Apr. 01, 2022
Debt Disclosure [Abstract]  
Debt And Credit Facilities DEBT AND CREDIT FACILITIES
The components of the Company’s debt were as follows ($ in millions):
April 1, 2022December 31, 2021
Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $2.4 and $2.7, respectively
$647.6 $647.3 
Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.4 and $0.5, respectively
229.3 236.1 
Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $9.7 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively
507.8 432.1 
Other— 0.3 
Total debt1,384.7 1,315.8 
Less: current portion(507.8)(432.4)
Long-term debt$876.9 $883.4 
As of April 1, 2022 unamortized debt issuance costs totaled $12.5 million. As of December 31, 2021 unamortized debt issuance costs and discount totaled $88.6 million. Unamortized debt issuance costs and discount have been netted against their respective aggregate principal amounts of the related debt in the table above, and are being amortized to interest expense over the term of the respective debt.
Long-Term Indebtedness
Credit Agreement
On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan Facility and the three-year €600.0 million Euro Term Loan Facility (together with the Term Loan Facility, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (the “Revolving Credit Facility” and together with the Term Loans, the “Senior Credit Facilities”). Pursuant to the Separation Agreement, all of the net proceeds of the Term Loans were paid to Danaher as partial consideration for the Dental business Danaher transferred to Envista.

On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan Facility.

On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks including Bank of America, N.A. as administrative agent (the “Administrative Agent”). The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the Revolving Credit Facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the Revolving Credit Facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the Revolving Credit Facility and the Term Loan Facility has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

The Revolving Credit Facility includes an aggregate principal amount of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit. The Revolving Credit Facility can be used for working capital and other general corporate purposes. As of April 1, 2022 and December 31, 2021, there were no borrowings outstanding under the Revolving Credit Facility.
Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the Revolving Credit Facility, whether drawn or not.
The interest rates for borrowings under the Term Loan Facility were 1.34% and 1.25% as of April 1, 2022 and December 31, 2021, respectively. The interest rate for borrowings under the Euro Term Loan Facility was 0.95% as of April 1, 2022 and December 31, 2021. Interest is payable quarterly for the Term Loans. The Company has entered into interest rate swap derivative contracts for the Term Loan Facility, as further discussed in Note 8. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of April 1, 2022.
Convertible Senior Notes (the “Notes”)

On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.

Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.

Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, as discussed in Note 1, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs.

As of April 1, 2022, the unamortized debt issuance costs on the Notes was $9.7 million and is being amortized over the term of the Notes.

The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.
Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of April 1, 2022 and December 31, 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended April 1, 2022 and December 31, 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt.

The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption.

The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Three Months Ended
April 1, 2022April 2, 2021
Contractual interest expense
$3.1 $3.1 
Amortization of debt issuance costs
0.7 0.5 
Amortization of debt discount
— 4.6 
Total interest expense
$3.8 $8.2 

For the three months ended April 1, 2022, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0%, to interest expense over the term of the Notes.

As of April 1, 2022 and December 31, 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $667.0 million and $592.1 million, respectively.

Capped Call Transactions

In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Loss
 3 Months Ended
Apr. 01, 2022
Equity [Abstract]  
Accumulated Other Comprehensive Loss ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended April 1, 2022
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive (loss) income before reclassifications:
(Decrease) increase(53.8)1.8 — (52.0)
Income tax impact(5.8)(0.4)— (6.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(59.6)1.4 — (58.2)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.2)(0.2)
Income tax impact— — 0.1 0.1 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive (loss) income, net of income taxes(59.6)1.4 (0.1)(58.3)
Balance, April 1, 2022$(199.2)$(0.3)$(2.3)$(201.8)
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended April 2, 2021
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive loss before reclassifications:
(Decrease) increase(43.4)1.8 — (41.6)
Income tax impact(10.3)(0.4)— (10.7)
Other comprehensive (loss) income before reclassifications, net of income taxes(53.7)1.4 — (52.3)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — 0.2 0.2 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — 0.2 0.2 
Net current period other comprehensive (loss) income, net of income taxes(53.7)1.4 0.2 (52.1)
Balance, April 2, 2021$(116.2)$(4.9)$(22.8)$(143.9)
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue
 3 Months Ended
Apr. 01, 2022
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
The following table presents the Company’s revenues disaggregated by geographical region for the three months ended April 1, 2022 and April 2, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Three Months Ended April 1, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$179.3 $156.3 $335.6 
Western Europe106.3 32.0 138.3 
Other developed markets24.4 10.3 34.7 
Emerging markets87.1 35.7 122.8 
Total$397.1 $234.3 $631.4 

Three Months Ended April 2, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$162.6 $164.7 $327.3 
Western Europe94.7 31.0 125.7 
Other developed markets25.5 10.3 35.8 
Emerging markets83.5 40.3 123.8 
Total$366.3 $246.3 $612.6 

Sales by Major Product Group:
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Consumables$529.9 $514.0 
Equipment101.5 98.6 
Total$631.4 $612.6 
Remaining Performance Obligations
Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.
As of April 1, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $35.5 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.
Contract Liabilities
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of April 1, 2022 and December 31, 2021, the contract liabilities were $79.0 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Revenue recognized during the three months ended April 1, 2022 that was included in the contract liability balance at December 31, 2021 was $24.8 million. Revenue recognized during the three months ended April 2, 2021 that was included in the contract liability balance at December 31, 2020 was $18.9 million.
Significant Customers
Sales to the Company’s largest customer were 10% and 13% of sales for the three months ended April 1, 2022 and April 2, 2021, respectively. No other individual customer accounted for more than 10% of sales for the three months ended April 1, 2022 and April 2, 2021, respectively.

Seasonality

Based on historical experience, the Company generally has more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, the Company generally has more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in the Equipment & Consumables segment. As a result of this seasonality in sales, profitability in the Equipment & Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future and the ongoing COVID-19 pandemic may impact these trends.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring Activities And Related Impairments
 3 Months Ended
Apr. 01, 2022
Restructuring and Related Activities [Abstract]  
Restructuring Activities And Related Impairments RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS
Restructuring Activities
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, either in the normal course of business or pursuant to significant restructuring programs.
The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 $21.9 
Costs incurred(0.8)0.3 (0.5)
Paid/settled(7.0)(0.4)(7.4)
Balance, April 1, 2022$13.6 $0.4 $14.0 

Restructuring related charges recorded for the three months ended April 1, 2022 and April 2, 2021, by segment were as follows ($ in millions): 
Three Months Ended
April 1, 2022April 2, 2021
Specialty Products & Technologies$4.0 $3.4 
Equipment & Consumables(0.9)1.9 
Other0.6 2.5 
Total$3.7 $7.8 
The restructuring related charges incurred during the three months ended April 1, 2022 and April 2, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Cost of sales$(0.3)$2.9 
Selling, general and administrative expenses4.0 4.9 
Total$3.7 $7.8 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes
 3 Months Ended
Apr. 01, 2022
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES The Company’s effective tax rates from continuing operations of 18.0% and 20.2% for the three months ended April 1, 2022 and April 2, 2021, respectively, differ from the U.S. federal statutory rate of 21.0%, primarily due to the Company’s geographical mix of earnings and net discrete tax benefits.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share
 3 Months Ended
Apr. 01, 2022
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE
Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares in the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the three months ended April 1, 2022 and April 2, 2021.

In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 12), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.
The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Three Months Ended
April 1, 2022April 2, 2021
Numerator:
Income from continuing operations, net of tax$70.4 $61.8 
Income from discontinued operations, net of tax$4.5 $9.9 
Net income $74.9 $71.7 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share162.2 160.5 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units4.2 4.4 
Assumed conversion of the Notes13.4 11.0 
Weighted average common shares outstanding used in diluted earnings (loss) per share179.8 175.9 
Earnings per share:
Earnings from continuing operations - basic$0.43 $0.39 
Earnings from continuing operations - diluted$0.39 $0.35 
Earnings from discontinued operations - basic$0.03 $0.06 
Earnings from discontinued operations - diluted$0.03 $0.06 
Earnings - basic$0.46 $0.45 
Earnings - diluted$0.42 $0.41 

The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Three Months Ended
April 1, 2022April 2, 2021
Stock-based awards0.6 0.6 
Total0.6 0.6 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information
 3 Months Ended
Apr. 01, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense) and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.

The Company’s Specialty Products & Technologies products include implants, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.
On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment & Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 2 for more information on the Company’s discontinued operations.

Segment related information is shown below ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Sales:
Specialty Products & Technologies$397.1 $366.5 
Equipment & Consumables234.3 246.1 
Total$631.4 $612.6 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$70.3 $78.4 
Equipment & Consumables45.5 45.0 
Other(24.3)(28.3)
Operating profit91.5 95.1 
Nonoperating income (expense):
   Other income0.3 0.3 
   Interest expense, net(5.9)(18.0)
Income before taxes from continuing operations$85.9 $77.4 
Identifiable assets:April 1, 2022December 31, 2021
Specialty Products & Technologies$3,418.8 $3,498.2 
Equipment & Consumables2,005.0 1,946.1 
Held for Sale10.2 12.2 
Other1,138.3 1,117.7 
Total$6,572.3 $6,574.2 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
 3 Months Ended
Apr. 01, 2022
Subsequent Events [Abstract]  
Subsequent Events SUBSEQUENT EVENTOn April 20, 2022, the Company completed its purchase of Carestream Dental Technology Parent Limited’s (“Carestream”) intraoral scanner business for total consideration of approximately $582.5 million, subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021. The Company has purchased the intraoral scanner business through the acquisition of certain assets and the assumption of certain liabilities, as well as the acquisition of the equity of certain subsidiaries of Carestream.
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Business And Basis Of Presentation (Policies)
 3 Months Ended
Apr. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.

The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of April 1, 2022 and December 31, 2021, and its results of operations and cash flows for the three month periods ended April 1, 2022 and April 2, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.

As discussed in Note 2, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.
Accounting Standards Recently Adopted and Not Yet Adopted
Accounting Standards Recently Adopted

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Condensed Consolidated Financial Statements.

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.

The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 12 for a further discussion of the impact of adopting ASU 2020-06.
Accounting Standards Not Yet Adopted

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform, if certain criteria are met. The ASU is effective for public entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. If an entity elects to apply any of the amendments for an eligible hedging relationship existing as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of that interim period and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable). If an entity elects to apply any of the amendments for a new hedging relationship entered into as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of the hedging relationship and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable).
The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company has not yet completed its assessment of the impact of the new standard on the Company’s Condensed Consolidated Financial Statements.
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations (Tables)
 3 Months Ended
Apr. 01, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations
The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):

As of
April 1, 2022December 31, 2021
ASSETS
Current assets:
Assets for relevant jurisdictions$10.2 $12.2 
Current assets held for sale$10.2 $12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for relevant jurisdictions$2.4 $4.0 
Current liabilities held for sale$2.4 $4.0 

The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions):
 Three Months Ended
 April 1, 2022April 2, 2021
Sales$6.9 $96.6 
Cost of sales5.9 57.7 
Gross profit1.0 38.9 
Operating expenses:
Selling, general and administrative1.1 21.3 
Research and development— 4.4 
Operating (loss) profit(0.1)13.2 
Income tax (benefit) expense— 3.3 
(Loss) income from discontinued operations(0.1)9.9 
Gain on sale of discontinued operations, net of tax4.6 — 
Net income from discontinued operations$4.5 $9.9 

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Cash flows from operating activities
Depreciation and amortization1
$— $2.1 
Cash flows from investing activities:
Capital expenditures$— $0.9 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Credit Losses (Tables)
 3 Months Ended
Apr. 01, 2022
Credit Loss [Abstract]  
Allowance for Credit Loss
The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation0.2 
Provision for credit losses1.7 
Write-offs charged against the allowance(1.6)
Recoveries(0.7)
Balance at April 1, 2022$20.3 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Inventories (Tables)
 3 Months Ended
Apr. 01, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory
The classes of inventory are summarized as follows ($ in millions):
April 1, 2022December 31, 2021
Finished goods$228.0 $214.3 
Work in process23.5 22.0 
Raw materials87.5 88.3 
Reserve for inventory obsolescence(58.6)(60.8)
Total$280.4 $263.8 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Property, Plant And Equipment (Tables)
 3 Months Ended
Apr. 01, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
The classes of property, plant and equipment are summarized as follows ($ in millions):
April 1, 2022December 31, 2021
Land and improvements$10.7 $10.7 
Buildings and improvements161.1 168.7 
Machinery, equipment and other assets360.1 354.5 
Construction in progress48.9 45.6 
Gross property, plant and equipment580.8 579.5 
Less: accumulated depreciation(316.6)(315.4)
Property, plant and equipment, net$264.2 $264.1 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill (Tables)
 3 Months Ended
Apr. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Rollforward and Carrying Value Of Goodwill
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance at December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Foreign currency translation(33.0)(8.5)(41.5)
Balance at April 1, 2022$1,996.7 $1,093.8 $3,090.5 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses And Other Liabilities (Tables)
 3 Months Ended
Apr. 01, 2022
Accrued expenses and other [Abstract]  
The Components of Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities were as follows ($ in millions):
April 1, 2022December 31, 2021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$140.8 $19.6 $188.9 $17.9 
Restructuring-related employee severance, benefits and other14.0 — 21.9 — 
Pension benefits5.6 40.1 5.6 41.7 
Taxes, income and other48.3 184.4 48.1 201.4 
Contract liabilities73.3 5.7 60.1 5.1 
Sales and product allowances63.7 1.5 75.4 1.2 
Loss contingencies10.1 30.9 8.4 30.3 
Derivative financial instruments0.4 — 19.6 — 
Other185.2 6.0 134.3 6.6 
Total$541.4 $288.2 $562.3 $304.2 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Transactions And Derivative Financial Instruments (Tables)
 3 Months Ended
Apr. 01, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments, Gain (Loss)
The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):

Notional AmountGain Recognized in OCI
Three Months Ended April 1, 2022
Interest rate contract$250.0 $1.8 
Foreign currency contracts650.0 17.9 
Foreign currency denominated debt229.7 6.8 
Total$1,129.7 $26.5 
Notional AmountGain Recognized in OCI
Three Months Ended April 2, 2021
Interest rate contracts$450.0 $1.8 
Foreign currency contracts650.0 25.6 
Foreign currency denominated debt244.7 16.2 
Total$1,344.7 $43.6 
Schedule of Notional Amounts of Outstanding Derivative Positions
The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):

Notional AmountGain Recognized in OCI
Three Months Ended April 1, 2022
Interest rate contract$250.0 $1.8 
Foreign currency contracts650.0 17.9 
Foreign currency denominated debt229.7 6.8 
Total$1,129.7 $26.5 
Notional AmountGain Recognized in OCI
Three Months Ended April 2, 2021
Interest rate contracts$450.0 $1.8 
Foreign currency contracts650.0 25.6 
Foreign currency denominated debt244.7 16.2 
Total$1,344.7 $43.6 
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):
April 1, 2022December 31, 2021
Derivative Assets:
Other long-term assets$0.9 $— 
Derivative liabilities:
Accrued expenses and other liabilities$0.4 $19.6 
Nonderivative hedging instruments:
Long-term debt$229.7 $236.5 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
 3 Months Ended
Apr. 01, 2022
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets And Liabilities At Carrying and Fair Value
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
April 1, 2022:
Assets:
Cross-currency swap derivative contracts$— $0.9 $— $0.9 
Liabilities:
Interest rate swap derivative contracts$— $0.4 $— $0.4 
Deferred compensation plans$— $17.9 $— $17.9 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
April 1, 2022December 31, 2021
 Carrying AmountFair ValueCarrying AmountFair Value
Assets:
Cross-currency swap derivative contracts$0.9 $0.9 $— $— 
Liabilities:
Interest rate swap derivative contracts$0.4 $0.4 $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$507.8 $1,213.8 $432.1 $1,162.5 
Long-term debt$876.9 $876.9 $883.4 $883.4 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Warranty (Tables)
 3 Months Ended
Apr. 01, 2022
Commitments and Contingencies Disclosure [Abstract]  
Warranty Accrual
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year4.2 
Settlements made(3.7)
Effect of foreign currency translation(0.1)
Balance at April 1, 2022$9.8 
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Debt And Credit Facilities (Tables)
 3 Months Ended
Apr. 01, 2022
Debt Disclosure [Abstract]  
Components Of Debt
The components of the Company’s debt were as follows ($ in millions):
April 1, 2022December 31, 2021
Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $2.4 and $2.7, respectively
$647.6 $647.3 
Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.4 and $0.5, respectively
229.3 236.1 
Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $9.7 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively
507.8 432.1 
Other— 0.3 
Total debt1,384.7 1,315.8 
Less: current portion(507.8)(432.4)
Long-term debt$876.9 $883.4 
Components of Note Interest Expense
The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Three Months Ended
April 1, 2022April 2, 2021
Contractual interest expense
$3.1 $3.1 
Amortization of debt issuance costs
0.7 0.5 
Amortization of debt discount
— 4.6 
Total interest expense
$3.8 $8.2 
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Loss (Tables)
 3 Months Ended
Apr. 01, 2022
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended April 1, 2022
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive (loss) income before reclassifications:
(Decrease) increase(53.8)1.8 — (52.0)
Income tax impact(5.8)(0.4)— (6.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(59.6)1.4 — (58.2)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — (0.2)(0.2)
Income tax impact— — 0.1 0.1 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (0.1)(0.1)
Net current period other comprehensive (loss) income, net of income taxes(59.6)1.4 (0.1)(58.3)
Balance, April 1, 2022$(199.2)$(0.3)$(2.3)$(201.8)
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Three Months Ended April 2, 2021
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive loss before reclassifications:
(Decrease) increase(43.4)1.8 — (41.6)
Income tax impact(10.3)(0.4)— (10.7)
Other comprehensive (loss) income before reclassifications, net of income taxes(53.7)1.4 — (52.3)
Amounts reclassified from accumulated other comprehensive loss:
Increase— — 0.2 0.2 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — 0.2 0.2 
Net current period other comprehensive (loss) income, net of income taxes(53.7)1.4 0.2 (52.1)
Balance, April 2, 2021$(116.2)$(4.9)$(22.8)$(143.9)
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue (Tables)
 3 Months Ended
Apr. 01, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue by Geographical Region and Type
The following table presents the Company’s revenues disaggregated by geographical region for the three months ended April 1, 2022 and April 2, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Three Months Ended April 1, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$179.3 $156.3 $335.6 
Western Europe106.3 32.0 138.3 
Other developed markets24.4 10.3 34.7 
Emerging markets87.1 35.7 122.8 
Total$397.1 $234.3 $631.4 

Three Months Ended April 2, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$162.6 $164.7 $327.3 
Western Europe94.7 31.0 125.7 
Other developed markets25.5 10.3 35.8 
Emerging markets83.5 40.3 123.8 
Total$366.3 $246.3 $612.6 

Sales by Major Product Group:
Three Months Ended
($ in millions)April 1, 2022April 2, 2021
Consumables$529.9 $514.0 
Equipment101.5 98.6 
Total$631.4 $612.6 
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring Activities And Related Impairments (Tables)
 3 Months Ended
Apr. 01, 2022
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs
The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 $21.9 
Costs incurred(0.8)0.3 (0.5)
Paid/settled(7.0)(0.4)(7.4)
Balance, April 1, 2022$13.6 $0.4 $14.0 
Schedule of Restructuring Reserve by Type of Cost
Restructuring related charges recorded for the three months ended April 1, 2022 and April 2, 2021, by segment were as follows ($ in millions): 
Three Months Ended
April 1, 2022April 2, 2021
Specialty Products & Technologies$4.0 $3.4 
Equipment & Consumables(0.9)1.9 
Other0.6 2.5 
Total$3.7 $7.8 
The restructuring related charges incurred during the three months ended April 1, 2022 and April 2, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Cost of sales$(0.3)$2.9 
Selling, general and administrative expenses4.0 4.9 
Total$3.7 $7.8 
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share (Tables)
 3 Months Ended
Apr. 01, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Three Months Ended
April 1, 2022April 2, 2021
Numerator:
Income from continuing operations, net of tax$70.4 $61.8 
Income from discontinued operations, net of tax$4.5 $9.9 
Net income $74.9 $71.7 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share162.2 160.5 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units4.2 4.4 
Assumed conversion of the Notes13.4 11.0 
Weighted average common shares outstanding used in diluted earnings (loss) per share179.8 175.9 
Earnings per share:
Earnings from continuing operations - basic$0.43 $0.39 
Earnings from continuing operations - diluted$0.39 $0.35 
Earnings from discontinued operations - basic$0.03 $0.06 
Earnings from discontinued operations - diluted$0.03 $0.06 
Earnings - basic$0.46 $0.45 
Earnings - diluted$0.42 $0.41 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Three Months Ended
April 1, 2022April 2, 2021
Stock-based awards0.6 0.6 
Total0.6 0.6 
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information (Tables)
 3 Months Ended
Apr. 01, 2022
Segment Reporting [Abstract]  
Segment Results
Segment related information is shown below ($ in millions):
Three Months Ended
April 1, 2022April 2, 2021
Sales:
Specialty Products & Technologies$397.1 $366.5 
Equipment & Consumables234.3 246.1 
Total$631.4 $612.6 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$70.3 $78.4 
Equipment & Consumables45.5 45.0 
Other(24.3)(28.3)
Operating profit91.5 95.1 
Nonoperating income (expense):
   Other income0.3 0.3 
   Interest expense, net(5.9)(18.0)
Income before taxes from continuing operations$85.9 $77.4 
Identifiable assets:April 1, 2022December 31, 2021
Specialty Products & Technologies$3,418.8 $3,498.2 
Equipment & Consumables2,005.0 1,946.1 
Held for Sale10.2 12.2 
Other1,138.3 1,117.7 
Total$6,572.3 $6,574.2 
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Business And Basis Of Presentation - Narrative (Details)
$ in Millions
 3 Months Ended
Apr. 01, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Apr. 02, 2021
USD ($)
Dec. 31, 2020
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Number of business segments (in segments) | segment 2      
Long-term Debt $ 1,384.7 $ 1,315.8    
Stockholders' equity 4,030.9 4,058.0    
Additional Paid-in Capital        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Stockholders' equity 3,667.9 3,732.6 $ 3,691.1 $ 3,684.4
Retained Earnings        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Stockholders' equity $ 563.2 466.9 $ 198.1 $ 126.4
Adjustment        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net deferred tax liability   (18.6)    
Adjustment | Convertible Debt        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Long-term Debt   75.0    
Adjustment | Additional Paid-in Capital        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Stockholders' equity   (77.8)    
Adjustment | Retained Earnings        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Stockholders' equity   $ 21.4    
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Proceeds from sale of Kavo treatment unit and instrument business $ 30.0 $ 0.0  
Discontinued Operations, Disposed of by Sale | Plamenca      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Consideration     $ 317.3
Gain (loss) on disposal 4.6 $ 0.0  
Proceeds from sale of Kavo treatment unit and instrument business $ 30.0    
Liability for proceeds related to the Relevant Jurisdictions     $ 10.8
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Current assets:    
Current assets held for sale $ 10.2 $ 12.2
Current liabilities:    
Current liabilities held for sale 2.4 4.0
Discontinued Operations, Disposed of by Sale | Plamenca    
Current assets:    
Assets for relevant jurisdictions 10.2 12.2
Current assets held for sale 10.2 12.2
Current liabilities:    
Liabilities for relevant jurisdictions 2.4 4.0
Current liabilities held for sale $ 2.4 $ 4.0
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations - Operating Results (Details) - Discontinued Operations, Disposed of by Sale - Plamenca - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Sales $ 6.9 $ 96.6
Cost of sales 5.9 57.7
Gross profit 1.0 38.9
Operating expenses:    
Selling, general and administrative 1.1 21.3
Research and development 0.0 4.4
Operating (loss) profit (0.1) 13.2
Income tax (benefit) expense 0.0 3.3
(Loss) income from discontinued operations (0.1) 9.9
Gain on sale of discontinued operations, net of tax 4.6 0.0
Net income from discontinued operations $ 4.5 $ 9.9
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) - Discontinued Operations, Disposed of by Sale - Plamenca - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Cash flows from operating activities    
Depreciation and amortization $ 0.0 $ 2.1
Cash flows from investing activities:    
Capital expenditures $ 0.0 $ 0.9
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Credit Losses - Narrative (Details)
 3 Months Ended
Apr. 01, 2022
segment
Credit Loss [Abstract]  
Number of portfolio segments (in segments) 1
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Credit Losses - Allowance for Credit Losses (Details)
$ in Millions
 3 Months Ended
Apr. 01, 2022
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Beginning balance $ 20.7
Foreign currency translation 0.2
Provision for credit losses 1.7
Write-offs charged against the allowance (1.6)
Recoveries (0.7)
Ending balance $ 20.3
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Inventories - Summary (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Finished goods $ 228.0 $ 214.3
Work in process 23.5 22.0
Raw materials 87.5 88.3
Reserve for inventory obsolescence (58.6) (60.8)
Total $ 280.4 $ 263.8
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Property, Plant And Equipment (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 580.8 $ 579.5
Less: accumulated depreciation (316.6) (315.4)
Property, plant and equipment, net 264.2 264.1
Land and improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 10.7 10.7
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 161.1 168.7
Machinery, equipment and other assets    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 360.1 354.5
Construction in progress    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 48.9 $ 45.6
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill - Rollforward (Details)
$ in Millions
 3 Months Ended
Apr. 01, 2022
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 3,132.0
Foreign currency translation (41.5)
Ending balance 3,090.5
Specialty Products & Technologies  
Goodwill [Roll Forward]  
Beginning balance 2,029.7
Foreign currency translation (33.0)
Ending balance 1,996.7
Equipment & Consumables  
Goodwill [Roll Forward]  
Beginning balance 1,102.3
Foreign currency translation (8.5)
Ending balance $ 1,093.8
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses And Other Liabilities - Summary (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Current    
Compensation and benefits $ 140.8 $ 188.9
Restructuring-related employee severance, benefits and other 14.0 21.9
Pension benefits 5.6 5.6
Taxes, income and other 48.3 48.1
Contract liabilities 73.3 60.1
Sales and product allowances 63.7 75.4
Loss contingencies 10.1 8.4
Derivative financial instruments 0.4 19.6
Other 185.2 134.3
Total 541.4 562.3
Noncurrent    
Compensation and benefits 19.6 17.9
Restructuring-related employee severance, benefits and other 0.0 0.0
Pension benefits 40.1 41.7
Taxes, income and other 184.4 201.4
Contract liabilities 5.7 5.1
Sales and product allowances 1.5 1.2
Loss contingencies 30.9 30.3
Derivative financial instruments 0.0 0.0
Other 6.0 6.6
Total $ 288.2 $ 304.2
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Transactions And Derivative Financial Instruments - Narrative (Details)
Apr. 01, 2022
USD ($)
Apr. 01, 2022
EUR (€)
Dec. 31, 2021
USD ($)
Sep. 20, 2019
USD ($)
Sep. 20, 2019
EUR (€)
Derivative [Line Items]          
Total debt $ 1,384,700,000   $ 1,315,800,000    
US term loan due 2024          
Derivative [Line Items]          
Total debt 647,600,000   647,300,000 $ 650,000,000.0  
Term loan       $ 650,000,000.0  
Euro term loan due 2024          
Derivative [Line Items]          
Total debt $ 229,300,000   $ 236,100,000    
Term loan | €   € 208,000,000.0     € 600,000,000.0
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount $ 1,129.7 $ 1,344.7
Gain Recognized in OCI 26.5 43.6
Net investment hedging | Interest rate contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount 250.0 450.0
Gain Recognized in OCI 1.8 1.8
Net investment hedging | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount 650.0 650.0
Gain Recognized in OCI 17.9 25.6
Net investment hedging | Foreign currency denominated debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount 229.7 244.7
Gain Recognized in OCI $ 6.8 $ 16.2
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Other long-term assets    
Derivatives, Fair Value [Line Items]    
Derivative assets $ 0.9 $ 0.0
Accrued expenses and other liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liabilities 0.4 19.6
Long-term debt    
Derivatives, Fair Value [Line Items]    
Nonderivative hedging instruments $ 229.7 $ 236.5
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Liability    
Liabilities:    
Noncurrent deferred compensation liability $ 17.9 $ 16.5
Liability | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Noncurrent deferred compensation liability 0.0 0.0
Liability | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Noncurrent deferred compensation liability 17.9 16.5
Liability | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Noncurrent deferred compensation liability 0.0 0.0
Interest rate swap derivative contracts    
Liabilities:    
Derivative liabilities 0.4 2.2
Interest rate swap derivative contracts | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Derivative liabilities 0.0 0.0
Interest rate swap derivative contracts | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Derivative liabilities 0.4 2.2
Interest rate swap derivative contracts | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Derivative liabilities 0.0 0.0
Cross-currency swap derivative contracts    
Liabilities:    
Derivative assets 0.9  
Derivative liabilities   17.4
Cross-currency swap derivative contracts | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Derivative assets 0.0  
Derivative liabilities   0.0
Cross-currency swap derivative contracts | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Derivative assets 0.9  
Derivative liabilities   17.4
Cross-currency swap derivative contracts | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Derivative assets $ 0.0  
Derivative liabilities   $ 0.0
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible senior notes due 2025 $ 507.8 $ 432.1
Long-term debt 876.9 883.4
Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible senior notes due 2025 1,213.8 1,162.5
Long-term debt 876.9 883.4
Interest rate swap derivative contracts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 0.4 2.2
Interest rate swap derivative contracts | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 0.4 2.2
Interest rate swap derivative contracts | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 0.4 2.2
Cross-currency swap derivative contracts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 0.9  
Derivative liabilities   17.4
Cross-currency swap derivative contracts | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 0.9 0.0
Derivative liabilities 0.0 17.4
Cross-currency swap derivative contracts | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 0.9 0.0
Derivative liabilities $ 0.0 $ 17.4
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Warranty - Narrative (Details)
 3 Months Ended
Apr. 01, 2022
Commitments and Contingencies Disclosure [Abstract]  
Product warranty period 90 days
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.22.1
Warranty - Warranty Accrual (Details)
$ in Millions
 3 Months Ended
Apr. 01, 2022
USD ($)
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]  
Beginning balance $ 9.4
Accruals for warranties issued during the year 4.2
Settlements made (3.7)
Effect of foreign currency translation (0.1)
Ending balance $ 9.8
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.22.1
Litigation And Contingencies - Narrative (Details) - USD ($)
$ in Millions
Apr. 01, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Accrual for legal matters $ 41.0 $ 38.7
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.22.1
Debt And Credit Facilities - Components Of Debt (Details)
Apr. 01, 2022
USD ($)
Apr. 01, 2022
EUR (€)
Dec. 31, 2021
USD ($)
May 21, 2020
USD ($)
Sep. 20, 2019
USD ($)
Sep. 20, 2019
EUR (€)
Debt Instrument [Line Items]            
Total debt $ 1,384,700,000   $ 1,315,800,000      
Less: current portion (507,800,000)   (432,400,000)      
Long-term debt 876,900,000   883,400,000      
US term loan due 2024            
Debt Instrument [Line Items]            
Term loan         $ 650,000,000.0  
Debt issuance costs 2,400,000   2,700,000      
Total debt 647,600,000   647,300,000   $ 650,000,000.0  
Euro term loan due 2024            
Debt Instrument [Line Items]            
Term loan | €   € 208,000,000.0       € 600,000,000.0
Debt issuance costs 400,000   500,000      
Total debt 229,300,000   236,100,000      
Other            
Debt Instrument [Line Items]            
Total debt 0   300,000      
Convertible Debt | Convertible senior notes due 2025            
Debt Instrument [Line Items]            
Term loan       $ 517,500,000    
Debt issuance costs 9,700,000   8,900,000      
Unamortized discount 0.0   76,500,000      
Total debt $ 507,800,000   $ 432,100,000      
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.22.1
Debt And Credit Facilities - Narrative (Details)
$ / shares in Units, shares in Millions
 3 Months Ended 12 Months Ended
Jun. 15, 2021
USD ($)
Feb. 09, 2021
USD ($)
May 21, 2020
USD ($)
tradingDay
$ / shares
shares
Sep. 20, 2019
USD ($)
Apr. 01, 2022
USD ($)
tradingDay
$ / shares
Dec. 31, 2021
USD ($)
tradingDay
$ / shares
Apr. 01, 2022
EUR (€)
Apr. 02, 2021
USD ($)
Dec. 31, 2020
USD ($)
Sep. 20, 2019
EUR (€)
Debt Instrument [Line Items]                    
Unamortized debt issuance costs and discount         $ 12,500,000 $ 88,600,000        
Total borrowings under term loan       $ 1,300,000,000            
Senior unsecured revolving credit facility       $ 250,000,000.0            
Rate in excess of Federal funds rate         0.0050   0.0050      
Rate in excess of Eurocurrency rate         0.010   0.010      
Leverage ratio         3.75   3.75      
Contingency provision on the ratio of indebtedness to net capital         4.25   4.25      
Contingency provision, purchase price in excess of $100 million         $ 100,000,000.0          
Interest coverage ratio (at least)         3.00   3.00      
Conversion price (in USD per share) | $ / shares         $ 21.01 $ 21.01        
Total debt         $ 1,384,700,000 $ 1,315,800,000        
Stockholders' equity         4,030,900,000 4,058,000,000        
Additional Paid-in Capital                    
Debt Instrument [Line Items]                    
Stockholders' equity         3,667,900,000 3,732,600,000   $ 3,691,100,000 $ 3,684,400,000  
Retained Earnings                    
Debt Instrument [Line Items]                    
Stockholders' equity         563,200,000 466,900,000   198,100,000 $ 126,400,000  
Adjustment                    
Debt Instrument [Line Items]                    
Net deferred tax liability           (18,600,000)        
Adjustment | Additional Paid-in Capital                    
Debt Instrument [Line Items]                    
Stockholders' equity           (77,800,000)        
Adjustment | Retained Earnings                    
Debt Instrument [Line Items]                    
Stockholders' equity           21,400,000        
Fair Value                    
Debt Instrument [Line Items]                    
Fair value of notes         $ 876,900,000 $ 883,400,000        
US term loan due 2024                    
Debt Instrument [Line Items]                    
Debt instrument, term       3 years            
Term loan       $ 650,000,000.0            
Loan facility interest rates         1.34% 1.25%        
Total debt       $ 650,000,000.0 $ 647,600,000 $ 647,300,000        
Debt issuance costs         $ 2,400,000 $ 2,700,000        
Euro term loan due 2024                    
Debt Instrument [Line Items]                    
Debt instrument, term       3 years            
Term loan | €             € 208,000,000.0     € 600,000,000.0
Repayment of debt   $ 472,000,000.0                
Loan facility interest rates         0.95% 0.95%        
Total debt         $ 229,300,000 $ 236,100,000        
Debt issuance costs         400,000 500,000        
Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Senior unsecured revolving credit facility $ 750,000,000.0     $ 250,000,000.0            
Increase limit of revolving credit facility 350,000,000.0                  
Cash and cash equivalent threshold $ 250,000,000.0                  
EBITDA threshold 0.50                  
Payments of debt restructuring costs $ 2,100,000                  
Revolving credit facility maximum borrowing capacity         750,000,000.0          
Line of credit facility, outstanding borrowings         0 0        
Revolving Credit Facility | Standby letters of credit                    
Debt Instrument [Line Items]                    
Revolving credit facility maximum borrowing capacity         $ 20,000,000.0          
Minimum                    
Debt Instrument [Line Items]                    
Facility fee         0.09%          
Maximum                    
Debt Instrument [Line Items]                    
Facility fee         0.225%          
LIBOR | Minimum | Credit facility                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         0.785%          
LIBOR | Maximum | Credit facility                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         1.625%          
Base Rate | Minimum                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         0.00%          
Base Rate | Maximum                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         0.625%          
Line of Credit | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Debt instrument, term       5 years            
Convertible Debt | Adjustment                    
Debt Instrument [Line Items]                    
Total debt           75,000,000        
Unamortized discount (premium), net           76,500,000        
Debt issuance and deferred financing costs           1,500,000        
Convertible Debt | 2.375% convertible senior notes over allotment option                    
Debt Instrument [Line Items]                    
Term loan     $ 67,500,000              
Convertible Debt | 2.375% convertible senior notes                    
Debt Instrument [Line Items]                    
Term loan     517,500,000              
Proceeds from issuance of convertible senior notes     $ 502,600,000              
Interest rate     2.375%              
Conversion price (in USD per share) | $ / shares     $ 21.01              
Total debt         $ 507,800,000 $ 432,100,000        
Debt issuance and deferred financing costs               $ 9,700,000    
Redemption price     100.00%              
Threshold percentage of stock price trigger     130.00%   130.00% 130.00%        
Convertible debt, trading days (in trading days) | tradingDay     20   20 20        
Convertible debt, consecutive trading days (in trading days) | tradingDay     30   30 30        
Debt issuance costs         $ 9,700,000 $ 8,900,000        
Effective interest rate         3.00%   3.00%      
If-converted value in excess of principal         $ 667,000,000.0 $ 592,100,000        
Convertible debt, conversion ratio     0.0475862              
Convertible Debt | 2.375% convertible senior notes, capped calls                    
Debt Instrument [Line Items]                    
Conversion price (in USD per share) | $ / shares     $ 23.79              
Convertible debt, stock price trigger (in USD per share) | $ / shares     $ 21.01              
Convertible debt, capped calls (in shares) | shares     2.9              
Convertible debt expense, capped calls     $ 20,700,000              
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.22.1
Debt And Credit Facilities - Interest Expense (Details) - Convertible Debt - 2.375% convertible senior notes - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Debt Instrument [Line Items]    
Contractual interest expense $ 3.1 $ 3.1
Amortization of debt issuance costs 0.7 0.5
Amortization of debt discount 0.0 4.6
Total interest expense $ 3.8 $ 8.2
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Loss - Rollforward (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning of period $ 4,058.0  
Total other comprehensive loss, net of income taxes (58.3) $ (52.1)
Balance, end of period 4,030.9  
Accumulated Other Comprehensive Loss    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning of period (143.5) (91.8)
Increase (decrease) before reclassifications (52.0) (41.6)
Income tax impact (6.2) (10.7)
Other comprehensive (loss) income before reclassifications, net of income taxes (58.2) (52.3)
Increase (0.2) 0.2
Income tax impact 0.1  
Amounts reclassified from accumulated other comprehensive loss, net of income taxes (0.1) 0.2
Total other comprehensive loss, net of income taxes (58.3) (52.1)
Balance, end of period (201.8) (143.9)
Foreign Currency Translation Adjustments    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning of period (139.6) (62.5)
Increase (decrease) before reclassifications (53.8) (43.4)
Income tax impact (5.8) (10.3)
Other comprehensive (loss) income before reclassifications, net of income taxes (59.6) (53.7)
Increase 0.0 0.0
Income tax impact 0.0  
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0.0 0.0
Total other comprehensive loss, net of income taxes (59.6) (53.7)
Balance, end of period (199.2) (116.2)
Unrealized Gain (Loss) on Cash Flow Hedges    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning of period (1.7) (6.3)
Increase (decrease) before reclassifications 1.8 1.8
Income tax impact (0.4) (0.4)
Other comprehensive (loss) income before reclassifications, net of income taxes 1.4 1.4
Increase 0.0 0.0
Income tax impact 0.0  
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0.0 0.0
Total other comprehensive loss, net of income taxes 1.4 1.4
Balance, end of period (0.3) (4.9)
Unrealized Pension Costs    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning of period (2.2) (23.0)
Increase (decrease) before reclassifications 0.0 0.0
Income tax impact 0.0 0.0
Other comprehensive (loss) income before reclassifications, net of income taxes 0.0 0.0
Increase (0.2) 0.2
Income tax impact 0.1  
Amounts reclassified from accumulated other comprehensive loss, net of income taxes (0.1) 0.2
Total other comprehensive loss, net of income taxes (0.1) 0.2
Balance, end of period $ (2.3) $ (22.8)
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue - Disaggregation by Revenue Type and Geographical Region (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Disaggregation of Revenue [Line Items]    
Sales $ 631.4 $ 612.6
Consumables    
Disaggregation of Revenue [Line Items]    
Sales 529.9 514.0
Equipment    
Disaggregation of Revenue [Line Items]    
Sales 101.5 98.6
North America    
Disaggregation of Revenue [Line Items]    
Sales 335.6 327.3
Western Europe    
Disaggregation of Revenue [Line Items]    
Sales 138.3 125.7
Other developed markets    
Disaggregation of Revenue [Line Items]    
Sales 34.7 35.8
Emerging markets    
Disaggregation of Revenue [Line Items]    
Sales 122.8 123.8
Specialty Products & Technologies    
Disaggregation of Revenue [Line Items]    
Sales 397.1 366.3
Specialty Products & Technologies | North America    
Disaggregation of Revenue [Line Items]    
Sales 179.3 162.6
Specialty Products & Technologies | Western Europe    
Disaggregation of Revenue [Line Items]    
Sales 106.3 94.7
Specialty Products & Technologies | Other developed markets    
Disaggregation of Revenue [Line Items]    
Sales 24.4 25.5
Specialty Products & Technologies | Emerging markets    
Disaggregation of Revenue [Line Items]    
Sales 87.1 83.5
Equipment & Consumables    
Disaggregation of Revenue [Line Items]    
Sales 234.3 246.3
Equipment & Consumables | North America    
Disaggregation of Revenue [Line Items]    
Sales 156.3 164.7
Equipment & Consumables | Western Europe    
Disaggregation of Revenue [Line Items]    
Sales 32.0 31.0
Equipment & Consumables | Other developed markets    
Disaggregation of Revenue [Line Items]    
Sales 10.3 10.3
Equipment & Consumables | Emerging markets    
Disaggregation of Revenue [Line Items]    
Sales $ 35.7 $ 40.3
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue - Remaining Performance Obligations (Details)
$ in Millions
Apr. 01, 2022
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 35.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-02  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 12 months
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Contract liability $ 79.0   $ 65.2
Revenue recognized $ 24.8 $ 18.9  
Revenue Benchmark | Customer Concentration Risk | Largest customer      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 10.00% 13.00%  
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)
$ in Millions
 3 Months Ended
Apr. 01, 2022
USD ($)
Restructuring Reserve [Roll Forward]  
Balance at beginning of year $ 21.9
Costs incurred (0.5)
Paid/settled (7.4)
Balance at end of year 14.0
Employee Severance and Related  
Restructuring Reserve [Roll Forward]  
Balance at beginning of year 21.4
Costs incurred (0.8)
Paid/settled (7.0)
Balance at end of year 13.6
Facility Exit and Related  
Restructuring Reserve [Roll Forward]  
Balance at beginning of year 0.5
Costs incurred 0.3
Paid/settled (0.4)
Balance at end of year $ 0.4
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Restructuring Cost and Reserve [Line Items]    
Costs incurred $ 3.7 $ 7.8
Specialty Products & Technologies    
Restructuring Cost and Reserve [Line Items]    
Costs incurred 4.0 3.4
Equipment & Consumables    
Restructuring Cost and Reserve [Line Items]    
Costs incurred (0.9) 1.9
Other    
Restructuring Cost and Reserve [Line Items]    
Costs incurred $ 0.6 $ 2.5
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Restructuring Cost and Reserve [Line Items]    
Costs incurred $ 3.7 $ 7.8
Cost of sales    
Restructuring Cost and Reserve [Line Items]    
Costs incurred (0.3) 2.9
Selling, general and administrative expenses    
Restructuring Cost and Reserve [Line Items]    
Costs incurred $ 4.0 $ 4.9
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes - Narrative (Details)
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Income Tax Disclosure [Abstract]    
Effective tax rate 18.00% 20.20%
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share - Narrative (Details) - $ / shares
Apr. 01, 2022
Dec. 31, 2021
May 21, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Conversion price (in USD per share) $ 21.01 $ 21.01  
2.375% convertible senior notes | Convertible Debt      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Conversion price (in USD per share)     $ 21.01
Dilution threshold (in USD per share) $ 23.79    
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Numerator:    
Income from continuing operations, net of tax $ 70.4 $ 61.8
Income from discontinued operations, net of tax (refer to Note 2) 4.5 9.9
Net income $ 74.9 $ 71.7
Denominator:    
Weighted-average common shares outstanding used in basic earnings per share (in shares) 162.2 160.5
Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares) 4.2 4.4
Assumed conversion of the Notes (in shares) 13.4 11.0
Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares) 179.8 175.9
Earnings per share:    
Earnings from continuing operations - basic (in USD per share) $ 0.43 $ 0.39
Earnings from continuing operations - diluted (in USD per share) 0.39 0.35
Earnings from discontinued operations - basic (in USD per share) 0.03 0.06
Earnings from discontinued operations - diluted (in USD per share) 0.03 0.06
Earnings - basic (in USD per share) 0.46 0.45
Earnings - diluted (in USD per share) $ 0.42 $ 0.41
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) - shares
shares in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) 0.6 0.6
Stock-based awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) 0.6 0.6
XML 87 R76.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information - Narrative (Details)
 3 Months Ended
Apr. 01, 2022
segment
Segment Reporting [Abstract]  
Number of reportable segments (in segments) 2
Number of operating segments (in segments) 2
XML 88 R77.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information - Segment Results (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Sales $ 631.4 $ 612.6  
Operating profit (loss) 91.5 95.1  
Other income 0.3 0.3  
Interest expense, net (5.9) (18.0)  
Income before income taxes 85.9 77.4  
Identifiable assets 6,572.3   $ 6,574.2
Other      
Segment Reporting Information [Line Items]      
Operating profit (loss) (24.3) (28.3)  
Identifiable assets 1,138.3   1,117.7
Held for sale | Discontinued Operations, Disposed of by Sale      
Segment Reporting Information [Line Items]      
Held for Sale 10.2   12.2
Specialty Products & Technologies      
Segment Reporting Information [Line Items]      
Sales 397.1 366.3  
Specialty Products & Technologies | Operating segments      
Segment Reporting Information [Line Items]      
Sales 397.1 366.5  
Operating profit (loss) 70.3 78.4  
Identifiable assets 3,418.8   3,498.2
Equipment & Consumables      
Segment Reporting Information [Line Items]      
Sales 234.3 246.3  
Equipment & Consumables | Operating segments      
Segment Reporting Information [Line Items]      
Sales 234.3 246.1  
Operating profit (loss) 45.5 $ 45.0  
Identifiable assets $ 2,005.0   $ 1,946.1
XML 89 R78.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details)
$ in Millions
Apr. 20, 2022
USD ($)
Subsequent Event | Carestream Dental Technology  
Subsequent Event [Line Items]  
Consideration transferred $ 582.5
XML 90 nvst-20220401_htm.xml IDEA: XBRL DOCUMENT 0001757073 2022-01-01 2022-04-01 0001757073 2022-04-29 0001757073 2022-04-01 0001757073 2021-12-31 0001757073 2021-01-01 2021-04-02 0001757073 us-gaap:CommonStockMember 2021-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 us-gaap:RetainedEarningsMember 2021-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001757073 us-gaap:ParentMember 2021-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2021-12-31 0001757073 2021-01-01 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ParentMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:ParentMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:NoncontrollingInterestMember 2021-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-04-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-04-01 0001757073 us-gaap:ParentMember 2022-01-01 2022-04-01 0001757073 us-gaap:RetainedEarningsMember 2022-01-01 2022-04-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-04-01 0001757073 us-gaap:CommonStockMember 2022-04-01 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 0001757073 us-gaap:RetainedEarningsMember 2022-04-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 0001757073 us-gaap:ParentMember 2022-04-01 0001757073 us-gaap:NoncontrollingInterestMember 2022-04-01 0001757073 us-gaap:CommonStockMember 2020-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001757073 us-gaap:RetainedEarningsMember 2020-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001757073 us-gaap:ParentMember 2020-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2020-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-04-02 0001757073 us-gaap:ParentMember 2021-01-01 2021-04-02 0001757073 us-gaap:RetainedEarningsMember 2021-01-01 2021-04-02 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-04-02 0001757073 us-gaap:CommonStockMember 2021-04-02 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-04-02 0001757073 us-gaap:RetainedEarningsMember 2021-04-02 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-02 0001757073 us-gaap:ParentMember 2021-04-02 0001757073 us-gaap:NoncontrollingInterestMember 2021-04-02 0001757073 2020-12-31 0001757073 2021-04-02 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ConvertibleDebtMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2022-01-01 2022-04-01 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2022-04-01 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-01-01 2021-04-02 0001757073 us-gaap:LandAndLandImprovementsMember 2022-04-01 0001757073 us-gaap:LandAndLandImprovementsMember 2021-12-31 0001757073 us-gaap:BuildingAndBuildingImprovementsMember 2022-04-01 0001757073 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001757073 us-gaap:MachineryAndEquipmentMember 2022-04-01 0001757073 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001757073 us-gaap:ConstructionInProgressMember 2022-04-01 0001757073 us-gaap:ConstructionInProgressMember 2021-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-12-31 0001757073 nvst:EquipmentandConsumablesMember 2021-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-04-01 0001757073 nvst:EquipmentandConsumablesMember 2022-01-01 2022-04-01 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-04-01 0001757073 nvst:EquipmentandConsumablesMember 2022-04-01 0001757073 nvst:USTermLoanDue2024Member 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2022-04-01 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-04-01 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-04-01 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-04-01 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-04-01 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-04-01 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-04-01 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-04-02 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-04-02 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-04-02 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-04-02 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-04-02 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-04-02 0001757073 us-gaap:OtherNoncurrentAssetsMember 2022-04-01 0001757073 us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001757073 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-04-01 0001757073 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2021-12-31 0001757073 us-gaap:LongTermDebtMember 2022-04-01 0001757073 us-gaap:LongTermDebtMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member 2022-04-01 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member 2022-04-01 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member 2022-04-01 0001757073 us-gaap:CurrencySwapMember 2022-04-01 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2022-04-01 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2022-04-01 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2022-04-01 0001757073 us-gaap:InterestRateSwapMember 2022-04-01 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel1Member 2022-04-01 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel2Member 2022-04-01 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel3Member 2022-04-01 0001757073 us-gaap:LiabilityMember 2022-04-01 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember 2021-12-31 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:LiabilityMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-04-01 0001757073 us-gaap:CurrencySwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-04-01 0001757073 us-gaap:CurrencySwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-04-01 0001757073 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-04-01 0001757073 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-04-01 0001757073 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-04-01 0001757073 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 nvst:USTermLoanDue2024Member 2022-04-01 0001757073 nvst:USTermLoanDue2024Member 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-04-01 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-12-31 0001757073 us-gaap:OtherDebtSecuritiesMember 2022-04-01 0001757073 us-gaap:OtherDebtSecuritiesMember 2021-12-31 0001757073 2019-09-20 2019-09-20 0001757073 nvst:USTermLoanDue2024Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2019-09-20 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2021-02-09 2021-02-09 0001757073 us-gaap:RevolvingCreditFacilityMember 2019-09-20 2019-09-20 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-06-15 2021-06-15 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-06-15 0001757073 us-gaap:RevolvingCreditFacilityMember 2022-04-01 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:StandbyLettersOfCreditMember 2022-04-01 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001757073 srt:MinimumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-04-01 0001757073 srt:MaximumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-04-01 0001757073 srt:MinimumMember us-gaap:BaseRateMember 2022-01-01 2022-04-01 0001757073 srt:MaximumMember us-gaap:BaseRateMember 2022-01-01 2022-04-01 0001757073 srt:MinimumMember 2022-01-01 2022-04-01 0001757073 srt:MaximumMember 2022-01-01 2022-04-01 0001757073 nvst:USTermLoanDue2024Member 2022-01-01 2022-04-01 0001757073 nvst:USTermLoanDue2024Member 2021-01-01 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2022-01-01 2022-04-01 0001757073 nvst:EuroTermLoanDue2024Member 2021-01-01 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesOverAllotmentOptionMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-05-21 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-04-02 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-01-01 2022-04-01 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-04-02 0001757073 nvst:A2.375ConvertibleSeniorNotesCappedCallsMember us-gaap:ConvertibleDebtMember 2020-05-21 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesCappedCallsMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-04-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-04-01 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-04-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-04-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-04-01 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-04-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-04-02 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-04-02 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-04-02 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-02 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-04-02 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-04-02 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-04-01 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-04-01 0001757073 srt:NorthAmericaMember 2022-01-01 2022-04-01 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-04-01 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-04-01 0001757073 nvst:WesternEuropeMember 2022-01-01 2022-04-01 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-04-01 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-04-01 0001757073 nvst:OtherDevelopedMarketsMember 2022-01-01 2022-04-01 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-04-01 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-04-01 0001757073 nvst:HighGrowthMarketsMember 2022-01-01 2022-04-01 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-04-02 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-04-02 0001757073 srt:NorthAmericaMember 2021-01-01 2021-04-02 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-04-02 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-04-02 0001757073 nvst:WesternEuropeMember 2021-01-01 2021-04-02 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-04-02 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-04-02 0001757073 nvst:OtherDevelopedMarketsMember 2021-01-01 2021-04-02 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-04-02 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-04-02 0001757073 nvst:HighGrowthMarketsMember 2021-01-01 2021-04-02 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-04-02 0001757073 nvst:EquipmentandConsumablesMember 2021-01-01 2021-04-02 0001757073 nvst:ConsumablesMember 2022-01-01 2022-04-01 0001757073 nvst:ConsumablesMember 2021-01-01 2021-04-02 0001757073 nvst:EquipmentSalesMember 2022-01-01 2022-04-01 0001757073 nvst:EquipmentSalesMember 2021-01-01 2021-04-02 0001757073 2022-04-02 2022-04-01 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-04-01 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-04-02 0001757073 us-gaap:EmployeeSeveranceMember 2021-12-31 0001757073 us-gaap:FacilityClosingMember 2021-12-31 0001757073 us-gaap:EmployeeSeveranceMember 2022-01-01 2022-04-01 0001757073 us-gaap:FacilityClosingMember 2022-01-01 2022-04-01 0001757073 us-gaap:EmployeeSeveranceMember 2022-04-01 0001757073 us-gaap:FacilityClosingMember 2022-04-01 0001757073 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-04-01 0001757073 us-gaap:AllOtherSegmentsMember 2021-01-01 2021-04-02 0001757073 us-gaap:CostOfSalesMember 2022-01-01 2022-04-01 0001757073 us-gaap:CostOfSalesMember 2021-01-01 2021-04-02 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-04-01 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-04-02 0001757073 us-gaap:StockCompensationPlanMember 2022-01-01 2022-04-01 0001757073 us-gaap:StockCompensationPlanMember 2021-01-01 2021-04-02 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-04-01 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-04-02 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-04-01 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-04-02 0001757073 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-04-01 0001757073 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-04-02 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-04-01 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-04-01 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-12-31 0001757073 us-gaap:MaterialReconcilingItemsMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-04-01 0001757073 us-gaap:MaterialReconcilingItemsMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2022-04-01 0001757073 us-gaap:CorporateNonSegmentMember 2021-12-31 0001757073 nvst:CarestreamDentalTechnologyMember us-gaap:SubsequentEventMember 2022-04-20 2022-04-20 shares iso4217:USD iso4217:USD shares nvst:segment iso4217:EUR pure nvst:tradingDay false 2022 Q1 --12-31 0001757073 http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member 0.0475862 10-Q true 2022-04-01 false 001-39054 ENVISTA HOLDINGS CORPORATION DE 83-2206728 200 S. Kraemer Blvd., Building E 92821-6208 Brea, CA 714 817-7000 Common stock, $0.01 par value NVST NYSE Yes Yes Large Accelerated Filer false false false 162617557 1078300000 1073600000 20300000 20700000 342600000 331900000 280400000 263800000 197400000 154300000 10200000 12200000 1908900000 1835800000 264200000 264100000 127000000.0 128100000 174900000 167800000 3090500000 3132000000 1006800000 1046400000 6572300000 6574200000 507800000 432400000 180600000 185800000 541400000 562300000 23500000 23700000 2400000 4000000.0 1255700000 1208200000 120600000 120400000 288200000 304200000 876900000 883400000 0.01 0.01 15000000 15000000 0 0 0 0 0 0 0.01 0.01 500000000 500000000 163200000 162600000 162000000 161600000 1600000 1600000 3667900000 3732600000 563200000 466900000 -201800000 -143500000 4030900000 4057600000 0 400000 4030900000 4058000000 6572300000 6574200000 631400000 612600000 257300000 254200000 374100000 358400000 258200000 237500000 24400000 25800000 91500000 95100000 300000 300000 5900000 18000000.0 85900000 77400000 15500000 15600000 70400000 61800000 4500000 9900000 74900000 71700000 0.43 0.39 0.39 0.35 0.03 0.06 0.03 0.06 0.46 0.45 0.42 0.41 162200000 160500000 179800000 175900000 74900000 71700000 -59600000 -53700000 1400000 1400000 100000 -200000 -58300000 -52100000 16600000 19600000 1600000 3732600000 466900000 -143500000 4057600000 400000 -77800000 21400000 -56400000 1600000 3654800000 488300000 -143500000 4001200000 400000 -400000 13100000 13100000 74900000 74900000 -58300000 -58300000 1600000 3667900000 563200000 -201800000 4030900000 0 1600000 3684400000 126400000 -91800000 3720600000 400000 6700000 6700000 71700000 71700000 -52100000 -52100000 1600000 3691100000 198100000 -143900000 3746900000 400000 74900000 71700000 7800000 10300000 23500000 21000000.0 1700000 2900000 7500000 6400000 6000000.0 0 -1900000 0 3900000 1900000 6400000 7200000 1000000.0 6200000 16200000 5100000 20300000 20400000 -2500000 -27600000 16800000 7900000 -51500000 -37900000 8000000.0 12100000 3500000 16600000 19800000 8300000 30000000.0 0 5100000 -2800000 5100000 -5500000 0 400000 300000 0 500000 475500000 13100000 5300000 7600000 5200000 0 6200000 5300000 -469600000 -9200000 10800000 4700000 -447700000 1073600000 888900000 1078300000 441200000 2800000 10500000 14100000 5700000 7100000 2600000 BUSINESS AND BASIS OF PRESENTATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in two business segments: Specialty Products &amp; Technologies and Equipment &amp; Consumables. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Specialty Products &amp; Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment &amp; Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of April 1, 2022 and December 31, 2021, and its results of operations and cash flows for the three month periods ended April 1, 2022 and April 2, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Uncertainties</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company continued to see positive signs of recovery in certain markets in which it operates, however, certain markets continue to be more adversely impacted than others. Late in the first quarter of 2022, the Chinese authorities instituted COVID-19-related lockdowns, shut-downs and restrictions in certain parts of China, specifically the Shanghai area, which impacted the Company’s operations in China. The extent to which these restrictions continue and the possible geographical expansion of these restrictions will depend upon the Chinese authorities’ response to the affected regions of China. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the scope and duration of the pandemic, the rise of new variants, the extent and severity of the impact on the Company's customers, the measures that have been and may be taken to contain the virus (including its various mutations) and mitigate its impact, U.S. and foreign government actions to respond to the reduction in global economic activity, the ability of the Company to continue to manufacture and source its products and to find suitable alternative products at reasonable prices, the Company’s ability to continue to ship and deliver its products in a cost-effective and timely manner, uncertain demand, staffing shortages, the impact of the pandemic and associated economic downturn on the Company’s ability to access capital if and when needed and how quickly and to what extent normal economic and operating conditions can resume, all of which are uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, the Company may continue to experience materially adverse impacts on the Company’s financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including by impacting the Company’s ability to market and sell products in Russia, by impacting its ability to enforce its intellectual property rights in Russia, by creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Condensed Consolidated Financial Statements. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 12 for a further discussion of the impact of adopting ASU 2020-06.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform, if certain criteria are met. The ASU is effective for public entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. If an entity elects to apply any of the amendments for an eligible hedging relationship existing as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of that interim period and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable). If an entity elects to apply any of the amendments for a new hedging relationship entered into as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of the hedging relationship and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable).</span></div>The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company has not yet completed its assessment of the impact of the new standard on the Company’s Condensed Consolidated Financial Statements. 2 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included in the financial statements. All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The accompanying Condensed Consolidated Financial Statements contain all adjustments (consisting of only normal recurring adjustments and reclassifications to conform to current year presentation) necessary to present fairly the financial position of the Company as of April 1, 2022 and December 31, 2021, and its results of operations and cash flows for the three month periods ended April 1, 2022 and April 2, 2021. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Consolidated and Combined Financial Statements and accompanying notes for the three years ended December 31, 2021, included in the Annual Report on Form 10-K filed by the Company with the SEC on February 24, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2, Discontinued Operations, on December 31, 2021, the Company completed the sale of its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Condensed Consolidated Financial Statements. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 12 for a further discussion of the impact of adopting ASU 2020-06.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform, if certain criteria are met. The ASU is effective for public entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. If an entity elects to apply any of the amendments for an eligible hedging relationship existing as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of that interim period and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable). If an entity elects to apply any of the amendments for a new hedging relationship entered into as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of the hedging relationship and recognized in accordance with the guidance in Reference Rate Reform Subtopics 848-30, 848-40, and 848-50 (as applicable).</span></div>The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company has not yet completed its assessment of the impact of the new standard on the Company’s Condensed Consolidated Financial Statements. 75000000 -77800000 21400000 -18600000 DISCONTINUED OPERATIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2021, the Company completed the sale of substantially all of KaVo Treatment Units and Instruments Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. In accordance with the terms of the Purchase Agreement, the Company received cash consideration of $317.3 million upon closing, which remains subject to certain adjustments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The Company recognized a gain of $4.6 million on the Divestiture during the three months ended April 1, 2022 primarily due to the recognition of certain purchase price adjustments. In addition, the Company received an earnout payment of $30.0 million in the first quarter of 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") will be deferred until the purchaser has formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement can be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture. The Company recognized a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions as of April 1, 2022, and December 31, 2021. The Company will recognize the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. As of April 1, 2022, none of the Relevant Jurisdictions had closed. The Relevant Jurisdictions are expected to close at various points throughout 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In conjunction with the Divestiture, the Company entered into a customary transition services agreement, which requires support transition services to Planmeca throughout the applicable transition period. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended April 1, 2022 the Divestiture continued to meet the criteria to be classified as held for sale and to be presented as a discontinued operation. Accordingly, the Company reclassified the results of operations and financial position of the Divestiture to discontinued operations in its accompanying Condensed Consolidated Statements of Income and Condensed Consolidated Balance Sheets for all periods presented. The Company’s Condensed Consolidated Statements of Cash Flows for all periods presented include the financial results of the KaVo Treatment Unit and Instruments Business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended April 2, 2021, balances represent activity for the entire Divestiture, while balances for the three month ended April 1, 2022, represent activity for the remaining Relevant Jurisdictions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets for relevant jurisdictions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities for relevant jurisdictions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.955%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.</span></div></td></tr></table></div> 317300000 4600000 30000000 10800000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets for relevant jurisdictions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities for relevant jurisdictions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the Divestiture are reflected in the Condensed Consolidated Statements of Income within income from discontinued operations, net of tax as follows ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.955%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.</span></div></td></tr></table></div> 10200000 12200000 10200000 12200000 2400000 4000000.0 2400000 4000000.0 6900000 96600000 5900000 57700000 1000000.0 38900000 1100000 21300000 0 4400000 -100000 13200000 0 3300000 -100000 9900000 4600000 0 4500000 9900000 0 2100000 0 900000 CREDIT LOSSESThe allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of the allowance for credit losses is summarized as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at April 1, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of the allowance for credit losses is summarized as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at April 1, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 20700000 -200000 1700000 1600000 700000 20300000 INVENTORIES<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of inventory are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for inventory obsolescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of inventory are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for inventory obsolescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 228000000.0 214300000 23500000 22000000.0 87500000 88300000 58600000 60800000 280400000 263800000 PROPERTY, PLANT AND EQUIPMENT <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of property, plant and equipment are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of property, plant and equipment are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10700000 10700000 161100000 168700000 360100000 354500000 48900000 45600000 580800000 579500000 316600000 315400000 264200000 264100000 GOODWILL<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s goodwill by segment ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at April 1, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,090.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s goodwill by segment ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at April 1, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,090.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2029700000 1102300000 3132000000 -33000000.0 -8500000 -41500000 1996700000 1093800000 3090500000 ACCRUED EXPENSES AND OTHER LIABILITIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related employee severance, benefits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes, income and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and product allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related employee severance, benefits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes, income and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and product allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 140800000 19600000 188900000 17900000 14000000.0 0 21900000 0 5600000 40100000 5600000 41700000 48300000 184400000 48100000 201400000 73300000 5700000 60100000 5100000 63700000 1500000 75400000 1200000 10100000 30900000 8400000 30300000 400000 0 19600000 0 185200000 6000000.0 134300000 6600000 541400000 288200000 562300000 304200000 HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS The Company uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintains cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively convert the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offsets the impact of changes in currency rates on foreign currency denominated net investments. The changes in the fair value of these instruments are recorded in accumulated other comprehensive loss in equity, in the accompanying Condensed Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss as reflected in Note 13. Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps is recorded in interest expense, net in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. These instruments mature in September 2024.<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Condensed Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 13). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 12 for a further discussion of the above loan facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchange interest payments based on variable rates for interest payments based on fixed rates. The changes in the fair value of these instruments are recorded in accumulated other comprehensive loss in equity (see Note 13). Any ineffective portions of the cash flow hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps is recorded in interest expense in the Company’s Condensed Consolidated Statements of Income consistent with the classification of interest expense attributable to the underlying debt. The current outstanding interest rate swap matures in September 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gains or losses related to the foreign currency contracts and foreign currency denominated debt are classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 13, as these items are attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts are classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 13. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the three months ended April 1, 2022 and April 2, 2021. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the three months ended April 1, 2022 and April 2, 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Condensed Consolidated Statements of Cash Flows. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonderivative hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.</span></div> 650000000.0 650000000.0 208000000.0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of April 1, 2022 and April 2, 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the three months ended April 1, 2022 and April 2, 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 250000000.0 1800000 650000000.0 17900000 229700000 6800000 1129700000 26500000 450000000.0 1800000 650000000.0 25600000 244700000 16200000 1344700000 43600000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified in the Company’s Condensed Consolidated Balance Sheets as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonderivative hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 900000 0 400000 19600000 229700000 236500000 FAIR VALUE MEASUREMENTS <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. The interest rate swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and forward curves as inputs. Refer to Note 8 for additional information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Condensed Consolidated Balance Sheets (refer to Note 7). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"/><td style="width:45.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes due 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on April 1, 2022 and December 31, 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"/><td style="width:45.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes due 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 900000 0 900000 0 400000 0 400000 0 17900000 0 17900000 0 2200000 0 2200000 0 17400000 0 17400000 0 16500000 0 16500000 900000 900000 0 0 400000 400000 2200000 2200000 0 0 17400000 17400000 507800000 1213800000 432100000 1162500000 876900000 876900000 883400000 883400000 WARRANTYThe Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at April 1, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> P90D <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at April 1, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 9400000 4200000 3700000 100000 9800000 LITIGATION AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $41.0 million and $38.7 million as of April 1, 2022 and December 31, 2021, respectively, which are included in accrued liabilities in the Condensed Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Condensed Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.</span></div> 41000000 38700000 DEBT AND CREDIT FACILITIES <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s debt were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $2.4 and $2.7, respectively</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.4 and $0.5, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $9.7 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(507.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2022 unamortized debt issuance costs totaled $12.5 million. As of December 31, 2021 unamortized debt issuance costs and discount totaled $88.6 million. Unamortized debt issuance costs and discount have been netted against their respective aggregate principal amounts of the related debt in the table above, and are being amortized to interest expense over the term of the respective debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term Indebtedness</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan Facility and the three-year €600.0 million Euro Term Loan Facility (together with the Term Loan Facility, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (the “Revolving Credit Facility” and together with the Term Loans, the “Senior Credit Facilities”). Pursuant to the Separation Agreement, all of the net proceeds of the Term Loans were paid to Danaher as partial consideration for the Dental business Danaher transferred to Envista. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan Facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks including Bank of America, N.A. as administrative agent (the “Administrative Agent”). The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021). </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the Revolving Credit Facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the Revolving Credit Facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the Revolving Credit Facility and the Term Loan Facility has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility includes an aggregate principal amount of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit. The Revolving Credit Facility can be used for working capital and other general corporate purposes. As of April 1, 2022 and December 31, 2021, there were no borrowings outstanding under the Revolving Credit Facility.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the Revolving Credit Facility, whether drawn or not. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rates for borrowings under the Term Loan Facility were 1.34% and 1.25% as of April 1, 2022 and December 31, 2021, respectively. The interest rate for borrowings under the Euro Term Loan Facility was 0.95% as of April 1, 2022 and December 31, 2021. Interest is payable quarterly for the Term Loans. The Company has entered into interest rate swap derivative contracts for the Term Loan Facility, as further discussed in Note 8. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of April 1, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes (the “Notes”)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, as discussed in Note 1, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and a $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">As of April 1, 2022, the unamortized debt issuance costs on the Notes was $9.7 million and is being amortized over the term of the Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of April 1, 2022 and December 31, 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended April 1, 2022 and December 31, 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Notes ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual interest expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt discount</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total interest expense</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended April 1, 2022, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0%, to interest expense over the term of the Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2022 and December 31, 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $667.0 million and $592.1 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capped Call Transactions</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s debt were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior term loan facility due 2024 ($650.0 aggregate principal amount) (the “Term Loan Facility”), net of deferred debt issuance costs of $2.4 and $2.7, respectively</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior euro term loan facility due 2024 (€208.0 aggregate principal amount) (the “Euro Term Loan Facility”), net of deferred debt issuance costs of $0.4 and $0.5, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible senior notes due 2025 ($517.5 aggregate principal amount), net of deferred debt issuance costs of $9.7 and $8.9, respectively, and unamortized discount of $0.0 and $76.5, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(507.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 650000000.0 2400000 2700000 647600000 647300000 208000000.0 400000 500000 229300000 236100000 517500000 9700000 8900000 0.0 76500000 507800000 432100000 0 300000 1384700000 1315800000 507800000 432400000 876900000 883400000 12500000 88600000 1300000000 P3Y 650000000.0 P3Y 600000000.0 P5Y 250000000.0 472000000.0 250000000.0 750000000.0 350000000.0 250000000.0 0.50 2100000 750000000.0 20000000.0 0 0 0.00785 0.01625 0.0050 0.010 0.0000 0.00625 0.0009 0.00225 0.0134 0.0125 0.0095 0.0095 3.75 4.25 100000000.0 3.00 67500000 517500000 502600000 0.02375 21.01 75000000 76500000 1500000 -77800000 21400000 -18600000 9700000 1.000 1.30 1.30 21.01 21.01 20 20 30 30 1.300 20 30 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Notes ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual interest expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt discount</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total interest expense</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 3100000 3100000 700000 500000 0 4600000 3800000 8200000 0.030 667000000.0 592100000 21.01 23.79 2900000 20700000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCUMULATED OTHER COMPREHENSIVE LOSS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 2, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive loss by component are summarized below ($ in millions).</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 2, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -139600000 -1700000 -2200000 -143500000 -53800000 1800000 0 -52000000.0 5800000 400000 0 6200000 -59600000 1400000 0 -58200000 0 0 200000 200000 0 0 100000 100000 0 0 100000 100000 -59600000 1400000 -100000 -58300000 -199200000 -300000 -2300000 -201800000 -62500000 -6300000 -23000000.0 -91800000 -43400000 1800000 0 -41600000 10300000 400000 0 10700000 -53700000 1400000 0 -52300000 0 0 -200000 -200000 0 0 -200000 -200000 -53700000 1400000 200000 -52100000 -116200000 -4900000 -22800000 -143900000 REVENUE <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues disaggregated by geographical region for the three months ended April 1, 2022 and April 2, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.980%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.980%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales by Major Product Group:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $35.5 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of April 1, 2022 and December 31, 2021, the contract liabilities were $79.0 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Revenue recognized during the three months ended April 1, 2022 that was included in the contract liability balance at December 31, 2021 was $24.8 million. Revenue recognized during the three months ended April 2, 2021 that was included in the contract liability balance at December 31, 2020 was $18.9 million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to the Company’s largest customer were 10% and 13% of sales for the three months ended April 1, 2022 and April 2, 2021, respectively. No other individual customer accounted for more than 10% of sales for the three months ended April 1, 2022 and April 2, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on historical experience, the Company generally has more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, the Company generally has more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in the Equipment &amp; Consumables segment. As a result of this seasonality in sales, profitability in the Equipment &amp; Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future and the ongoing COVID-19 pandemic may impact these trends.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues disaggregated by geographical region for the three months ended April 1, 2022 and April 2, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.980%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 1, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.980%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales by Major Product Group:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 179300000 156300000 335600000 106300000 32000000.0 138300000 24400000 10300000 34700000 87100000 35700000 122800000 397100000 234300000 631400000 162600000 164700000 327300000 94700000 31000000.0 125700000 25500000 10300000 35800000 83500000 40300000 123800000 366300000 246300000 612600000 529900000 514000000.0 101500000 98600000 631400000 612600000 35500000 P12M 79000000 65200000 24800000 18900000 0.10 0.13 RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS <div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Activities</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, either in the normal course of business or pursuant to significant restructuring programs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Severance<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Exit<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid/settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring related charges recorded for the three months ended April 1, 2022 and April 2, 2021, by segment were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring related charges incurred during the three months ended April 1, 2022 and April 2, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related liability which is included in accrued liabilities in the Condensed Consolidated Balance Sheets is summarized below ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Severance<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Exit<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid/settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 21400000 500000 21900000 -800000 300000 -500000 7000000.0 400000 7400000 13600000 400000 14000000.0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring related charges recorded for the three months ended April 1, 2022 and April 2, 2021, by segment were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring related charges incurred during the three months ended April 1, 2022 and April 2, 2021, are reflected in the following captions in the accompanying Condensed Consolidated Statements of Income ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4000000.0 3400000 -900000 1900000 600000 2500000 3700000 7800000 -300000 2900000 4000000.0 4900000 3700000 7800000 INCOME TAXES The Company’s effective tax rates from continuing operations of 18.0% and 20.2% for the three months ended April 1, 2022 and April 2, 2021, respectively, differ from the U.S. federal statutory rate of 21.0%, primarily due to the Company’s geographical mix of earnings and net discrete tax benefits. 0.180 0.202 EARNINGS PER SHARE <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares in the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the three months ended April 1, 2022 and April 2, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 12), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:72.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding used in basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental common shares from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed exercise of dilutive options and vesting of dilutive restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed conversion of the Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding used in diluted earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from discontinued operations - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from discontinued operations - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.805%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 21.01 23.79 23.79 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:72.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding used in basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental common shares from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed exercise of dilutive options and vesting of dilutive restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed conversion of the Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding used in diluted earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from discontinued operations - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from discontinued operations - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div> 70400000 61800000 4500000 9900000 74900000 71700000 162200000 160500000 4200000 4400000 13400000 11000000.0 179800000 175900000 0.43 0.39 0.39 0.35 0.03 0.06 0.03 0.06 0.46 0.45 0.42 0.41 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.805%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 600000 600000 600000 600000 SEGMENT INFORMATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates and reports its results in two separate business segments, the Specialty Products &amp; Technologies and Equipment &amp; Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense) and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Specialty Products &amp; Technologies products include implants, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment &amp; Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment &amp; Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 2 for more information on the Company’s discontinued operations.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment related information is shown below ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.435%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.336%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit and reconciliation to income before taxes from continuing operations:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonoperating income (expense):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes from continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held for Sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,572.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,574.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2 2 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment related information is shown below ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.435%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.336%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit and reconciliation to income before taxes from continuing operations:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonoperating income (expense):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes from continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held for Sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,572.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,574.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 397100000 366500000 234300000 246100000 631400000 612600000 70300000 78400000 45500000 45000000.0 -24300000 -28300000 91500000 95100000 300000 300000 5900000 18000000.0 85900000 77400000 3418800000 3498200000 2005000000 1946100000 10200000 12200000 1138300000 1117700000 6572300000 6574200000 SUBSEQUENT EVENTOn April 20, 2022, the Company completed its purchase of Carestream Dental Technology Parent Limited’s (“Carestream”) intraoral scanner business for total consideration of approximately $582.5 million, subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021. The Company has purchased the intraoral scanner business through the acquisition of certain assets and the assumption of certain liabilities, as well as the acquisition of the equity of certain subsidiaries of Carestream. 582500000 EXCEL 91 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 93 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 94 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 244 301 1 false 70 0 false 7 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.envistaco.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited Condensed Consolidated Statements of Income (Unaudited) Statements 4 false false R5.htm 1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 5 false false R6.htm 1005006 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 2101101 - Disclosure - Business And Basis Of Presentation Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentation Business And Basis Of Presentation Notes 8 false false R9.htm 2104102 - Disclosure - Discontinued Operations Sheet http://www.envistaco.com/role/DiscontinuedOperations Discontinued Operations Notes 9 false false R10.htm 2110103 - Disclosure - Credit Losses Sheet http://www.envistaco.com/role/CreditLosses Credit Losses Notes 10 false false R11.htm 2114104 - Disclosure - Inventories Sheet http://www.envistaco.com/role/Inventories Inventories Notes 11 false false R12.htm 2117105 - Disclosure - Property, Plant And Equipment Sheet http://www.envistaco.com/role/PropertyPlantAndEquipment Property, Plant And Equipment Notes 12 false false R13.htm 2120106 - Disclosure - Goodwill Sheet http://www.envistaco.com/role/Goodwill Goodwill Notes 13 false false R14.htm 2123107 - Disclosure - Accrued Expenses And Other Liabilities Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities Accrued Expenses And Other Liabilities Notes 14 false false R15.htm 2126108 - Disclosure - Hedging Transactions And Derivative Financial Instruments Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments Hedging Transactions And Derivative Financial Instruments Notes 15 false false R16.htm 2131109 - Disclosure - Fair Value Measurements Sheet http://www.envistaco.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 2135110 - Disclosure - Warranty Sheet http://www.envistaco.com/role/Warranty Warranty Notes 17 false false R18.htm 2139111 - Disclosure - Litigation And Contingencies Sheet http://www.envistaco.com/role/LitigationAndContingencies Litigation And Contingencies Notes 18 false false R19.htm 2141112 - Disclosure - Debt And Credit Facilities Sheet http://www.envistaco.com/role/DebtAndCreditFacilities Debt And Credit Facilities Notes 19 false false R20.htm 2146113 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 20 false false R21.htm 2149114 - Disclosure - Revenue Sheet http://www.envistaco.com/role/Revenue Revenue Notes 21 false false R22.htm 2154115 - Disclosure - Restructuring Activities And Related Impairments Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments Restructuring Activities And Related Impairments Notes 22 false false R23.htm 2159116 - Disclosure - Income Taxes Sheet http://www.envistaco.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2161117 - Disclosure - Earnings Per Share Sheet http://www.envistaco.com/role/EarningsPerShare Earnings Per Share Notes 24 false false R25.htm 2166118 - Disclosure - Segment Information Sheet http://www.envistaco.com/role/SegmentInformation Segment Information Notes 25 false false R26.htm 2170119 - Disclosure - Subsequent Events Sheet http://www.envistaco.com/role/SubsequentEvents Subsequent Events Notes 26 false false R27.htm 2202201 - Disclosure - Business And Basis Of Presentation (Policies) Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies Business And Basis Of Presentation (Policies) Policies 27 false false R28.htm 2305301 - Disclosure - Discontinued Operations (Tables) Sheet http://www.envistaco.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.envistaco.com/role/DiscontinuedOperations 28 false false R29.htm 2311302 - Disclosure - Credit Losses (Tables) Sheet http://www.envistaco.com/role/CreditLossesTables Credit Losses (Tables) Tables http://www.envistaco.com/role/CreditLosses 29 false false R30.htm 2315303 - Disclosure - Inventories (Tables) Sheet http://www.envistaco.com/role/InventoriesTables Inventories (Tables) Tables http://www.envistaco.com/role/Inventories 30 false false R31.htm 2318304 - Disclosure - Property, Plant And Equipment (Tables) Sheet http://www.envistaco.com/role/PropertyPlantAndEquipmentTables Property, Plant And Equipment (Tables) Tables http://www.envistaco.com/role/PropertyPlantAndEquipment 31 false false R32.htm 2321305 - Disclosure - Goodwill (Tables) Sheet http://www.envistaco.com/role/GoodwillTables Goodwill (Tables) Tables http://www.envistaco.com/role/Goodwill 32 false false R33.htm 2324306 - Disclosure - Accrued Expenses And Other Liabilities (Tables) Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables Accrued Expenses And Other Liabilities (Tables) Tables http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities 33 false false R34.htm 2327307 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables Hedging Transactions And Derivative Financial Instruments (Tables) Tables http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments 34 false false R35.htm 2332308 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.envistaco.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.envistaco.com/role/FairValueMeasurements 35 false false R36.htm 2336309 - Disclosure - Warranty (Tables) Sheet http://www.envistaco.com/role/WarrantyTables Warranty (Tables) Tables http://www.envistaco.com/role/Warranty 36 false false R37.htm 2342310 - Disclosure - Debt And Credit Facilities (Tables) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesTables Debt And Credit Facilities (Tables) Tables http://www.envistaco.com/role/DebtAndCreditFacilities 37 false false R38.htm 2347311 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss 38 false false R39.htm 2350312 - Disclosure - Revenue (Tables) Sheet http://www.envistaco.com/role/RevenueTables Revenue (Tables) Tables http://www.envistaco.com/role/Revenue 39 false false R40.htm 2355313 - Disclosure - Restructuring Activities And Related Impairments (Tables) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables Restructuring Activities And Related Impairments (Tables) Tables http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments 40 false false R41.htm 2362314 - Disclosure - Earnings Per Share (Tables) Sheet http://www.envistaco.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.envistaco.com/role/EarningsPerShare 41 false false R42.htm 2367315 - Disclosure - Segment Information (Tables) Sheet http://www.envistaco.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.envistaco.com/role/SegmentInformation 42 false false R43.htm 2403401 - Disclosure - Business And Basis Of Presentation - Narrative (Details) Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails Business And Basis Of Presentation - Narrative (Details) Details 43 false false R44.htm 2406402 - Disclosure - Discontinued Operations - Narrative (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails Discontinued Operations - Narrative (Details) Details 44 false false R45.htm 2407403 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) Details 45 false false R46.htm 2408404 - Disclosure - Discontinued Operations - Operating Results (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails Discontinued Operations - Operating Results (Details) Details 46 false false R47.htm 2409405 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) Details 47 false false R48.htm 2412406 - Disclosure - Credit Losses - Narrative (Details) Sheet http://www.envistaco.com/role/CreditLossesNarrativeDetails Credit Losses - Narrative (Details) Details 48 false false R49.htm 2413407 - Disclosure - Credit Losses - Allowance for Credit Losses (Details) Sheet http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails Credit Losses - Allowance for Credit Losses (Details) Details 49 false false R50.htm 2416408 - Disclosure - Inventories - Summary (Details) Sheet http://www.envistaco.com/role/InventoriesSummaryDetails Inventories - Summary (Details) Details 50 false false R51.htm 2419409 - Disclosure - Property, Plant And Equipment (Details) Sheet http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails Property, Plant And Equipment (Details) Details http://www.envistaco.com/role/PropertyPlantAndEquipmentTables 51 false false R52.htm 2422410 - Disclosure - Goodwill - Rollforward (Details) Sheet http://www.envistaco.com/role/GoodwillRollforwardDetails Goodwill - Rollforward (Details) Details 52 false false R53.htm 2425411 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details) Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails Accrued Expenses And Other Liabilities - Summary (Details) Details 53 false false R54.htm 2428412 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails Hedging Transactions And Derivative Financial Instruments - Narrative (Details) Details http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables 54 false false R55.htm 2429413 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) Details 55 false false R56.htm 2430414 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) Details 56 false false R57.htm 2433415 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) Sheet http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) Details 57 false false R58.htm 2434416 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details) Sheet http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails Fair Value Measurements - Fair Value of Financial Instruments (Details) Details 58 false false R59.htm 2437417 - Disclosure - Warranty - Narrative (Details) Sheet http://www.envistaco.com/role/WarrantyNarrativeDetails Warranty - Narrative (Details) Details 59 false false R60.htm 2438418 - Disclosure - Warranty - Warranty Accrual (Details) Sheet http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails Warranty - Warranty Accrual (Details) Details 60 false false R61.htm 2440419 - Disclosure - Litigation And Contingencies - Narrative (Details) Sheet http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails Litigation And Contingencies - Narrative (Details) Details 61 false false R62.htm 2443420 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails Debt And Credit Facilities - Components Of Debt (Details) Details 62 false false R63.htm 2444421 - Disclosure - Debt And Credit Facilities - Narrative (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails Debt And Credit Facilities - Narrative (Details) Details 63 false false R64.htm 2445422 - Disclosure - Debt And Credit Facilities - Interest Expense (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails Debt And Credit Facilities - Interest Expense (Details) Details 64 false false R65.htm 2448423 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details) Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails Accumulated Other Comprehensive Loss - Rollforward (Details) Details 65 false false R66.htm 2451424 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details) Sheet http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails Revenue - Disaggregation by Revenue Type and Geographical Region (Details) Details 66 false false R67.htm 2452425 - Disclosure - Revenue - Remaining Performance Obligations (Details) Sheet http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails Revenue - Remaining Performance Obligations (Details) Details 67 false false R68.htm 2453426 - Disclosure - Revenue - Narrative (Details) Sheet http://www.envistaco.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 68 false false R69.htm 2456427 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) Details 69 false false R70.htm 2457428 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) Details 70 false false R71.htm 2458429 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) Details 71 false false R72.htm 2460430 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.envistaco.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 72 false false R73.htm 2463431 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.envistaco.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 73 false false R74.htm 2464432 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) Sheet http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) Details 74 false false R75.htm 2465433 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) Sheet http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) Details 75 false false R76.htm 2468434 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.envistaco.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 76 false false R77.htm 2469435 - Disclosure - Segment Information - Segment Results (Details) Sheet http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails Segment Information - Segment Results (Details) Details 77 false false R78.htm 2471436 - Disclosure - Subsequent Events (Details) Sheet http://www.envistaco.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.envistaco.com/role/SubsequentEvents 78 false false All Reports Book All Reports nvst-20220401.htm carestreamclosingagreement.htm exhibit311412022.htm exhibit312412022.htm exhibit321412022.htm nvst-20220401.xsd nvst-20220401_cal.xml nvst-20220401_def.xml nvst-20220401_lab.xml nvst-20220401_pre.xml nvst-20220401_g1.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 97 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nvst-20220401.htm": { "axisCustom": 0, "axisStandard": 28, "contextCount": 244, "dts": { "calculationLink": { "local": [ "nvst-20220401_cal.xml" ] }, "definitionLink": { "local": [ "nvst-20220401_def.xml" ] }, "inline": { "local": [ "nvst-20220401.htm" ] }, "labelLink": { "local": [ "nvst-20220401_lab.xml" ] }, "presentationLink": { "local": [ "nvst-20220401_pre.xml" ] }, "schema": { "local": [ "nvst-20220401.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 518, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 2, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 7 }, "keyCustom": 22, "keyStandard": 279, "memberCustom": 17, "memberStandard": 53, "nsprefix": "nvst", "nsuri": "http://www.envistaco.com/20220401", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.envistaco.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110103 - Disclosure - Credit Losses", "role": "http://www.envistaco.com/role/CreditLosses", "shortName": "Credit Losses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114104 - Disclosure - Inventories", "role": "http://www.envistaco.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117105 - Disclosure - Property, Plant And Equipment", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipment", "shortName": "Property, Plant And Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120106 - Disclosure - Goodwill", "role": "http://www.envistaco.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123107 - Disclosure - Accrued Expenses And Other Liabilities", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities", "shortName": "Accrued Expenses And Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126108 - Disclosure - Hedging Transactions And Derivative Financial Instruments", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments", "shortName": "Hedging Transactions And Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2131109 - Disclosure - Fair Value Measurements", "role": "http://www.envistaco.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2135110 - Disclosure - Warranty", "role": "http://www.envistaco.com/role/Warranty", "shortName": "Warranty", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2139111 - Disclosure - Litigation And Contingencies", "role": "http://www.envistaco.com/role/LitigationAndContingencies", "shortName": "Litigation And Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2141112 - Disclosure - Debt And Credit Facilities", "role": "http://www.envistaco.com/role/DebtAndCreditFacilities", "shortName": "Debt And Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2146113 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2149114 - Disclosure - Revenue", "role": "http://www.envistaco.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2154115 - Disclosure - Restructuring Activities And Related Impairments", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments", "shortName": "Restructuring Activities And Related Impairments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2159116 - Disclosure - Income Taxes", "role": "http://www.envistaco.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2161117 - Disclosure - Earnings Per Share", "role": "http://www.envistaco.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2166118 - Disclosure - Segment Information", "role": "http://www.envistaco.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2170119 - Disclosure - Subsequent Events", "role": "http://www.envistaco.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Business And Basis Of Presentation (Policies)", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies", "shortName": "Business And Basis Of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Discontinued Operations (Tables)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311302 - Disclosure - Credit Losses (Tables)", "role": "http://www.envistaco.com/role/CreditLossesTables", "shortName": "Credit Losses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "role": "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315303 - Disclosure - Inventories (Tables)", "role": "http://www.envistaco.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318304 - Disclosure - Property, Plant And Equipment (Tables)", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, Plant And Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321305 - Disclosure - Goodwill (Tables)", "role": "http://www.envistaco.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2324306 - Disclosure - Accrued Expenses And Other Liabilities (Tables)", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables", "shortName": "Accrued Expenses And Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327307 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables", "shortName": "Hedging Transactions And Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2332308 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.envistaco.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2336309 - Disclosure - Warranty (Tables)", "role": "http://www.envistaco.com/role/WarrantyTables", "shortName": "Warranty (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2342310 - Disclosure - Debt And Credit Facilities (Tables)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables", "shortName": "Debt And Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2347311 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2350312 - Disclosure - Revenue (Tables)", "role": "http://www.envistaco.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Condensed Consolidated Statements of Income (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "shortName": "Condensed Consolidated Statements of Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2355313 - Disclosure - Restructuring Activities And Related Impairments (Tables)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables", "shortName": "Restructuring Activities And Related Impairments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2362314 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.envistaco.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2367315 - Disclosure - Segment Information (Tables)", "role": "http://www.envistaco.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:NumberOfReportableSegments", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - Business And Basis Of Presentation - Narrative (Details)", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "shortName": "Business And Basis Of Presentation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Discontinued Operations - Narrative (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "shortName": "Discontinued Operations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i2fe4fe01395045a58aeb7f1c74527e75_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "shortName": "Discontinued Operations - Carrying Amount of Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i1690facf5cdd465d91fbf8df25f7b47d_I20220401", "decimals": "-5", "lang": "en-US", "name": "nvst:DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ic052f8e5c2a54344a20af55cd6ac614b_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Discontinued Operations - Operating Results (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "shortName": "Discontinued Operations - Operating Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ic052f8e5c2a54344a20af55cd6ac614b_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ic052f8e5c2a54344a20af55cd6ac614b_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409405 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details)", "role": "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "shortName": "Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ic052f8e5c2a54344a20af55cd6ac614b_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "INF", "first": true, "lang": "en-US", "name": "nvst:NumberOfPortfolioSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Credit Losses - Narrative (Details)", "role": "http://www.envistaco.com/role/CreditLossesNarrativeDetails", "shortName": "Credit Losses - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "INF", "first": true, "lang": "en-US", "name": "nvst:NumberOfPortfolioSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - Credit Losses - Allowance for Credit Losses (Details)", "role": "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails", "shortName": "Credit Losses - Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416408 - Disclosure - Inventories - Summary (Details)", "role": "http://www.envistaco.com/role/InventoriesSummaryDetails", "shortName": "Inventories - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419409 - Disclosure - Property, Plant And Equipment (Details)", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "shortName": "Property, Plant And Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422410 - Disclosure - Goodwill - Rollforward (Details)", "role": "http://www.envistaco.com/role/GoodwillRollforwardDetails", "shortName": "Goodwill - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425411 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details)", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "shortName": "Accrued Expenses And Other Liabilities - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428412 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429413 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i907c848325fc41239de270fa7a31069b_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430414 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details)", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i907c848325fc41239de270fa7a31069b_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ibe58277a200144cfba20dbff50dd3755_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433415 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)", "role": "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "shortName": "Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ibe58277a200144cfba20dbff50dd3755_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i2834021baa7a46a3a7a9991a975da1fd_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtFairValueDisclosures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434416 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details)", "role": "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Fair Value of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i2834021baa7a46a3a7a9991a975da1fd_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtFairValueDisclosures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:ProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437417 - Disclosure - Warranty - Narrative (Details)", "role": "http://www.envistaco.com/role/WarrantyNarrativeDetails", "shortName": "Warranty - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:ProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i3c4184ea6f2f4d61ba07b13bc6f4f606_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ie1d55a0e2ace40adab71e0c21125555f_D20210101-20210402", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438418 - Disclosure - Warranty - Warranty Accrual (Details)", "role": "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails", "shortName": "Warranty - Warranty Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440419 - Disclosure - Litigation And Contingencies - Narrative (Details)", "role": "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails", "shortName": "Litigation And Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443420 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "shortName": "Debt And Credit Facilities - Components Of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DebtCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444421 - Disclosure - Debt And Credit Facilities - Narrative (Details)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "shortName": "Debt And Credit Facilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i76d385b6289b4efca70ddd82dcfb90b6_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445422 - Disclosure - Debt And Credit Facilities - Interest Expense (Details)", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "shortName": "Debt And Credit Facilities - Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i76d385b6289b4efca70ddd82dcfb90b6_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448423 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details)", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "shortName": "Accumulated Other Comprehensive Loss - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i274a6183d4ef4b88a06bd44d443fcf51_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451424 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details)", "role": "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "shortName": "Revenue - Disaggregation by Revenue Type and Geographical Region (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "ia7c521b0044747aab23009f705970649_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452425 - Disclosure - Revenue - Remaining Performance Obligations (Details)", "role": "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails", "shortName": "Revenue - Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453426 - Disclosure - Revenue - Narrative (Details)", "role": "http://www.envistaco.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456427 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i20c8b5e5ecc34584bf490ceae05674a6_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2457428 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i7aa7bc690efa4bbda90a9a64bba1ed67_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458429 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details)", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i61fdc967f0df4397be3c54e71e1c9d61_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2460430 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "iecf8624ab6df4bd99dc643f835046f7a_I20220401", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2463431 - Disclosure - Earnings Per Share - Narrative (Details)", "role": "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i2657d77d38894da1a1b9e9d119beb73a_I20220401", "decimals": "INF", "lang": "en-US", "name": "nvst:DerivativeCapPriceDilutionThreshold", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2464432 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details)", "role": "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails", "shortName": "Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2465433 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details)", "role": "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails", "shortName": "Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468434 - Disclosure - Segment Information - Narrative (Details)", "role": "http://www.envistaco.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2469435 - Disclosure - Segment Information - Segment Results (Details)", "role": "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails", "shortName": "Segment Information - Segment Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i2404d70c8bd04029bd786c7b645251ea_D20220101-20220401", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "id39578fe80ad49da8c9af09ed50c38b4_D20220420-20220420", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2471436 - Disclosure - Subsequent Events (Details)", "role": "http://www.envistaco.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "id39578fe80ad49da8c9af09ed50c38b4_D20220420-20220420", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Business And Basis Of Presentation", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentation", "shortName": "Business And Basis Of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104102 - Disclosure - Discontinued Operations", "role": "http://www.envistaco.com/role/DiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20220401.htm", "contextRef": "i5d68790c045c4e7e87b51c62abe137cc_D20220101-20220401", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 70, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "nvst_A2.375ConvertibleSeniorNotesCappedCallsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes, Capped Calls [Member]", "label": "2.375% Convertible Senior Notes, Capped Calls [Member]", "terseLabel": "2.375% convertible senior notes, capped calls" } } }, "localname": "A2.375ConvertibleSeniorNotesCappedCallsMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2.375ConvertibleSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes [Member]", "label": "2.375% Convertible Senior Notes [Member]", "terseLabel": "2.375% convertible senior notes", "verboseLabel": "Convertible senior notes due 2025" } } }, "localname": "A2.375ConvertibleSeniorNotesMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2.375ConvertibleSeniorNotesOverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes Over Allotment Option [Member]", "label": "2.375% Convertible Senior Notes Over Allotment Option [Member]", "terseLabel": "2.375% convertible senior notes over allotment option" } } }, "localname": "A2.375ConvertibleSeniorNotesOverAllotmentOptionMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_AccountsReceivableCreditLossExpenseReversalAdjustedForDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations", "label": "Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations", "verboseLabel": "Provision for credit losses" } } }, "localname": "AccountsReceivableCreditLossExpenseReversalAdjustedForDiscontinuedOperations", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_AccruedexpensesandotherAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses and other [Abstract]", "label": "Accrued expenses and other [Abstract]", "terseLabel": "Accrued expenses and other [Abstract]" } } }, "localname": "AccruedexpensesandotherAbstract", "nsuri": "http://www.envistaco.com/20220401", "xbrltype": "stringItemType" }, "nvst_CarestreamDentalTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carestream Dental Technology", "label": "Carestream Dental Technology [Member]", "terseLabel": "Carestream Dental Technology" } } }, "localname": "CarestreamDentalTechnologyMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "nvst_ConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumables [Member]", "label": "Consumables [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumablesMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_ContingencyProvisionPurchasePriceinExcessof100million": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingency Provision, Purchase Price in Excess of $100 million", "label": "Contingency Provision, Purchase Price in Excess of $100 million", "terseLabel": "Contingency provision, purchase price in excess of $100 million" } } }, "localname": "ContingencyProvisionPurchasePriceinExcessof100million", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility [Member]", "label": "Credit Facility [Member]", "terseLabel": "Credit facility" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_DebtInstrumentAccordionFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Accordion Feature, Increase Limit", "label": "Debt Instrument, Accordion Feature, Increase Limit", "terseLabel": "Increase limit of revolving credit facility" } } }, "localname": "DebtInstrumentAccordionFeatureIncreaseLimit", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentConvertibleCappedCallsExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Capped Calls, Expense", "label": "Debt Instrument, Convertible, Capped Calls, Expense", "terseLabel": "Convertible debt expense, capped calls" } } }, "localname": "DebtInstrumentConvertibleCappedCallsExpense", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentConvertibleCappedCallsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Capped Calls, Shares", "label": "Debt Instrument, Convertible, Capped Calls, Shares", "terseLabel": "Convertible debt, capped calls (in shares)" } } }, "localname": "DebtInstrumentConvertibleCappedCallsShares", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "nvst_DebtInstrumentCovenantCashAndCashEquivalentThreshold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Cash and Cash Equivalent Threshold", "label": "Debt Instrument, Covenant, Cash and Cash Equivalent Threshold", "terseLabel": "Cash and cash equivalent threshold" } } }, "localname": "DebtInstrumentCovenantCashAndCashEquivalentThreshold", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentCovenantPercentageOfEarningsBeforeTaxesThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold", "label": "Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold", "terseLabel": "EBITDA threshold" } } }, "localname": "DebtInstrumentCovenantPercentageOfEarningsBeforeTaxesThreshold", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_DerivativeCapPriceDilutionThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Cap Price, Dilution Threshold", "label": "Derivative, Cap Price, Dilution Threshold", "terseLabel": "Dilution threshold (in USD per share)" } } }, "localname": "DerivativeCapPriceDilutionThreshold", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current", "label": "Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current", "terseLabel": "Assets for relevant jurisdictions" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationCashFlowsFromDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations", "label": "Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashFlowsFromDiscontinuedOperationsAbstract", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationCashFlowsFromInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities", "label": "Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashFlowsFromInvestingActivitiesAbstract", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationOperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Expenses", "label": "Disposal Group, Including Discontinued Operation, Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpensesAbstract", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 3.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "label": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationsLiabilityForRelevantJurisdictionProceedsCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current", "label": "Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current", "terseLabel": "Liabilities for relevant jurisdictions" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationsLiabilityForRelevantJurisdictionProceedsCurrent", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_EquipmentSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment Sales [Member]", "label": "Equipment Sales [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentSalesMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_EquipmentandConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment and Consumables", "label": "Equipment and Consumables [Member]", "terseLabel": "Equipment & Consumables" } } }, "localname": "EquipmentandConsumablesMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "nvst_EuroTermLoanDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro Term Loan Due 2024", "label": "Euro Term Loan Due 2024 [Member]", "verboseLabel": "Euro term loan due 2024" } } }, "localname": "EuroTermLoanDue2024Member", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Denominated debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign currency denominated debt" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "nvst_HighGrowthMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia).", "label": "High-Growth Markets [Member]", "terseLabel": "Emerging markets" } } }, "localname": "HighGrowthMarketsMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_InterestCoverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Coverage Ratio", "label": "Interest Coverage Ratio", "terseLabel": "Interest coverage ratio (at least)" } } }, "localname": "InterestCoverageRatio", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_LargestCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Largest Customer", "label": "Largest Customer [Member]", "terseLabel": "Largest customer" } } }, "localname": "LargestCustomerMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_NonderivativeHedgingInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Nonderivative Hedging Instruments", "label": "Nonderivative Hedging Instruments", "terseLabel": "Nonderivative hedging instruments" } } }, "localname": "NonderivativeHedgingInstruments", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_NumberOfPortfolioSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Portfolio Segments", "label": "Number Of Portfolio Segments", "terseLabel": "Number of portfolio segments (in segments)" } } }, "localname": "NumberOfPortfolioSegments", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/CreditLossesNarrativeDetails" ], "xbrltype": "integerItemType" }, "nvst_OtherDevelopedMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other developed markets [Member]", "label": "Other Developed Markets [Member]", "terseLabel": "Other developed markets" } } }, "localname": "OtherDevelopedMarketsMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_PlamencaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plamenca", "label": "Plamenca [Member]", "terseLabel": "Plamenca" } } }, "localname": "PlamencaMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "domainItemType" }, "nvst_PrimeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime Rate", "label": "Prime Rate", "terseLabel": "Rate in excess of Federal funds rate" } } }, "localname": "PrimeRate", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_ProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Warranty Period", "label": "Product Warranty Period", "terseLabel": "Product warranty period" } } }, "localname": "ProductWarrantyPeriod", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/WarrantyNarrativeDetails" ], "xbrltype": "durationItemType" }, "nvst_RateinexcessofEurocurrencyrate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate in excess of Eurocurrency rate", "label": "Rate in excess of Eurocurrency rate", "terseLabel": "Rate in excess of Eurocurrency rate" } } }, "localname": "RateinexcessofEurocurrencyrate", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_RatioofIndebtednesstoNetCapitalContingencyProvision": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of Indebtedness to Net Capital, Contingency Provision", "label": "Ratio of Indebtedness to Net Capital, Contingency Provision", "terseLabel": "Contingency provision on the ratio of indebtedness to net capital" } } }, "localname": "RatioofIndebtednesstoNetCapitalContingencyProvision", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_SalesAndProductAllowancesCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales And Product Allowances, Current", "label": "Sales And Product Allowances, Current", "terseLabel": "Sales and product allowances" } } }, "localname": "SalesAndProductAllowancesCurrent", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SalesAndProductAllowancesNoncurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales And Product Allowances, Noncurrent", "label": "Sales And Product Allowances, Noncurrent", "terseLabel": "Sales and product allowances" } } }, "localname": "SalesAndProductAllowancesNoncurrent", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SeniorUnsecuredRevolvingCreditFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Revolving Credit Facility", "label": "Senior Unsecured Revolving Credit Facility", "terseLabel": "Senior unsecured revolving credit facility" } } }, "localname": "SeniorUnsecuredRevolvingCreditFacility", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SpecialtyProductsandTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty Products and Technologies", "label": "Specialty Products and Technologies [Member]", "terseLabel": "Specialty Products & Technologies" } } }, "localname": "SpecialtyProductsandTechnologiesMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "nvst_TotalBorrowingsunderTermLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total Borrowings under Term Loan", "label": "Total Borrowings under Term Loan", "terseLabel": "Total borrowings under term loan" } } }, "localname": "TotalBorrowingsunderTermLoan", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_USTermLoanDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Term Loan Due 2024", "label": "US Term Loan Due 2024 [Member]", "verboseLabel": "US term loan due 2024" } } }, "localname": "USTermLoanDue2024Member", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_WesternEuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Western Europe [Member]", "label": "Western Europe [Member]", "terseLabel": "Western Europe" } } }, "localname": "WesternEuropeMember", "nsuri": "http://www.envistaco.com/20220401", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r157", "r203", "r216", "r217", "r218", "r219", "r221", "r223", "r227", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r327", "r329", "r331", "r332" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r157", "r203", "r216", "r217", "r218", "r219", "r221", "r223", "r227", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r327", "r329", "r331", "r332" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r2", "r161", "r169", "r247", "r431", "r432", "r433", "r447", "r448", "r503", "r508", "r509", "r664" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Adjusted balance" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r161", "r169", "r175", "r247", "r431", "r432", "r433", "r447", "r448", "r503", "r506", "r508", "r509", "r664" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r161", "r169", "r175", "r247", "r431", "r432", "r433", "r447", "r448", "r503", "r506", "r508", "r509", "r664" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r161", "r169", "r175", "r247", "r431", "r432", "r433", "r447", "r448", "r503", "r506", "r508", "r509", "r664" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r234", "r396", "r402", "r623" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r338", "r375", "r421", "r423", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r620", "r624", "r653", "r654" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r338", "r375", "r421", "r423", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r620", "r624", "r653", "r654" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r234", "r396", "r402", "r623" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r230", "r396", "r400", "r574", "r619", "r621" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r230", "r396", "r400", "r574", "r619", "r621" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r338", "r375", "r411", "r421", "r423", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r620", "r624", "r653", "r654" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r338", "r375", "r411", "r421", "r423", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r620", "r624", "r653", "r654" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r231", "r232", "r396", "r401", "r622", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r231", "r232", "r396", "r401", "r622", "r639", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r162", "r163", "r164", "r165", "r240", "r241", "r244", "r245", "r246", "r247", "r248", "r249", "r318", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r447", "r448", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r555", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r662", "r663", "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r40", "r68" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Allowance for Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CreditLossesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r34", "r52", "r236", "r237" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, less allowance for credit losses of $20.3 and $20.7, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r47", "r582", "r602" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Taxes, income and other" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r49", "r582", "r602" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Taxes, income and other" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r93", "r99", "r107", "r108", "r109", "r471" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Unrealized Pension Costs" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r66", "r280" ], "calculation": { "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r99", "r107", "r108", "r109", "r110", "r470" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Unrealized Gain (Loss) on Cash Flow Hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r55", "r96", "r98", "r99", "r605", "r632", "r636" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r107", "r108", "r534", "r535", "r536", "r537", "r538", "r540" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r95", "r99", "r107", "r108", "r109", "r158", "r159", "r160", "r471", "r627", "r628", "r666" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r92", "r99", "r107", "r108", "r109", "r471", "r535", "r536", "r537", "r538", "r540" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r53", "r434", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r158", "r159", "r160", "r431", "r432", "r433", "r508" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Noncash items:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r424", "r425", "r435", "r436" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Common stock-based award activity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r198", "r216", "r217", "r218", "r219", "r221" ], "lang": { "en-us": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "Other" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r238", "r250", "r252", "r256" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "auth_ref": [ "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "negatedTerseLabel": "Recoveries" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r254" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-offs charged against the allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r125", "r147", "r358", "r543" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r119", "r147", "r358", "r545" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r147", "r358", "r371", "r372", "r545" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of diluted (loss) income per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r154", "r211", "r218", "r225", "r243", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r328", "r330", "r332", "r333", "r468", "r473", "r524", "r557", "r559", "r580", "r601" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Identifiable assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r35", "r36", "r86", "r154", "r243", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r328", "r330", "r332", "r333", "r468", "r473", "r524", "r557", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Held for Sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r277", "r283" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Assets held for sale", "totalLabel": "Current assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r484", "r487" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r420", "r422" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r420", "r422", "r458", "r459" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r460", "r461", "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of capital expenditure attributable to discontinued operations.", "label": "Capital Expenditure, Discontinued Operations", "terseLabel": "Capital expenditures" } } }, "localname": "CapitalExpenditureDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r520", "r521" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r32", "r64", "r149" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r142", "r149", "r151" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Ending balance of cash and cash equivalents", "periodStartLabel": "Beginning balance of cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r142", "r533" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r79", "r306", "r587", "r610" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": { "auth_ref": [ "r305", "r307", "r316" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments, contingencies, and guarantees.", "label": "Commitments Contingencies and Guarantees [Text Block]", "terseLabel": "Litigation And Contingencies" } } }, "localname": "CommitmentsContingenciesAndGuaranteesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r158", "r159", "r508" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in USD per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r51", "r376" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r51", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock - $0.01 par value, 500.0 million shares authorized;163.2 million shares issued and 162.6 million shares outstanding at April 1, 2022; 162.0 million shares issued and 161.6 million outstanding at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r103", "r105", "r106", "r116", "r593", "r615" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r115", "r128", "r592", "r614" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r196", "r197", "r234", "r522", "r523", "r640" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r196", "r197", "r234", "r522", "r523", "r637", "r640" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r196", "r197", "r234", "r522", "r523", "r637", "r640" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r196", "r197", "r234", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r196", "r197", "r234", "r522", "r523", "r640" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r383", "r384", "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r383", "r384", "r397" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r383", "r384", "r397" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r398" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt, Fair Value Disclosures", "verboseLabel": "Convertible senior notes due 2025" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r334", "r335", "r336", "r338", "r348", "r349", "r350", "r354", "r355", "r356", "r357", "r358", "r369", "r370", "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Components of Note Interest Expense" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r216", "r217", "r218", "r219", "r221", "r227", "r229" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r122", "r574" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CreditLossFinancialInstrumentTextBlock": { "auth_ref": [ "r251", "r258", "r259", "r260", "r261", "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security.", "label": "Credit Loss, Financial Instrument [Text Block]", "terseLabel": "Credit Losses" } } }, "localname": "CreditLossFinancialInstrumentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CreditLosses" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Cross-currency swap derivative contracts", "verboseLabel": "Cross-currency swap derivative contracts" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r195", "r234" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r70" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "negatedLabel": "Less: current portion" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r152", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r352", "r359", "r360", "r362", "r373" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt And Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r46", "r47", "r48", "r153", "r157", "r335", "r336", "r337", "r338", "r339", "r340", "r342", "r348", "r349", "r350", "r351", "r353", "r354", "r355", "r356", "r357", "r358", "r369", "r370", "r371", "r372", "r547", "r581", "r583", "r600" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Margin spread of variable interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r337", "r365" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in USD per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r75", "r337", "r377", "r378", "r380" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Convertible debt, conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": { "auth_ref": [ "r366" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.", "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal", "terseLabel": "If-converted value in excess of principal" } } }, "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective.", "label": "Debt Instrument, Convertible, Stock Price Trigger", "terseLabel": "Convertible debt, stock price trigger (in USD per share)" } } }, "localname": "DebtInstrumentConvertibleStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Convertible debt, consecutive trading days (in trading days)" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Convertible debt, trading days (in trading days)" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r335", "r369", "r370", "r544", "r547", "r548" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Term loan" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r74", "r355", "r544" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Loan facility interest rates" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r74", "r367", "r544", "r547" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r74", "r336" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r76", "r153", "r157", "r335", "r336", "r337", "r338", "r339", "r340", "r342", "r348", "r349", "r350", "r351", "r353", "r354", "r355", "r356", "r357", "r358", "r369", "r370", "r371", "r372", "r547" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r76", "r153", "r157", "r335", "r336", "r337", "r338", "r339", "r340", "r342", "r348", "r349", "r350", "r351", "r353", "r354", "r355", "r356", "r357", "r358", "r361", "r369", "r370", "r371", "r372", "r377", "r379", "r380", "r381", "r543", "r544", "r547", "r548", "r599" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r348", "r543", "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r348", "r363", "r369", "r370", "r545" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Unamortized debt issuance costs and discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r348", "r543", "r544", "r545", "r546", "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "terseLabel": "Unamortized discount (premium), net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Noncurrent deferred compensation liability" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r545" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r67", "r348", "r545" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Debt issuance and deferred financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r438", "r439" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Net deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r147", "r278" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": { "auth_ref": [ "r22", "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.", "label": "Depreciation and Amortization, Discontinued Operations", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortizationDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r88", "r89", "r90", "r519" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r90", "r485", "r486", "r490", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r499", "r511" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Hedging Transactions and Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r482", "r485", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r482", "r485", "r490", "r493", "r494", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r88", "r89", "r90", "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r88" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r88" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r478", "r480" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "verboseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r477", "r479", "r480", "r482", "r483", "r488", "r490", "r495", "r496", "r498", "r499" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r396", "r400", "r401", "r402", "r403", "r404", "r405", "r406" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue by Geographical Region and Type" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "auth_ref": [ "r8", "r10", "r12", "r26" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax", "terseLabel": "Gain (loss) on disposal", "verboseLabel": "Gain on sale of discontinued operations, net of tax" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "auth_ref": [ "r8", "r9", "r26" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "totalLabel": "(Loss) income from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Earnings from discontinued operations - basic (in USD per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Earnings from discontinued operations - diluted (in USD per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r9", "r10", "r11", "r12", "r20", "r26", "r440", "r450", "r453" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "terseLabel": "Income tax (benefit) expense" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]", "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale [Member]", "terseLabel": "Discontinued Operations, Disposed of by Sale" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r21", "r29" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "auth_ref": [ "r21" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "auth_ref": [ "r21", "r29" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "totalLabel": "Gross profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "auth_ref": [ "r21" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "totalLabel": "Operating (loss) profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r21", "r29" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r30", "r287" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r420", "r422" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueToEmployeesNoncurrent": { "auth_ref": [ "r77", "r556" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to Employee, not to include stockholders or officers, which are due after one year (or one business cycle).", "label": "Due to Employees, Noncurrent", "terseLabel": "Compensation and benefits" } } }, "localname": "DueToEmployeesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r117", "r167", "r168", "r169", "r170", "r171", "r176", "r178", "r185", "r186", "r187", "r191", "r192", "r509", "r510", "r594", "r616" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "totalLabel": "Earnings - basic (in USD per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r117", "r167", "r168", "r169", "r170", "r171", "r178", "r185", "r186", "r187", "r191", "r192", "r509", "r510", "r594", "r616" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "totalLabel": "Earnings - diluted (in USD per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r188", "r189", "r190", "r193" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r533" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r71" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance and Related" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r107", "r108", "r109", "r158", "r159", "r160", "r163", "r172", "r174", "r194", "r247", "r376", "r382", "r431", "r432", "r433", "r447", "r448", "r508", "r534", "r535", "r536", "r537", "r538", "r540", "r627", "r628", "r629", "r666" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r350", "r369", "r370", "r519" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair\u00a0Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FacilityClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Facility Closing [Member]", "terseLabel": "Facility Exit and Related" } } }, "localname": "FacilityClosingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r512", "r513", "r514", "r516" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]", "verboseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r350", "r369", "r370", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r513", "r563", "r564", "r565" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r350", "r369", "r370", "r512", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r350", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r350", "r412", "r413", "r418", "r419", "r513", "r563" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "verboseLabel": "Quoted\u00a0Prices\u00a0in Active Market (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r350", "r369", "r370", "r412", "r413", "r418", "r419", "r513", "r564" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant\u00a0Other Observable\u00a0Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r350", "r369", "r370", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r513", "r565" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r350", "r369", "r370", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r563", "r564", "r565" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r484", "r488", "r497" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation": { "auth_ref": [ "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation", "negatedLabel": "Foreign currency translation" } } }, "localname": "FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r90", "r412", "r492" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r147", "r472" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "negatedTerseLabel": "Gain on sale of Kavo treatment unit and instrument business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r268", "r269", "r559", "r579" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r270" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r120", "r154", "r211", "r217", "r221", "r224", "r227", "r243", "r319", "r320", "r321", "r324", "r325", "r326", "r328", "r330", "r332", "r333", "r524" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r147", "r276" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-lived", "terseLabel": "Impairment charges" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r121", "r148", "r167", "r168", "r169", "r170", "r184", "r187", "r466" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income from continuing operations, net of tax", "totalLabel": "Income from continuing operations, net of tax" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r113", "r211", "r217", "r221", "r224", "r227", "r578", "r589", "r596", "r617" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r111", "r117", "r162", "r167", "r168", "r169", "r170", "r178", "r185", "r186", "r510", "r588", "r590", "r594", "r611" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Earnings from continuing operations - basic (in USD per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r111", "r117", "r162", "r167", "r168", "r169", "r170", "r178", "r185", "r186", "r187", "r510", "r594", "r611", "r614", "r616" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Earnings from continuing operations - diluted (in USD per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r8", "r9", "r10", "r11", "r12", "r26", "r29", "r454", "r612" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net income from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r8", "r9", "r10", "r11", "r12", "r20", "r26", "r467" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income from discontinued operations, net of tax (refer to Note 2)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r420", "r422" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r6", "r14", "r15", "r16", "r17", "r18", "r19", "r24", "r27", "r28", "r29", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r282", "r292" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r155", "r442", "r443", "r444", "r449", "r451", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r156", "r173", "r174", "r209", "r440", "r450", "r452", "r618" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r144", "r150" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r146" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Change in trade accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r146" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Change in trade accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1": { "auth_ref": [ "r485", "r489" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) related to the fair value of interest rate derivatives designated as fair value hedging instruments, as offset by the gain (loss) on the hedged item to the extent that the fair value hedge is determined to be effective.", "label": "Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments", "terseLabel": "Gain Recognized in OCI" } } }, "localname": "IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r146" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Change in inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r146" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Change in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r146" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Change in prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r182", "r183", "r187" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Assumed conversion of the Notes (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r179", "r180", "r181", "r187" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r274", "r275" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r112", "r205", "r542", "r545", "r595" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r125", "r356", "r368", "r371", "r372" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "totalLabel": "Total interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r127", "r357", "r371", "r372" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r140", "r143", "r150" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r90", "r412", "r491" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest rate contracts" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap derivative contracts", "verboseLabel": "Interest rate swap derivative contracts" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r82" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r33", "r85", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r84" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r85", "r266" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedTerseLabel": "Reserve for inventory obsolescence" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r83" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r265" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Restructuring charges" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and improvements" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r58", "r154", "r243", "r524", "r559", "r585", "r608" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r73", "r154", "r243", "r319", "r320", "r321", "r324", "r325", "r326", "r328", "r330", "r332", "r333", "r469", "r473", "r474", "r524", "r557", "r558", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r283" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Liability for proceeds related to the Relevant Jurisdictions" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r5", "r6", "r23", "r25", "r29", "r277", "r283" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Liabilities held for sale", "totalLabel": "Current liabilities held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liability [Member]", "terseLabel": "Liability" } } }, "localname": "LiabilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r48", "r583", "r600" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Line of credit facility, outstanding borrowings" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Facility fee" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Revolving credit facility maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r48", "r349", "r364", "r369", "r370", "r583", "r604" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Long-term Debt", "totalLabel": "Total debt", "verboseLabel": "Total debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term debt", "verboseLabel": "Fair value of notes" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r76" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r76", "r317" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r306" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Accrual for legal matters" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r306" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Loss contingencies" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": { "auth_ref": [ "r306" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Noncurrent", "terseLabel": "Loss contingencies" } } }, "localname": "LossContingencyAccrualCarryingValueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery, equipment and other assets" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Held for sale" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r81", "r154", "r243", "r319", "r324", "r325", "r326", "r332", "r333", "r524", "r584", "r607" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Change in noncontrolling interest" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r142" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r142" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r142", "r145", "r148" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r29", "r101", "r104", "r109", "r114", "r148", "r154", "r162", "r167", "r168", "r169", "r170", "r173", "r174", "r184", "r211", "r217", "r221", "r224", "r227", "r243", "r319", "r320", "r321", "r324", "r325", "r326", "r328", "r330", "r332", "r333", "r510", "r524", "r591", "r613" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r161", "r162", "r163", "r164", "r165", "r166", "r169", "r175", "r191", "r240", "r241", "r244", "r245", "r246", "r247", "r248", "r249", "r318", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r445", "r446", "r447", "r448", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r555", "r575", "r576", "r577", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r662", "r663", "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Standards Recently Adopted and Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r158", "r159", "r160", "r382", "r464" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Nonoperating income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of business segments (in segments)", "verboseLabel": "Number of operating segments (in segments)" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments (in segments)" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r211", "r217", "r221", "r224", "r227" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r550" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r550" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r551", "r552" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedLabel": "Change in operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r549" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r147" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r216", "r217", "r218", "r219", "r221", "r227" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r31", "r476" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Business and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r39", "r40", "r41", "r71" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r78" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAmortizationOfDeferredCharges": { "auth_ref": [ "r123", "r147" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization of other deferred costs recognized in the income statement.", "label": "Amortization of Other Deferred Charges", "terseLabel": "Amortization" } } }, "localname": "OtherAmortizationOfDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r67" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r99", "r107", "r108", "r534", "r536", "r540" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Increase (decrease) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r99", "r107", "r108", "r110", "r534", "r536", "r540" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Other comprehensive (loss) income before reclassifications, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r97", "r107" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedLabel": "Income tax impact" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "verboseLabel": "Cash flow hedge adjustments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r91" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r102", "r105", "r107", "r108", "r110", "r115", "r376", "r534", "r539", "r540", "r592", "r614" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive loss, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive (loss) income, net of income taxes:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r94", "r96" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension plan adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDebtSecuritiesMember": { "auth_ref": [ "r242", "r262", "r412", "r515" ], "lang": { "en-us": { "role": { "documentation": "Investments in debt securities classified as other.", "label": "Other Debt Obligations [Member]", "terseLabel": "Other" } } }, "localname": "OtherDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r38", "r39", "r71", "r559" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Accrued expenses and other liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current [Abstract]", "terseLabel": "Current" } } }, "localname": "OtherLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses And Other Liabilities" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r78" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent [Abstract]", "terseLabel": "Noncurrent" } } }, "localname": "OtherLiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Other Liabilities [Table Text Block]", "terseLabel": "The Components of Accrued Expenses and Other Liabilities" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other long-term assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r126" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Envista Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r130", "r132" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "All other investing activities, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r141", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Paid/settled" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r138" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance and other deferred financing costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtRestructuringCosts": { "auth_ref": [ "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.", "label": "Payments of Debt Restructuring Costs", "terseLabel": "Payments of debt restructuring costs" } } }, "localname": "PaymentsOfDebtRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r136" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Tax withholding payment related to net settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r131" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Payments for additions to property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "auth_ref": [ "r47", "r408", "r409", "r410" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current", "terseLabel": "Pension benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r49", "r408", "r409", "r410" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "terseLabel": "Pension benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r50", "r374" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in USD per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r50", "r374" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r50", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at April 1, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r35", "r62", "r63" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r134" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible senior notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from sale of Kavo treatment unit and instrument business" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r135", "r139" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "All other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r134" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within three months.", "label": "Proceeds from Short-term Debt, Maturing in Three Months or Less", "terseLabel": "Proceeds from borrowings" } } }, "localname": "ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r133", "r426" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock option exercises" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r312", "r313", "r586" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accruals for warranties issued during the year" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Disclosure [Text Block]", "terseLabel": "Warranty" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/Warranty" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r66", "r281" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r287", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant And Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r65", "r279" ], "calculation": { "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Gross property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r43", "r44", "r281", "r559", "r597", "r609" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r43", "r281" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r43", "r279" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r118", "r253" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Allowance for credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RatioOfIndebtednessToNetCapital1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indebtedness divided by net capital.", "label": "Ratio of Indebtedness to Net Capital", "terseLabel": "Leverage ratio" } } }, "localname": "RatioOfIndebtednessToNetCapital1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r99", "r107", "r108", "r534", "r538", "r540" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Increase" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r99", "r107", "r108", "r110", "r534", "r538", "r540" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amounts reclassified from accumulated other comprehensive loss, net of income taxes" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r97", "r100", "r107" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Income tax impact" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r137" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment within three months.", "label": "Repayments of Short-term Debt, Maturing in Three Months or Less", "negatedTerseLabel": "Repayment of borrowings" } } }, "localname": "RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r437", "r573", "r655" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r289", "r291", "r294", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Activities And Related Impairments" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r147", "r288", "r297", "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Costs incurred" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r290", "r291", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "auth_ref": [ "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs and Asset Impairment Charges", "terseLabel": "Costs incurred" } } }, "localname": "RestructuringCostsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r291", "r298" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of year" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r47", "r291", "r301" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring-related employee severance, benefits and other" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveNoncurrent": { "auth_ref": [ "r87", "r291", "r301" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Noncurrent", "terseLabel": "Restructuring-related employee severance, benefits and other" } } }, "localname": "RestructuringReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r54", "r382", "r434", "r559", "r606", "r631", "r636" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r158", "r159", "r160", "r163", "r172", "r174", "r247", "r431", "r432", "r433", "r447", "r448", "r508", "r627", "r629" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r202", "r203", "r216", "r222", "r223", "r230", "r231", "r234", "r395", "r396", "r574" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r385", "r386", "r387", "r388", "r389", "r390", "r393", "r394", "r399", "r407" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Expected timing of satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r553", "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for operating lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r196", "r234" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r99", "r539", "r540" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r76", "r157", "r369", "r371", "r377", "r379", "r380", "r381", "r543", "r544", "r548", "r599" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Components Of Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r485", "r490", "r494" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Derivative Instruments, Gain (Loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r6", "r14", "r15", "r16", "r17", "r18", "r19", "r24", "r27", "r28", "r29", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of Discontinued Operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r512", "r513" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Financial Assets And Liabilities At Carrying and Fair Value" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Rollforward and Carrying Value Of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r42", "r59", "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Warranty Accrual" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/WarrantyTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r66", "r281" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r290", "r291", "r292", "r293", "r300", "r301", "r302" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r295", "r296", "r299" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r291", "r301" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r211", "r214", "r220", "r271" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r211", "r214", "r220", "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment Results" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r198", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r216", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r227", "r234", "r293", "r302", "r619" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r198", "r200", "r201", "r211", "r215", "r221", "r225", "r226", "r227", "r228", "r230", "r233", "r234", "r235" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r124" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r146" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r45", "r559", "r581", "r603" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "verboseLabel": "Short-term debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r311" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.", "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "negatedLabel": "Effect of foreign currency translation" } } }, "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r308", "r315", "r463", "r638" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby letters of credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r13", "r198", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r216", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r227", "r234", "r271", "r284", "r293", "r302", "r619" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/GoodwillRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r80", "r107", "r108", "r109", "r158", "r159", "r160", "r163", "r172", "r174", "r194", "r247", "r376", "r382", "r431", "r432", "r433", "r447", "r448", "r508", "r534", "r535", "r536", "r537", "r538", "r540", "r627", "r628", "r629", "r666" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r158", "r159", "r160", "r194", "r574" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-based Payment Arrangement [Member]", "terseLabel": "Stock-based awards" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r51", "r56", "r57", "r154", "r239", "r243", "r524", "r559" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Envista stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r2", "r3", "r108", "r154", "r158", "r159", "r160", "r163", "r172", "r243", "r247", "r382", "r431", "r432", "r433", "r447", "r448", "r464", "r465", "r475", "r508", "r524", "r534", "r535", "r540", "r628", "r629", "r666" ], "calculation": { "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period", "terseLabel": "Stockholders' equity", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.envistaco.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r541", "r561" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r541", "r561" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r541", "r561" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r541", "r561" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r560", "r562" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental data:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r290", "r291", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r177", "r187" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Average common stock and common equivalent shares outstanding:", "verboseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r176", "r187" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average common shares outstanding used in basic earnings per share (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.envistaco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r235": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919269-210447" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919236-210447" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r267": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r307": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r31": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250" }, "r316": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "http://asc.fasb.org/topic&trid=2155896" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r373": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r407": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r457": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r476": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r511": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r562": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r656": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r657": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r658": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r659": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r661": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" } }, "version": "2.1" } ZIP 98 0001757073-22-000061-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001757073-22-000061-xbrl.zip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